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ABSTRACT OF DISSERTATION

INFLUENCES OF CHROMIUM (III) PICOLINATE ON PIGS UNDER
THERMAL, IMMUNE OR DIETARY STRESS, AND
ON ADRENAL STEROID SECRETION
The objectives were to investigate the effects of chromium (III) picolinate (CrPic;
up to 2,000 ppb of Cr) on growing pigs subjected to a variety of stressors including
thermal, immune, or dietary stress and to examine the effects of CrPic on steroidogenesis
from adrenocortical cells. In the thermal stress study, high ambient temperature caused
reduced weight gain and feed consumption (P < 0.01), and low ambient temperature
caused increased feed intake and feed:gain (P < 0.01). However, these effects were not
moderated by CrPic, and respiratory rate, plasma cortisol, or plasma glucose were
unaffected by CrPic. In the immune stress study, pigs challenged with lipopolysaccharide
(LPS) lost 951 g during 12 hours post injection, while the phosphate buffer saline (PBS)
injected group gained 170 g (P < 0.001). The LPS group showed higher rectal
temperature (P < 0.05), higher respiratory rate (P < 0.05), greater plasma cortisol (P <
0.001), and lower plasma glucose (P < 0.05) than the PBS group. These effects were not
ameliorated by CrPic. In the dietary stress study, pigs fed the high-fat diet (HFD) gained
weight faster (P < 0.05), consumed less feed (P < 0.001), and had lower feed:gain (P <
0.001). Plasma insulin concentration on d 14 decreased with CrPic (P < 0.05) in a linear
manner (P = 0.05). Consumption of the HFD resulted in increases of slaughter weight,
perirenal fat, and back fat measurements (P < 0.01). The CrPic resulted in linear
reductions of carcass weight, last rib fat, last lumbar fat and average backfat (P < 0.10).
The effects of CrPic on carcass fat measurements were more significant in barrows than
gilts. In the adrenocortical cell study, forskolin stimulated cortisol and DHEAs secretion
from H295R cells. CrPic inhibited aspects of steroidogenesis in agonist-stimulated
adrenocortical cells. Overall, dietary CrPic was unable to moderate the stress related
effects due to high ambient temperature, low ambient temperature, or an endotoxin
challenge. However, CrPic attenuated effects of HFD, mainly on body fat accretion of
pigs, especially in barrows, and CrPic inhibited steroidogenesis in stimulated
adrenocorticoid cells.
KEYWORDS: Chromium (III) Picolinate, Thermal Stress, Immune Stress, High-FatDiets, Adrenal Steroids
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논문 초록

크롬 피콜리네이트가 온도, 면역, 혹은 영양 스트레스하의 돼지
및 부신 스테로이드 호르몬의 분비에 미치는 영향
일련의 실험을 통해 사료내 크롬 피콜리네이트가 온도, 면역, 혹은 영양
스트레스하의 돼지 및 부신 스테로이드 호르몬의 분비에 미치는 영향이 연구 되었다. 온도
스트레스 실험 (제 3 장)의 경우 높은 환경온도에서 증체 및 사료 섭취량이 낮았고 (P <
0.01), 낮은 환경온도에서는 사료 섭취량 및 사료요구율 (섭취:증체)가 높았다 (P < 0.01).
하지만 이러한 환경온도의 영향은 사료내 크롬 피콜리네이트에 의해 완화되지 않았으며,
호흡률 및 혈청 조사항목들도 크롬 피콜리네이트에 의해 달라지지 않았다. 면역 스트레스
연구 (제 4 장)에서는 리포다당류 (lipopolysaccharide, LPS)를 주사한 돼지들 (26.0 kg)은
12 시간 동안 951 g 체중이 낮아진 반면 인산완충식염수 (phosphate buffer saline, PBS)를
주사한 돼지들은 170 g 증체하였다 (P < 0.001). 체온 (P < 0.05), 호흡율 (P < 0.05) 및 혈청내
콜티졸 농도 (P < 0.001)는 PBS 처리구에 비해 LPS 처리구에서 높게 나타난 반면 혈청내
포도당의 농도는 PBS 처리구에서 높은 결과를 보였다 (P < 0.05). 이와 같은 LPS 처리에
의한 효과는 사료내 크롬 피콜리네이트에 의해 영향을 받지 않았다. 영양학적 스트레스
연구 (제 5 장) 에서는 고지방 사료를 섭취한 돼지들이 빠른 증체 (P < 0.05), 적은 사료섭취
(P < 0.001) 및 낮은 사료 요구율 (P < 0.001)을 보였다. 혈청내 인슐린의 농도는 실험
14 일째에 사료내 크롬 피콜리네이트의 첨가 수준에 따라 직선적으로 (P = 0.05) 낮아졌다
(P < 0.05). 도축 체중, 신장주위의 지방, 및 등지방 측정치는 고지방 사료 처리구에서 높게
나타났다 (P < 0.01). 도체중, 제 1 늑골 등지방, 최후 요추 등지방, 및 평균 등지방 두께는
사료내 크롬의 첨가 수준에 따라 직선적으로 감소하였다 (P < 0.10). 크롬 피콜리네이트가
도체 지방 측정치에 미치는 이러한 영향은 암퇘지보다는 거세수퇘지에서 더욱 두드러지게
나타났다. 부신피질 세포를 이용한 연구 (제 6 장)에서는 작용제로 이용된 forskolin 에 의해
콜티졸 및 DHEAs 의 분비가 촉진되었다. 크롬 피콜리네이트가 부신피질 세포 배양액에
첨가 되었을 때에는 작용제에 의해 촉진된 스테로이드 호르몬의 합성이 억제되었다. 본
연구에서 사료내 크롬 피콜리네이트의 첨가는 높은 환경온도, 낮은 환경온도, 혹은
내독소에 기인한 스트레스를 완화시키지 못하였다. 하지만 크롬 피콜리네이트는 고지방
사료에 의한 체지방 축적의 증가를 특히 거세수퇘지에서 감소시켰으며, 부신피질에서
촉진된 스테로이드의 합성을 억제시켰다.
주요어: 크롬 피콜리네이트, 온도 스트레스, 면역스트레스, 고지방 사료, 부신 스테로이드

论文 节录

吡啶羧酸铬对温度、免疫、日粮应激下猪的效果及对肾上腺甾类分泌的影响
本项研究通过一系列的试验，探讨了日粮中添加吡啶羧酸铬对处于温度应激
、免疫应激和日粮应激下猪的效果，并研究了吡啶羧酸铬对肾上腺皮质细胞甾类产
生的影响。在温度应激试验中 (第三章)，外界高温导致试验猪体增重和采食量下降
(P < 0.01)，外界低温导致采食量和料重比增加 (P < 0.01)。日粮中添加吡啶羧酸铬
对这些影响无调控作用，对试验猪呼吸频率、血浆检测指标也无显著作用。在免疫
应激试验中 (第四章)，试验猪 (26 公斤) 在注射脂多糖后 12 小时失重 951 克，而注
射磷酸盐缓冲液的试验猪增重 170 克 (P < 0.001)。与注射磷酸盐缓冲液的试验猪相
比，注射脂多糖组试验猪具有较高的直肠温度 (P < 0.05)、呼吸频率 (P < 0.05)、血
浆皮质醇水平 (P < 0.001)，和较低的血糖水平 (P < 0.05)。日粮中添加吡啶羧酸铬
对这些影响无改善效果。在日粮应激试验中 (第五章)，饲喂高脂饲粮的试验猪具有
较高的增重速度 (P < 0.05) ，较少的饲料消耗 (P < 0.001) 和较低的料重比 (P < 0.00
1)。添加吡啶羧酸铬组试验猪第 14 日血浆胰岛素水平显著下降 (P < 0.05)，并与饲
粮吡啶羧酸铬水平呈线性相关 (P = 0.05)。高脂饲粮提高了猪的屠体重、板油重和
背脂厚 (P < 0.01)。日粮中添加吡啶羧酸铬使胴体重、最后肋骨背脂厚、最后腰骨
背脂厚和平均背脂厚线性下降 (P < 0.10)。吡啶羧酸铬对胴体脂肪的影响在阉公猪
上的效果优于小母猪。在肾上腺皮质细胞培养试验中 (第六章), 毛喉素促进了皮质
醇和 DHEAs 从 H295R 细胞中的分泌。吡啶羧酸铬抑制了受激动剂刺激的肾上腺皮
质细胞的甾类产生状况。总而言之，日粮中添加吡啶羧酸铬无法调节来源于外界高
温、外界低温和内毒素应激产生的对猪的影响。然而，吡啶羧酸铬可以改善高脂饲
粮的不良影响，主要是减少胴体脂肪沉积，尤其表现在阉公猪。吡啶羧酸铬能抑制
激动肾上腺皮质的甾类产生。
关键词: 吡啶羧酸铬，温度应激，免疫应激，高脂饲粮，肾上腺甾类
翻译 - 王敏奇 博士 (浙江大学动物科学学院 中国)
Translated by Dr. Minqi Wang, College of Animal Science, Zhejiang University, China

ABSTRACTO DE LA DISERTACIÓN

INFLUENCIAS DEL TRIPICOLINATO DE CROMIO EN CERDOS BAJO ESTRÉS
TÉRMICO, INMUNITARIO O ALIMENTARIO, Y EN LA SECRECIÓN
ADRENAL DE ESTEROIDES
Los objetivos fueron la investigación de los efectos del tripicolinato de cromio
(CrPic; hasta 2.000 ppb de Cr) en cerdos en crecimiento bajo una serie de agents
estresantes de tipo térmico, inmunitario o dietético así como la investigación de sus
efectos en la esteroidogénesis de las células adrenocorticales. En el estudio del esters
térmico (capítulo 3), altas temperatures causaron una reducción en ganacia de peso y en
consume (P < 0.01), y bajas temperaturas ambientales causaron un incremento del
consumo y del índice de conversión (P < 0.01). Sin embargo, estos efectos no fueron
moderados por el CAPIC, y el ritmo respiratorio, el nivel plasmático de cortisol o glucosa
no resultaron afectados por el CAPIC. En el estudio del esters inmunitario (Capítulo 4),
los cerdos retados con lipopolisacárido (LPS) perdieron 951 g durante las 12 horas
siguientes a la inyección, mientras que le grupo inyectado con tampón fosfato-salino
ganó 170 g (P < 0.001). El grupo LPS mostró temperaturas rectales más altas (P < 0.05),
mayor cortisol plasmático (P < 0.001), y mayor nivel de glucosa en plasma (P < 0.05) que
el grupo PBS. La adición de CAPIC no disminuyó esos efectos. En el estudio del estrés
alimentario (Capítulo 5), los cerdos alimentados con la dieta rica en grasa (HFD)
crecieron más rápido (P < 0.05), consumieron menos pienso (P < 0.001), y tuvieron un
menor IT (P < 0.001). La concentración de insulina plasmática en el día 14 disminuyó
mediante la adición de CrPic (P < 0.05) de manera lineal (P = 0.05). El consumo de la
dieta rica en grasa produjo incrementos de peso al matadero, de grasa perineal y de la
medida de grasa dorsal (P < 0.01). La adición de CrPic produjo reducciones lineales de
peso de canal, grasa en la última costilla y en la última lumbar así como de la grasa dorsal
media (P < 0.10). Los efectos del CrPic en las medidas de grasa en la canal no fueron más
significativas en machos que en hembras. En el estudio de las células adrenocorticales
(Capítulo 6), forskolin estimuló las secreciones de cortisol y DHEAs de las células
H295R. El CrPic inhibió aspectos de la esteroidogénesis en las células adrenocorticales
de estimulación agonista. En resumen, el CrPic dietético fue incapaz de moderar los
efectos del estrés causado por altas o bajas temperaturas ambientales o mediante reto
endotóxico. Sin embargo, CrPic atenuó los efectos de una dieta rica en grasas,

principalmente con respecto a la deposición de grasa corporal, sobre todo en machos, y el
CrPic inhibió la esteroidogénesis en células adrenocorticales estimuladas.
PALABRAS CLAVE: Tripicolinato de cromio, estrés térmico, estrés inmunitario, dietas
ricas en grasa, esteroides adrenales
Traducido por Sr. Aitor Balfagon, SCA Iberica, Mequinenza, España
Translated by Mr. Aitor Balfagon, SCA Iberica, Mequinenza, Spain
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CHAPTER 1. Introduction
Since chromium (Cr) was first reported to be an essential component in the
glucose tolerance factor (Schwarz and Mertz, 1959), the functions of Cr have been
widely investigated in humans, animal models, and livestock. Generally Cr has been
shown to potentiate the action of insulin (Mertz et al., 1974; Vincent, 2000) and
accordingly to modulate carbohydrate, protein, and lipid metabolism (Davis and Vincent,
1997; Cefalu et al., 2002; Bernao et al., 2004). In domestic animals, Cr has been
recognized as an essential trace mineral (Anderson, 1987; Offenbacher and Pi-Sunyer,
1988) and suggested to alleviate stress associated effects (Chang and Mowat, 1992;
Anderson, 1994; NRC, 1997).
Khansari et al. (1990) define ‘stress’ as the reaction of the body to stimuli causing
disturbance of the normal physiological status. In swine production systems, stress
sources include cold/hot (relative to thermoneutrality) environmental temperature (Stahly
and Cromwell, 1979), microbial infection (Webel et al., 1997), insufficient floor space
(Brumm and Miller, 1996; Wolter et al., 2000), social mixing (Barnett et al., 1993;
Marchant et al., 1995), and nutritional deficiency or excess (NRC, 1998). These stressors
may cause growth retardation, changes in hormone secretion, increased disease
susceptibility, and/or behavioral changes.
Dietary supplementation of Cr has alleviated the detrimental effects of thermal
stress in poultry (Sahin et al., 2001; Onderci et al., 2003), and transport stress in calves
(Chang and Mowat, 1992; Moonsier-Shageer and Mowat, 1993). Lindemann and Purser
(1997) have suggested that dietary Cr may be more effective in a fatter-type animal. In a
recent study, supplemental Cr has lowered body weight gain, body fat gain, and visceral
fat gain in obese mice fed fat-enriched diet (Bhattacharya et al., 2006).
However, studies on dietary Cr for pigs kept in stressful thermal environments or
for pigs fed high levels of dietary fat have been rare. The effects of dietary Cr on immune
responses in animals have been inconclusive in pigs (van Heugten and Spears, 1997; Lee
et al., 2000; van de Ligt et al., 2002c). In addition, direct effects of Cr on adrenocortical
steroidogenesis have not been reported.
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Therefore, the objective of the present research was to determine the effects of Cr
supplementation on pigs in thermoneutral or thermal stress environment (Chapter 3), pigs
challenged with an immune stressor (Chapter 4), and pigs fed high-fat diets (Chapter 5).
Additionally, effects of Cr on adrenocortical steroids secretion from H295R
adrenocortical cells are studied (Chapter 6).
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CHAPTER 2. Literature Review
2.1. Stressors in swine production
Stress can be defined as the reaction of the body to stimuli causing disturbance of
the normal physiological equilibrium (Khansari et al., 1990). Stressors often result in
detrimental effects. In the swine industry, various stress sources interfere with animal
health and limit the maximum production rate. The stressors existing in swine production
systems would include cold/hot environmental temperature (Stahly and Cromwell, 1979),
microbial infection (Webel et al., 1997), insufficient space allowance (Brumm and Miller,
1996; Wolter et al., 2000), social mixing (Marchant et al., 1995; Barnett et al., 2001), and
nutritional deficiency or imbalance (NRC, 1998). These stressors cause growth
retardation, changes in hormone release, increased disease susceptibility, and/or
behavioral changes.
2.1.1. Thermal stress
The thermal environment is important in pig production, because the ambient
temperature can directly affect the animal’s energy expenditure, feed intake, weight gain,
and feed efficiency. Moreover, severe cold or hot temperatures may cause the death of
pigs. Thus, the effects of environmental temperature in combination with nutritional and
environmental factors on pig performance have been of great interest to many researchers
(Stahly and Cromwell, 1979; Schenck et al., 1992ab; Quiniou et al., 2000; Frank et al.,
2003).

Thermoneutral zone
Ambient temperature affects heat production, heat loss and body temperature.
Figure 2.1 demonstrates the relation between heat production (heat loss) and body
temperature as affected by ambient temperature. The thermoneutral zone (alternately
called the zone of thermal neutrality) was defined as “the range of ambient temperature
over which, at a fixed level of food intake, heat production is minimal and constant” by
Mount (1974). The highest and the lowest temperatures of the thermoneutral zone are
called lower critical temperature (LCT) and the upper critical temperature (UCT),
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respectively. Body temperature is constant even below the LCT. However, as the ambient
temperature decreases below the LCT, total heat production linearly increases. Total heat
production is partitioned into sensible and evaporative heat loss. When ambient
temperature is below LCT, sensible heat loss increases with total heat production,
whereas evaporative heat loss is constant. In the relatively higher temperature of the
thermoneutral zone, evaporative heat loss increases as the ambient temperature increases.
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Figure 2.1. The relationship between heat production (heat loss) and body temperature as
affected by ambient temperature (Mount, 1968). LCT and UCT represent lower critical
temperature and upper critical temperature, respectively.
The thermoneutral zone depends on various factors including animal body weight,
physiological state, air flow speed, humidity, and floor type (Holmes and Close, 1977).
The LCT is lowered by increasing the number of animals per pen, by using bedding, and
by reducing air flow rate (NRC, 1998).
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Low ambient temperature
Pigs in low ambient temperature below the LCT generally show increased feed
intake and a diminished feed efficiency. Stahly and Cromwell (1979) reported that
growing pigs (28 to 60 kg BW) in low ambient temperature (10°C) consumed 15% more
feed and had 19% higher feed:gain compared with pigs in a thermoneutral environment.
A similar response was shown in weanling pigs (8.6 to 10.2 kg BW) by Frank et al.
(2003). The increased feed consumption is used to compensate for the elevated
maintenance needs for metabolic activity (Holmes and Close, 1977). Thus, BW gain of
the animal may not be influenced by the cold stress depending on the degree of stress and
the degree of increase in feed intake. However, Le Dividich (1981) reported that piglets
housed in a 20°C environment after weaning (below LCT) gained less weight than pigs in
environments where the temperature decreased from 32, 28 or 24 to 20°C weekly.
Moreover, in an extremely low ambient temperature, animals may lose BW and even die.
This ‘extreme’ case will be below the threshold for hypothermia (Figure 2.1).
Most experiments in the literature used temperatures above the threshold for
hypothermia and below the LCT for low ambient temperature treatments. Representative
data of pig growth performance in cold stress situations are summarized (Table 2.1). Pigs
in cold environments consumed more feed and showed higher feed:gain ratio with no
major change in growth compared with the pigs in the thermoneutral environment.
Stressors are generally known to activate the hypothalamic-pituitary-adrenal
(HPA) axis by stimulating hypothalamus to release corticotrophin-releasing hormone
(CRH). The CRH stimulates the release of adrenocorticotropic hormone (ACTH),
resulting in elevated glucocorticoid secretion from the adrenal cortex. Detailed
mechanism of adrenal steroid secretion is discussed in a later section (2.5. Adrenal
steroid hormone physiology).
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Table 2.1. Growth performance changes in low ambient temperature
Temp, Initial Final
°C BW, kg BW, kg

Growth performance
ADG, g ADFI, g Feed:gain

23

27.5

60.8

794

1,895

2.39

10

27.5

59.9

772

2,165

2.83

20

24.3

55.2

735

1,735

2.36

10

24.3

54.6

721

2,000

2.79

23

25.3

55.4

717

1,857

2.61

10

25.3

55.1

710

2,080

2.97

26.7

8.5

10.1

402

477

1.22

15.6

8.6

10.2

415

606

1.49

Changes in low ambient
temperature, %
Reference
ADG

ADFI Feed:gain

-2.8

14.2

18.7

1

-1.9

15.3

18.0

1

-0.9

12.0

13.5

2

3.1

27.0

22.5

3

1

Stahly and Cromwell (1979). Initial BW for each temperature treatment were assumed to be the
same. Final BW was calculated as: Final BW = Initial BW + ADG × 42 d. Values are means of
three dietary treatments of high protein, low protein, and low protein + Lys.
2
Stahly et al. (1979). Initial BW for each temperature treatment were assumed to be the same.
Final BW was calculated as: Final BW = Initial BW + ADG × 42 d. Values are means of three
dietary treatments of 0 and 5% of fat.
3
Frank et al. (2003). Values are means of six dietary treatments (with or without spray dried
plasma).

Stressors resulting in elevated blood cortisol concentration in pigs include
shipping stress (Nyberg et al., 1988; McGlone et al., 1993), social mixing (Seguin et al.,
2006), and immune stress (Webel et al., 1997; Balaji et al., 2000). Frank et al. (2003)
reported that cold stress also increased circulating cortisol concentration in pigs. Pigs of
8.6 kg BW in cold environment (15.6°C) showed higher (P<0.001) serum ACTH (85.1 vs.
61.3 pg/mL) and cortisol (39.1 vs. 24.1 ng/mL) than those in thermoneutral environment
(26.7°C). Similarly, Hicks et al. (1998) reported that cortisol concentration was
numerically higher (53.2 vs. 43.2 ng/mL) in cold stressed pigs (9.0 kg BW) versus
unstressed pigs. Frank et al. (2003) induced cold stress for 4 d by changing ambient
temperature, but Hicks et al. (1998) sprayed water on the animals for 30 minutes every 4
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h with 1.5 m/s of air flow rate with a constant environmental temperature of 24.5°C. It
may be that the treatment in Hicks et al. (1998) did not induce enough cold stress as the
feed consumption was not increased, although the behavioral responses of cold stress
were observed.

High ambient temperature
In contrast to pigs in a low ambient temperature, those in high ambient
temperature typically consume less feed in efforts to reduce body heat production from
digestive and metabolic processes. Stahly and Cromwell (1979) reported that growing
pigs (28 to 57 kg BW) in the high ambient temperature (35°C) consumed 18% less feed
and gained 25% less BW compared with pigs in a thermoneutral environment. Similar
results of decreased feed intake and growth by heat stress have been shown in other
studies (Stahly et al., 1979; Schenck et al., 1992ab; Kerr et al., 2003) as summarized in
Table 2.2.
The feed intake reduction in high ambient temperature depends on several factors
including BW, breed, feed, and sex. Quiniou et al. (2000) developed an equation to
predict voluntary feed intake (VFI) from ambient temperature and BW:
VFI (g/d) = −1264 + 117T − 2.40T2 + 73.6BW − 0.26BW2 − 0.95T×BW,
in which VFI is daily voluntary feed intake and T is ambient temperature as degree
Celsius.

7

Table 2.2. Growth performance changes in high ambient temperature
Temp, Initial Final
°C BW, kg BW, kg

Growth performance
ADG, g ADFI, g Feed:gain

23

27.5

60.8

794

1,895

2.39

35

27.5

52.5

595

1,550

2.63

23

25.3

57.9

777

1,963

2.55

35

25.3

52.3

643

1,650

2.58

20

14.2

26.9

607

1,228

2.06

32

13.3

23.7

495

989

2.09

20

12.5

25.4

611

1,248

2.09

30

10.7

19.9

439

973

2.37

23

22.5

36.7

394

1,040

2.65

Changes in high ambient
temperature, %
Reference
ADG

ADFI Feed:gain

-25.1

-18.2

10.1

1

-17.2

-16.0

1.3

2

-18.5

-19.4

1.5

3

-28.2

-22.0

13.4

4

-20.6 -14.2
8.0
5
33
24.3
35.3
313
892
2.87
1
Stahly and Cromwell (1979). Initial BW for each temperature treatment were assumed to be the
same. Final BW was calculated as: Final BW = Initial BW + ADG × 42 d. Values are means of
three dietary treatments of high protein, low protein, and low protein + Lys.
2
Stahly et al. (1979). Initial BW for each temperature treatment were assumed to be the same.
Final BW was calculated as: Final BW = Initial BW + ADG * 42 d. Values are means of three
dietary treatments of 0 and 5% of fat.
3
Schenck et al. (1992a). Values are means of six dietary treatments (0 or 5% of fat addition × 0.7,
1.0, or 1.3% of Lys).
4
Schenck et al. (1992b). Values are mean of six dietary treatments (0 or 5% of fat addition × 0.7,
1.0, or 1.3% of Lys).
5
Kerr et al. (2003) Values are mean of three dietary treatments of high protein, low protein, and
low protein + Lys.
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As demonstrated in Figure 2.2, feed intake depends on ambient temperature and
BW, and the negative effect of high temperature was dramatic in heavier pigs.
Although high ambient temperature above the UCT is a source of stress to the
animals, the effect of heat stress on circulating cortisol concentration is inconclusive.
Occasionally, blood cortisol concentration was decreased by heat stress. Marple et al.
(1972) observed decreased plasma cortisol concentration in gilts exposed to heat stress
(32°C) for 8 d. Similarly, Hicks et al. (1998) reported numerically decreased plasma
cortisol concentration in pigs exposed to heat stress. Low plasma cortisol of heat stressed
pigs was confirmed in recent studies (Heo et al., 2005; Sutherland et al., 2006). The
reasons for low plasma concentration in heat stressed animals may be an increased
turnover of plasma cortisol and/or decreased adrenal responsiveness to ACTH as
suggested by Heo et al. (2005).

Daily feed intake, g/d

3,500
3,000
2,500
2,000
1,500
40 kg

60 kg

80 kg

100 kg

1,000
12

14

16

18 20 22 24
Temperature, °C

26

28

Figure 2.2. Effect of ambient temperature and body weight on voluntary feed intake in
growing pigs (Adapted from Quiniou et al., 2000).
Pigs in the hot environment generally exhibit more recumbent behavior with
increased respiratory rate, and thus fewer feeding and standing periods in response to
chronic (Morrow-Tesch et al., 1994) and acute (Hicks et al., 1998) heat stress treatments.
The respiratory rate has been demonstrated to be higher (124 vs. 26 breaths/min) in the
9

pregnant sow exposed to heat stress (29°C) compared with those in the thermoneutral
environment (18°C) (Quiniou and Noblet, 1999). A similar result was reported later by
the same group (Renaudeau et al., 2001).
Taken together, cold stress increases feed intake and feed:gain and elevates
cortisol secretion. Heat stress decreases feed intake and weight gain. Because thermal
stress is directly related to an animal’s energy expenditure, nutritional approaches can
potentially alleviate the detrimental effects of thermal stress.
2.1.2. Immunological stress
General concepts of immunity
The immunity refers to the state of protection from foreign organisms or
substances (antigens) which may cause infectious disease. The immunity is composed of
nonspecific and specific components. Nonspecific, or innate, immunity is the basic
inborn resistance to disease by preventing the entrance and establishment of infectious
agents. Specific, or acquired, immunity requires a functionally active immune system that
recognizes and eliminates specific foreign microorganisms and molecules (Albert et al.,
1994; Kuby, 1997). Nonspecific and specific components of immunity are summarized in
Table 2.3.

Table 2.3. Summary of nonspecific and specific immunity
Nonspecific (Innate) immunity
Anatomic barrier

skin, mucous membrane

Physiologic barrier

temperature, pH, chemical mediators

Phagocytic/endocytic barrier

internalizing cells

Inflammatory barrier

antibacterial activity and phagocytic cells

Specific (Adaptive) immunity
Humoral response (B cell)

antibody secretion and antigen elimination

Cell mediated response (T cell)
Helper T cell
Cytotoxic T cell

cytokine production
cytotoxic T lymphocytes
(Adapted from Albert et al., 1994; Kuby, 1997; Parham, 2005)
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Nonspecific immunity includes four barrier types: 1) anatomic, 2) physiological,
3) phagocytic/endocytic, and 4) inflammatory barriers. Anatomic barriers are the first line
of defense against infection. This type of barrier includes the skin and the surface of
mucous membranes. These barriers protect the organism from the entry of most
microorganisms. Physiological barriers include temperature, pH, and various soluble
factors. For example, the body temperature of chickens is high (41 to 45°C), thus
pathogens of which the growth condition is not in this temperature range cannot grow
well in chickens. Gastric acidity also inhibits the survival of pathogens. Soluble factors
contributing nonspecific immunity are lysozyme (a hydrolytic enzyme in mucosal
secretions), interferon (natural proteins produced by virus-infected cells), and
complement (serum proteins in an inactive state). Phagocytosis and endocytosis are the
process by which cells internalize and breakdown micromolecules and macromolecules,
respectively. The inflammatory responses including vasodilation, increase in capillary
permeability, and influx of phagocytes from the capillaries, also work as a defensive
system (Kuby, 1997; Parham, 2005).
Specific immunity, in contrast to nonspecific immunity, is adaptive and antigen
(foreign molecule) specific. An effective immune response involves lymphocytes and
antigen presenting cells. Lymphocytes are a class of white blood cells produced in the
bone marrow, and mediate the characteristics of acquired immunity, such as specificity,
diversity, memory, and self/nonself recognition. Two major populations of lymphocytes
are: 1) B lymphocytes which produce antibodies (humoral), and 2) T lymphocytes which
are responsible for cell-mediated immune response. In response to antigen, B cells are
differentiated to antibody-secreting plasma cells, and the secreted antibody binds to the
antigen and facilitates the antigen elimination. Helper T cells and cytotoxic T cells are
two main classes of T cells. When an antigen is recognized, helper T cells produce
cytokines which enhance the responses of other leukocytes and help B cells to make
antibody responses, and cytotoxic T cells develop into cytotoxic T lymphocytes which
directly kill altered self-cells such as virus-infected cells (Albert et al., 1994; Kuby, 1997).
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Immunological stress in swine production
In conventional swine production environments, pigs are commonly surrounded
by pathogenic microorganisms including bacteria, viruses, fungi, and parasites. These
microorganisms may cause infectious disease. In some cases, the infection causes clinical
disease symptoms. In other cases, however, the infection is subtle and the clinical
symptoms may not be obvious. In any case, animals consume less feed and grow more
slowly than those in hygienic environments. This clinical or subclinical pathogenic
infection is often referred to as immunological stress. The slower growth can by
explained by nutrient partitioning away from body protein accretion toward metabolic
responses for the immune system. Nutrient requirements for swine identified by the NRC
(1998) are based on experimental data. Considering that most experimental environments
are better controlled than conventional swine production units, the recommended
amounts or concentrations of nutrients (NRC, 1999) may be lower than the required
concentrations of nutrients for swine at commercial farms (Johnson, 1997; Johnson et al.,
2001).
Early weaned pigs (5.4 to 15.6 kg BW) raised in a conventional environment
gained less weight, consumed less feed, and had higher feed:gain than those in an
experimental environment (Coffey and Cromwell, 1995). The experimental environment
was equipped with newly purchased pens, feeders, and waters, thus likely had less
contamination and less pathogens than the conventional environment. Williams et al.
(1997) also reported that the pigs in less hygienic environment showed less weight gain,
feed intake, and higher feed:gain than those in sanitary environmental during 6 to 27, 27
to 112, and 6 to 112 kg growth phases. In these experiments, animals were exposed to
several antigens by making the environment unclean.

Lipopolysaccharide
In the previously cited studies (Coffey and Cromwell, 1995; Williams et al.,
1997) the immune system was chronically activated by environmental microorganisms.
Another technique of direct injection of pathogenic bacteria or bacterial endotoxin can
acutely activate the immune system. In swine experiments, bacterial challenges, such as
salmonella typhimurium (Balaji et al., 2000; Turner et al., 2002) and Escherichia coli (Yi
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et al., 2005), have been used to induce immune response. Endotoxins, most frequently
lipopolysaccharides (LPS), have also been extensively used in pigs to active the immune
system (van Heugten et al., 1996; van Heugten and Spears, 1997; Webel et al., 1997,
1998; Frank et al., 2003; Li et al., 2006).
In response to the pathogenic bacteria, acute inflammation is caused in animal
tissues. More specifically, the bacterial molecules that trigger this inflammation are for
the most part LPS. Lipopolysaccharides are the cell wall component of gram-negative
bacteria and act on neutrophils to activate integrins, on endothelial cells to activate
selectins, and on macrophages to produce cytokines (Tizard, 2000). The cytokines
produced by macrophages include tumor necrosis factor-α (TNF-α), interleukin-1 (IL-1),
interleukin-6 (IL-6), leukemia inhibitory factor (LIF), and oncostatin M (OSM) (Figure
2.3). The interleukines act on the hypothalamus to induce a fever response through
prostaglandin as a mediator (Kuby, 1997). Direct effects of endotoxin on the
prostaglandin formation have also been reported (Bishai and Coceani, 1996). Increased
levels of circulating cytokines (TNF-α, IL-1, and IL-6) activate the hypothalamuspituitary-adrenal axis causing increased corticosteroid secretion from the adrenal cortex
(Kuby, 1997). Additionally, LPS can directly stimulate the adrenal cortex to secret
corticosteroids (Vakharia and Hinson, 2005). Cytokines (TNF-α, IL-1, IL-6, LIF, and
OSM) and corticosteroids increased by inflammatory response stimulate liver to produce
acute-phase proteins (C-reactive protein, serum amyloid A, fibrinogen, mannose-binding
protein, and complement components). Tumor necrosis factor-α, and IL-6 act on bone
marrow to produce more leukocytes (Kuby, 1997).
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Figure 2.3. An overview of the organs and mediators involved in a systemic acute-phase
response. Interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α),
leukaemia inhibitory factor (LIF), and oncostatin M (OSM) are produced by activated
macrophages at the site of inflammation. These cytokines are particularly important in
mediating acute-phase effects of inflammation. Lipopolysaccharides (LPS) directly
trigger prostaglandin and corticosteroids secretion (Adapted from Bishai and Coceani,
1996; Kuby, 1997; Webel et al., 1997; Vakharia and Hinson, 2005).
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In pigs, intraperitoneal injection of Escherichia coli LPS induced an increase of
TNF-α, IL-6, and cortisol (Figure 2.4; Webel et al., 1997). This experiment showed the
acute activation of the immune system by the LPS challenge to the swine. Additionally,
the increase of cytokines and a corticosteroid was followed by a three fold increase in
plasma urea nitrogen. These results represent that immune stress may stimulate skeletal
muscle protein degradation.
200
20

TNF-α
IL-6
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PUN

Fold increase

15
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Hour after injection

Figure 2.4. The time course of elevated plasma levels of tumor necrosis factor-α (TNF-α),
interleukin-6 (IL-6), cortisol, and plasma urea nitrogen (PUN) following an
intraperitoneal injection of lipopolysaccharide (5 μg/kg BW) to 12 kg pigs (Webel et al.,
1997).
The optimum dosage of LPS is an important issue in experimentation. Webel et al.
(1997) reported that 5 μg/kg BW of LPS induced dramatic activation of the immune
system but 0.5 μg/kg BW of LPS had very minor effects. The dosage level of LPS to
induce an immune response has varied from 5 to 150 μg/kg BW in the literature (Table
2.4). The optimum dosage level depends on various factors including the serotype of LPS,
extraction method, animal body weight, injection method, and other environmental
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conditions. It is notable that a higher dosage of LPS was required with 0111:B4 serotypes
(Matteri et al., 1998; Frank et al., 2003) compared to K235 serotypes (Webel et al., 1997,
1998; Warren et al., 1997), although environmental variations exist among the
experiments.
Overall, immune stress exists in conventional swine production systems. Dietary
strategies may resolve at least some of immune stress. In identifying nutrients which can
alleviate immune stress, LPS can be used to activate the immune system of the animal.
Additionally, nutrient requirements may need to be established for specific swine
production system based on the immunological environment.
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Table 2.4. Effects of Escherichia coli lipopolysaccharide challenge to the pigs on
circulating tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and cortisol
concentration1
Plasma concentration3,
BW, Dosage, Injection Hrs post
ng/ml
Serotype
kg μg/kg BW method2 injection

Reference

TNF-α IL-6 Cortisol

K-235

12

5

IP

4

1.3

K-235

10

5

IP

2

055:B5

9

25

IP

3

055:B5

18

30

IP

1.5

K-235

20

50

IP

1.5

17.0

0111:B4

6

75

IV

4

32.0

055:B5

10

100

IP

2

3.0

0111:B4

6

150

IP

3

2.1

5.9

3.9

290

Webel et al., 19974

2.3

180

Webel et al., 1998

0.4

141

Li et al., 2006

2.1

510

Sakumoto et al., 20035

140

Warren et al., 19976

210

Frank et al., 2003

160

Wright et al., 2000

385

Matteri et al., 19987

20.0

0.4

1

When blood samples were collected at multiple time points, the time when cytokines or
cortisol showed the peak was selected. In all the cited studies, LPS significantly (P <
0.05) increased cytokines and cortisol concentration.
2
IP and IV represent intraperitoneal and intravenous, respectively.
3
In the references 6 and 8, serum samples were analyzed.
4
TNF-α concentration was highest (1.9 ng/ml) at 2 h post injection.
5
Cortisol concentration was highest (610 ng/ml) at 2.5 h post injection and Chinese
Meishan pigs were used.
6
Cortisol concentration was highest (195 ng/ml) at 3 h post injection.
7
Body weight was estimated based on the age (28 d old).
2.1.3. Crowding stress
Floor space allowance and group size for optimal pig growth are critical
determinants for designing modern swine production system (Brumm and Gonyou, 2001).
Swine producers try to maximize benefits by minimizing both performance retardation
and waste of space. Crowding stress - inadequate space allowance - deleteriously affects
growth performance of pigs and potentially reproductive performance.
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Floor space allowance
A number of studies demonstrated that the shortage of space allowance decreases
growth rate and feed intake. During the nursery period, inadequate space allowance
caused more than 10% of growth retardation (NCR-89, 1989; Kornegay et al., 1993ab).
NCR-89 (1989) allowed the space of 0.12 m2/pig for the reduced area treatment and that
of 0.248 m2/pig for the control group in a four-week nursery trial. Kornegay et al.
(1993ab) used reduced space allowance of 0.14 m2/pig for a treatment group in contrast
to the space of 0.28 m2/pig for a control group during 5 or 6 weeks after weaning.
The relationship between space allowance and body weight can be expressed as:
2

SA, m = k × kg BW0.667 (Petherick and Baxter, 1981), where SA is space allowance and
k is an empirical coefficient. Body weight is proportional to body volume which is threedimensional and space allowance is expressed as floor area which is two-dimensional.
Thus the use of two thirds of power on the BW is reasonable. Edwards and Armsby
(1988) suggested the optimal coefficient k was between 0.035 and 0.040. In the
previously described nursery studies (NCR-89, 1989; Kornegay et al., 1993ab; Wolter et
al., 2000), the coefficients for reduced floor area treatments were calculated as less than
0.020.
High stocking density negatively affects growth performance of pigs during the
growing-finishing period. Kornegay and Notter (1984) suggested the following equation
predicting the effect of decreasing space allowance on daily gain of growing pigs: daily
gain, kg = 0.489 + 0.520 × S – 0.281 × S2 (R2 = 0.93), where S is space per pig in m2/pig.
Brumm and Miller (1996) reported about 4 to 5% of daily gain decrease in space
restricted treatment (k = 0.024) compared to control (k = 0.034) in three experiments.
Gonyou and Stricklin (1998) also reported 4.8% decrease of growth with space restriction
(k = 0.030 vs. 0.039). In both articles, space restriction had no effect on feed efficiency.
When space restriction was more severe (k = 0.017 vs. 0.038), daily gain and feed
efficiency decreased by 16% and 10%, respectively (Hyun et al., 1998ab). These results
may be related to the fact that a high stocking density made pigs visit the feeder fewer
times but for a longer time and eat more feed per visit compared to uncrowded pens
(Hyun et al., 1998b).
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If a floor space restriction negatively affects growth performance due to the low
chance of feed intake, the interaction between sex and space allowance may exist because
barrow generally consume more feed than gilts when an ad libitum feed intake is allowed.
Hamilton et al. (2003a) observed that barrows had higher carcass lean percent in a space
unrestricted situation but gilts were leaner in a space restricted environment. However, no
interaction between sex and space allocation in growth performance or carcass lean
percent was observed by Hamilton et al. (2003b) or Brumm (2004).
Most of the studies on space allowance did not adjust the pen size as the pigs
grew and fixed pen size for a relatively long period, which resulted in enough space
allowance even in the space restricted treatment during the early period of experiments.
Even though this traditional design reflected actual conditions of commercial farms, it
prohibited examining the effect of stocking density during the early period of trials.
Gonyou and Stricklin (1998) adjusted pen sizes every two weeks to reflect the
requirements of the pigs at the midpoint of the subsequent two-week period.
Because limited space allowance is clearly detrimental to the growth of pigs, the
critical point of the flooring area is more important information to the swine industry.
Edwards and Armsby (1988) suggested the optimal coefficient k was between 0.035 and
0.040. In prediction equations suggested by Kornegay and Notter (1984), maximum
weight gain is achieved at a coefficient k of 0.048. In a recent meta-analysis study,
Gonyou et al. (2006) collected data from published studies and analyzed the data using
broken-line analysis to decide the critical k value. The critical coefficient k was estimated
as 0.034 from the analysis of nine peer-reviewed studies (Figure 2.5).
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Figure 2.5. Broken-line analysis of average daily gain for grower-finisher pigs on fully
slatted floors. The allometric expression of space allowance coefficient is k, where k =
area in m2 / BW in kg0.667. The average daily gain is expressed as a percentage of that in
the most spacious treatment within each experiment; r2 = 0.90, P < 0.001 (Gonyou et al.,
2006).
In Figure 2.6, the critical space allowance for the maximal growth of pigs in various
k values of 0.02, 0.03, 0.04, and 0.05. Additionally the k value of 0.0336 (Gonyou et al.,
2006) was added. The dashed line shows that 0.65 m2/pig of the space allowance is
insufficient for 100 kg pigs but sufficient for 80 kg pigs based on the critical k value of
0.036. In the experimentation, it is important to note that a fixed floor area can become a
stress to the pigs as the animals grow, but the space may not be a stress until the pigs
reach some marginal body weight.
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Figure 2.6. Space allowance requirement for various values of coefficient k. The
allometric expression of space allowance coefficient is k, where k = area in m2 / BW in
kg0.667 (Petherick and Baxter, 1981). The coefficient k, 0.0336, was recently suggested by
Gonyou et al. (2006). The dashed line shows that a specific space allowance as a fixed
area per pig can be a crowding stress at the BW of 100 kg but not for pigs lighter than 80
kg.

Factors on floor space allowance
Factors affecting the space allowance include floor types, ambient temperature,
air flow, and nutritional composition.
The type of floor may affect the optimal space allowance. The Canadian Code of
Practice (AAFC, 1993) suggested an increase in space allowance if pigs are on partially
slatted floor rather than totally slatted floor. However, Gonyou et al. (2006) reported that
floor type did not influence the space allowance effects.
If the decreased weight gain of pigs in crowding stress is because of decreased feed
intake, one may postulate that nutritional modifications can overcome the floor area issue.
Actually, antibiotics showed an interaction with space allowance on daily gain of pigs
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during first three weeks of the nursery period (NCR-89, 1984). In most of the other
studies, however, antibiotics (NCR-89, 1986), vitamin C (NCR-89, 1989), lysine
(Kornegay et al., 1993a; Brumm and Miller, 1996), and energy (Brumm and Miller,
1996) did not show any interaction with space allowance on the growth performance of
pigs.

Crowding stress on subsequent performance
The crowding stress on the subsequent performances has been studied by a few
groups. However, the residual effect of crowding stress is inconclusive. Wolter et al.
(2003) investigated the subsequent effect of eight weeks space restriction in weanling
pigs. During the first eight weeks, space restricted pigs showed growth retardation
compared with the pigs that had enough space (27.4 vs. 29.3 kg BW). However, during
the subsequent 15 weeks (all the pigs had enough floor allowance), the pigs with
restricted space previously compensated their BW gain, resulting the similar final BW
(114.5 vs. 114.3 kg). However, Brumm et al. (2001) reported no residual effect of nursery
crowding on grow-finish performance. Pigs that were crowded during the nursery period
and uncrowded during the grow-finish period had similar, although numerically rather
lower, daily gain (849 vs. 867 g/d, during the grow-finish period) than pigs that were
uncrowded during both the nursery and grow-finish period.
Space restriction of gilts during the growing-finishing period has been shown to
affect subsequent reproductive performance. Kuhlers et al. (1985) allowed control gilts to
have enough space of 1.06 and 1.25 m2/pig for 30 to 65 and 65 to 100 kg BW,
respectively, with eight pigs per pen. In the same size pens, 16 gilts were raised for the
crowding stress treatment group. In the subsequent reproductive performance, crowding
stress decreased the litter size by 1.0 pig at birth but increased 21-d litter size, litter
weights, and survival rates. The mechanism of the positive effects of the crowding stress
on some reproductive traits is not clear. The space allowance coefficient k (Edwards and
Armsby, 1988) of this experiment is calculated as 1.06 ÷ 650.667 = 0.065 and 1.25 ÷
1000.667 = 0.058 for 65 kg and 100 kg space unrestricted gilts, respectively. For the space
restricted gilts, the k values are 0.033 and 0.029 for 65 kg and 100 kg gilts, respectively.
Based on the critical k value of 0.0336 suggested by Gonyou et al. (2006), the crowding
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stress in the experiment by Kuhlers et al. (1985) may be insufficient at least in the early
period of each phase, for example 30 to 55 kg and 65 to 90 kg. More severe stress during
the grow-finishing stage may result in a more clear response in the subsequent
reproductive performance. In addition, the effects of crowding stress during the early
growth stage (< 10 weeks) on the subsequent reproductive traits have been unanswered.
Further research is warranted to investigate the effect of crowding stress on subsequent
reproductive performance.

Group size
Group size is also an important factor for designing a pig house. Petherick et al.
(1989) reported a decrease of daily gain of growing pigs when group size increased from
8 or 16 to 32, and Gonyou and Stricklin (1998) also reported a reduction of daily gain and
feed intake with increasing group size as 3, 5, 6, 7, 10, and 15. During the finishing
period, individually caged gilts grew faster than gilts penned in groups of four (Gomez et
al., 2000). Wolter et al. (2000) reported that piglets grouped as 100 gained 6% less
weight compared to the piglets grouped as 20.
However, other studies have demonstrated no effect of group size, 5 and 20
(Randolph et al., 1981), 10, 20 and 30 (Walker, 1991), and 10, 20, 40 and 80 (Schmolke
et al., 2003) on performance. Hyun and Ellis (2001, 2002) reported a negative effect of
large group size on growth rate and feed intake in growing pigs, but no effect in finishing
pigs. More recently, O’Connell et al. (2004) reported no effect of the number of pigs (10,
20, 30, 40, and 60) per pen on growth or feed intake.
Overall, space allowance and group size for optimal pig growth are important for
planning and designing modern swine production system. Many factors are involved in
the decision of a space allocation. Crowding stress has deleterious effects on growth
performance and potentially subsequent growth and/or reproductive performance.
2.1.4. Social mixing stress
In the commercial swine production environment, piglets are sorted at weaning by
weight for equal opportunity during the nursery period. Moreover, most of modern swine
farms rear 10 to 30 pigs in a pen (Wolter et al., 2000). Thus, in most cases pigs from
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more than one litter are inevitably placed in the same pen. Mixing with previously
unacquainted pigs clearly induces acute stress, as fighting behavior and increased
respiration rate are easily observed. Socially mixing the pigs results in increased cortisol
secretion indicating that the animals are stressed. Growth performance is also affected by
mixing stress during the first d. However, mixing stress may be an affordable stress to the
pigs for the long term growth performance.

Mixing stress on behavioral and hormonal responses
Social mixing of unfamiliar individual pigs results in acute aggressions and
increased corticosteroid secretion. The intensity and the length of the aggressions are
related to the number of alien pigs and the severe fighting behavior generally lasts less
than 24 h. Mixing stress may also affect feed consumption patterns.
Increased aggressive behavior by combining alien pigs has been observed in
many studies (Friend et al., 1983; McGlone et al., 1980; McGlone and Curtis, 1985;
Spoolder et al., 2000). Friend et al. (1983) reported that mixing 4-week-old piglets from
different litters showed apparently more fighting behavior than the littermates. Piglets
were regrouped at weaning as: treatment 1) one pig from each of eight different litters,
treatment 2) four pigs from each of two different litters, or treatment 3) eight pigs from
the same litter. When none of the piglets were littermates, the fighting frequency was the
highest during the first 3 h post mixing and the agonistic behavior was alleviated at 3 h
after mixing (Figure 2.7).
This is a theoretically reasonable result, because the number of couples that are
unaware of each other is 28, 12, and 0 for treatment 1, 2, and 3, respectively assuming
that the dominance of the littermates has been established during the suckling period. The
lowest fighting frequency in the littermate only treatment suggests that the increased
aggression was not by the weaning. In addition, vigorous fighting behavior was mostly
alleviated within 24 h after social mixing in pigs of eight weeks old (Meese and Ewbank,
1973) and finishing pigs of 84 kg BW (Stookey and Gonyou, 1994). However, in a
mixing stress study with 76 kg pigs (Tan et al., 1991), aggressive behavior pattern caused
by social mixing lasted up to three weeks. However, Tan et al. (1991) provided feed
twice daily which may have caused extension of mixing stress period.
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Figure 2.7. The effect of grouping methods on the number of fighting bouts occurring.
Short and long fights were combined. There were 10 pens of eight pigs in each treatment
(Friend et al., 1983).
The social stress of mixing may stimulate the HPA axis, resulting in cortisol
secretion with other physiological changes in the body (Christian, 1961). Mixing piglets
at weaning increased circulating cortisol concentration (Blecha et al., 1985). And when
piglets were regrouped at two weeks after weaning, plasma cortisol concentration was
increased again. Similarly, Warriss and Brown (1985) reported that the greater the
damage by fighting, the higher were the concentration of cortisol, glucose, and lactate.
Recently, Séguin et al. (2006) also observed elevated salivary cortisol concentration in
sows exposed to mixing stress.
Hyun et al. (1998b) reported that social mixing did not influence the feeding
pattern during the first day after mixing in 36 kg pig. However, the feeder occupation
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time and the feed intake per visit were higher and the feeder visiting frequency was lower
in socially mixed groups compared to unmixed groups on d 3, 4, and 5 after mixing with
no changes in daily feed intake. These results suggest that even though agonistic behavior
occurs only during the first few hours post mixing, feeding patterns may be influenced a
bit later after fighting. In the nursery pigs, eating activity was unaffected by social mixing
during the first 48 h after weaning (Dybkjær et al., 2006). Although this result may not be
directly compared with the study by Hyun et al. (1998b) because eating behavior was
recorded only for 48 h after mixing, and weaning pigs consume very little amount of feed
during the first few days after weaning, both studies are in agreement in that feeding
pattern is unaffected initially by social mixing.
Taken together, mixing stress causes agonistic behaviors in the pigs within a few
hours regardless of growth stage and elevates circulating cortisol concentration. Feeding
pattern is also affected by mixing unfamiliar pigs.

Mixing stress on growth performance
Growth performance is also affected by mixing stress during the first few days.
However, mixing stress may be an affordable stress to the pigs for the long term growth
performance. Initial decreases of growth performance by social mixing stress have been
reported in nursery (Friend et al., 1983), growing (Rundgren and Lofquist, 1989) and
finishing (Spoolder et al., 2000) swine. Friend et al. (1983) observed higher feed:gain in
the mixed weanling piglets during the first 7 d after mixing. However, they found no
difference in feed:gain among the mixing stress treatments during the first 28 d post
mixing. Daily feed intake and daily weight gain were unaffected by mixing treatments
either during the first 7 d or 28 d. The high feed:gain may be explained by the high
energy expenditure in the pigs exposed to mixing stress, as Heetkamp et al. (1995)
reported that pigs exposed to mixing produced significantly higher total heat production
and activity-related heat production.
Rundgren and Lofquist (1989) observed lower weight gain during the initial 7 d
following mixing in 23 kg pigs. However, body weight gain during the first 14 d post
mixing was unaffected by the mixing stress. Although Heetkamp et al. (1995) observed
acute changes of heat production by mixing stress in 10-week-old pigs, the authors failed
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to find the effects of mixing stress (five pigs from each of two litters) on feed intake,
daily gain, or feed efficiency during the initial two weeks post mixing. The possibility
that the growth performance may be affected by the mixing stress during the earlier
period cannot be ruled out.
In the case of finishing pigs (55 and 75 kg BW; ten pigs per pen), daily weight
gain was decreased by more than 10% and 30%, respectively, in the mixed group
compared to the unmixed group during the first two weeks following mixing (Spoolder et
al., 2000). It may be that heavier pigs hurt each other more severely during the
dominance establishing procedure. In the same experiment, more skin lesions were
observed in pigs mixed at 75 kg than in those mixed at 55 kg, although the levels of
aggression were indifferent.
Stookey and Gonyou (1994) conducted three mixing stress trials with pigs of 84
kg BW (three to five pigs per pen). The weight gain during the first week and second
week following the mixing was measured. The results were inconclusive: weight gain
was decreased by mixing during the first and the second week in trial 1, only the second
week in trial 2, and only the first week in trial 3. When the data from three trials were
pooled and analysed, mixing stress affected weight gain during only the second week.
The pooled data may be explained by the finding that fighting was decreased after
establishing a dominance order, but the aggressiveness such as threats and submissive
action were present within a stable group (Jensen, 1982). The other issue was group size:
Stookey and Gonyou (1994) grouped three to five pigs per pen, while Spoolder et al.
(2000) grouped ten pigs in each pen.
An opaque barrier – an incomplete wall separating the area in the pen – affects the
aggressive behavior and thus growth performance. Warant and Broom (1993) examined
the effects of a barrier on the behavioral responses and growth performance after mixing
at weaning. The presence of an opaque barrier in the pen alleviated the aggressive
behavior by 40% and improved weight gain by 15% during the first week after weaning.
As the space restriction is a stressor to the pigs, the quantity of the pen space is important.
In addition, the quality of the pen space is also important especially when animals are
exposed to mixing stress. Using a barrier in the pen may provide a hiding area where pigs
can escape from the unwanted attention of other pen mates. This is a possible mechanism
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whereby the presence of barrier decreased the frequency of aggression and improved the
growth performance. In a quantitative aspect, the area of walls was approximately 17%
increased by using a barrier.
Recently, Wellock et al. (2003) developed a model equation to calculate the
response of mixing stress as following:
Rmix = b3 – [(g4 × BW) – {(g5 × BW) × Ln(t)}]
where Rmix is the performance (%) relative to that of a nonmixed pig, the constant b3 is
equal to 100, g4 and g5 are scalars likely to change with genotype, and t is the time in
days where mixing occurs on d 1 (g4 = 0.8 + 0.04EX and g5 = 1.033 – 0.066EX, where
increasing EX – coping ability – from 0 to 10 represent a decreasing ability to cope and
modifies the effect of each stressor). The accuracy of this equation is limited, because the
amount of available data was insufficient. However, this model shows the general
relationship between mixing stress and growth performance. An example of the model is
demonstrated in Figure 2.8. Pigs of 70 kg BW encountered mixing stress on d 1 and
coping ability was 4, 5, or 6 (a decreasing coping ability).
Social mixing stress has deleterious effects on growth performance during a short
period post mixing. In the longer period, growth retardation by social mixing may be
compensated. The use of a physical barrier in the pen alleviates the deleterious effects of
social mixing with unacquainted pigs.
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Figure 2.8. Proportional performance (%) of pigs exposed to mixing stress relative to that
of a nonmixed pig (Adapted from Wellock et al., 2003).
Overall, mixing unfamiliar pigs results in aggressive behaviors and a high
concentration of circulating cortisol within a few hours. Mixing stressor also affects
feeding pattern. As a result, social mixing deleteriously affects growth performance
during a short period after mixing.
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2.2. Chromium (III) picolinate in animal production
Trivalent chromium (Cr) is an essential micro element for animals (Anderson,
1987; Offenbacher and Pi-Sunyer, 1988). Since the first report on the essentiality of Cr in
rats (Schwarz and Mertz, 1959), roles of Cr have been widely studied in humans and
animals. Generally Cr has been shown to potentiate the action of insulin (Mertz et al.,
1974; Vincent, 2000). In addition, Cr has been suggested to alleviate stress in animals
and humans (Chang and Mowat, 1992; Anderson, 1994; NRC, 1997).
Page et al. (1993) suggested that Cr is more available as an organic chelate.
Effects of the specific organic form of trivalent Cr, CrPic, on growth, carcass leanness,
and reproduction have been investigated in swine nutrition research. Influences of
supplemental CrPic on pigs under stress situations have also been studied.
2.2.1. Swine growth performance
The effects of Cr on growth performance of pigs have been variable. Some
researchers have reported that supplemental CrPic to swine diets may improve weight
gain (Mooney and Cromwell, 1995) and feed efficiency (Lindemann et al., 1995). Others
have reported that dietary CrPic effects on growth performance were absent or may be
even negative (Boleman et al., 1995; Mooney and Cromwell, 1999; Matthews et al.,
2001).
Lindemann et al. (1995) suggested that the supplementation of CrPic (200 ppb Cr)
improved feed efficiency in pigs fed marginal levels of lysine but not in pigs fed 120% of
the estimated requirement of lysine. Using the same dose of CrPic, Mooney and
Cromwell (1995) observed improved weight gain (979 vs. 929 g/d; P < 0.09) in pigs fed
supplemental Cr compared with the control group.
Boleman et al. (1995) reported that pigs fed 200 ppb Cr as CrPic during growing
finishing periods consumed less feed (P < 0.08) and grew slower (P < 0.05) than pigs fed
no supplemental Cr. Mooney and Cromwell (1999) observed no effects of supplemental
CrPic on weight gain, feed intake, or feed efficiency regardless of lean gain potential of
the animals. Matthews et al. (2001) conducted two experiments to assess the effects of
supplemental Cr on growing-finishing barrows. In the first experiment, supplemental Cr
decreased weight gain (P = 0.03) and feed intake (P = 0.05). But the growth trial was
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conducted only for 28 d (20 to 38 kg BW). In the second experiment (23 to 115 kg BW),
growth performance was unaffected by supplemental Cr.
In a review of supplemental CrPic in pig trials, an interaction between
supplemental Cr and dietary protein level was suggested (Lindemann, 1999), in that
supplemental Cr improves feed efficiency in the pigs fed protein marginal to the
requirement whereas not in the pigs fed excess protein. In a recent review (Lindemann,
2007), effects of Cr on the growth performance of pigs are inconsistent. However, the
author did not rule out the possibility of positive effects of Cr on feed efficiency in some
situations, based on the improved digestibilities of crude protein and dry matter by
supplemental CrPic (Kornegay et al., 1997).
2.2.2. Carcass leanness
The effects of supplemental Cr on the carcass characteristics of pigs have been
inconsistent. Since Page et al. (1993) reported that the supplemental Cr increased carcass
leanness, favorable effects of supplemental Cr have been demonstrated in multiple
experiments (Lindemann et al., 1995; Lien et al., 2001). However, these effects were not
observed in other studies (Evock-Clover et al., 1993; Mooney and Cromwell, 1999;
Matthews et al., 2001).
Page et al. (1993) found quadratically increased (P < 0.01) loin muscle area
(LMA) and percentage of muscling and quadratically decreased (P < 0.01) tenth rib fat
depth (TRF) by supplemental Cr (0, 100, 200, 400, or 800 ppb) as CrPic. Lindemann et al.
(1995) also reported that the supplementation of 200 ppb Cr as CrPic increased (P < 0.04)
LMA and decreased TRF (P < 0.04) regardless of dietary lysine levels (100 or 120% of
requirements). Lien et al. (2001) supported these findings by demonstrating similar
effects of CrPic on carcass leanness.
In contrast, Evock-Clover et al. (1993) reported that supplemental CrPic (300 ppb
Cr) to the pigs from 30 to 60 kg BW had no effects on carcass characteristics. Mooney
and Cromwell (1999) evaluated effects of supplemental CrPic (200 ppb Cr) to the pigs of
different lean gain potential from 55 to 109 kg BW on carcass characteristics and tissue
accretion. They found no effects of supplemental Cr on carcass traits, or accretion rates of
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carcass protein or lipid. Matthews et al. (2001) reported that the supplementation of 200
ppb Cr to barrows from 23 to 115 kg BW did not affect carcass traits.
Mooney and Cromwell (1995) observed increased muscle percentage and
decreased fat percentage of dissected carcass by supplemental Cr, but found no changes
in LMA or backfat depth. This implies that the carcass measurements of LMA and TRF
may not represent overall body leanness or fatness. Thus, in some studies that showed no
effects of supplemental Cr on the carcass measurements, there could have existed true
effects of supplemental Cr on the overall body lean percentage.
In an experiment involving 1,000 pigs under commercial environment,
Lindemann and Purser (1997) suggested that dietary CrPic (200 ppb Cr) was more
effective in animals with high propensity for body fat deposition. In this experiment, the
increase of percentage lean in the carcass by supplemental Cr was evident in barrows but
not in gilts. Generally barrows consume more feed but have a lower daily lean gain than
gilts. In barrows, thus, more extra energy is stored as body fat due to a lower energy need
for muscle synthesis (Cline and Richert, 2001).
2.2.3. Reproductive performance in swine
Since Lindemann et al. (1995) first reported that supplemental CrPic to the sow
diets increased litter size, similar effects of CrPic have been observed in other studies
(Hagen et al., 2000; Lindemann et al., 2004).
Lindemann et al. (1995) reported remarkable improvements of sow productivity
by dietary supplementation of CrPic. Supplemental Cr (200 ppb) from early in the growth
phase throughout later reproduction resulted in improved (P < 0.04) litter sizes in total
born (11.82 vs. 9.58 pigs/litter), born live (11.25 vs. 8.93 pigs/litter), at d 21 (10.30 vs.
8.15 pigs/litter), and at weaning (10.25 vs. 8.10 pigs/litter) compared with the control
group. Litter weights were also improved (P < 0.03) in total born (17.04 vs. 13.79
kg/litter) and born live (16.27 vs. 12.86 kg/litter) by supplemental CrPic. However, mean
BW of piglets at weaning was lower (6.79 vs. 8.15 kg; P = 0.01) in the CrPic group than
controls.
Hagen et al. (2000) studied the effects of supplemental CrPic on productivity of
sows in a commercial environment. In this study about 100,000 litters were used, and the
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Cr dose was 0 or 200 ppb. Supplemental CrPic increased percent sows bred within 7 d
(90.6 vs. 87.8%; P = 0.09). Dietary supplementation of CrPic increased pigs born live per
litter (10.42 vs. 10.05 pigs/litter; P = 0.02) and pigs weaned per litter (9.08 vs. 8.75
pigs/litter; P = 0.02). Sow mortality was lower (9.38 vs. 10.95%; P = 0.11) in the Cr
supplemented group than controls.
In a cooperative study involving 353 litters at three experimental stations
(Lindemann et al., 2004), influences of dietary CrPic (0, 200, 600, or 1,000 ppb Cr)
supplementation on the reproductive performance were investigated. The number of pigs
born live per litter was linearly (P = 0.08) and quadratically (P = 0.05) increased (9.49,
9.82, 10.94, and 10.07) and sow lactating weight change was linearly (P = 0.01) increased
(–0.2, 0.8, –4.1, and –3.9 kg) by increasing levels of supplemental CrPic. The Cr contents
in the adrenal gland, kidney, and liver linearly increased (P < 0.01) as more CrPic was
supplemented.
Taken

together,

supplemental

CrPic

positively

influences

reproductive

performance of swine in a variable magnitude perhaps due to the differences in animals,
diets, environment, and other factors. Further research to identify the specific factors
affecting the effectiveness of supplemental Cr may be needed.
2.2.4. Animals under stress situations
The inconsistent effects of dietary CrPic may be related to the condition of the
animals and the experimental environments. Supplemental Cr has been suggested to be
more effective in the animals under stress situations (Anderson, 1994; NRC, 1997). The
stressors existing in swine production systems include cold/hot environmental
temperature (Stahly and Cromwell, 1979; Schenck et al., 1992a,b), microbial infection
(Webel et al., 1997), nutritional deficiency or imbalance (NRC, 1998), insufficient space
allowance (Brumm and Miller, 1996; Wolter et al., 2000), and social mixing (Barnett et
al., 1993; Marchant et al., 1995).

Thermal stress
Studies of supplemental Cr on swine under thermal stress have been rare. In
poultry, however, effects of supplemental Cr in the stressful thermal environment have
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been extensively studied (Sahin et al., 2001, 2002abc, Onderci et al., 2003; Sahin et al.,
2005).
In an experiment employing 150 laying Japanese quail (Sahin et al., 2002b),
supplemental Cr (0, 200, 400, 800, or 1,200 ppb) as CrPic linearly increased feed intake,
BW, and feed efficiency of egg production (P < 0.05) of laying quail under conditions of
heat stress (32.5°C). Egg qualities were also linearly improved by increasing
supplemental CrPic levels including egg weight, specific gravity, eggshell thickness, and
interior egg quality (P < 0.05). In this experiment, all the measurements responded
linearly but not quadratically responded to supplemental Cr levels, and the highest
concentration (1,200 ppb) of Cr resulted in the best results. Thus supplemental Cr over
1,200 ppb may potentially cause even better results. The heat stress (32.8°C) on the
broiler chickens was also alleviated by dietary supplemental CrPic (Sahin et al., 2002a).
Dietary supplementation of Cr at levels of 0, 200, 400, 800, or 1,200 ppb linearly
increased feed intake, BW, and feed efficiency (P < 0.05). Similar effects of
supplemental CrPic on growth performance of Japanese quail under heat stress (34°C)
have been reported by the same research group (Sahin et al., 2005).
Supplemental CrPic has also attenuated the detrimental effects of cold stress in
poultry. Sahin et al. (2001) investigated the effects of supplemental Cr (0, 100, 200 or
400 ppb as CrPic) on performance and circulating hormones of laying hens housed under
low ambient temperature (6.9°C). They reported that BW gain, egg production, and feed
efficiency of egg production were linearly improved by supplemental CrPic (P < 0.001).
The circulating insulin concentration was linearly elevated (P < 0.001), but the
corticosterone concentration was linearly lowered (P < 0.001) by increasing levels of
supplemental CrPic. Onderci et al. (2003) conducted an experiment to determine the
effects of supplemental CrPic on nutrient digestibility, lipid peroxidation, and serum
antioxidants of laying hens under cold stress (6.9°C). Supplemental Cr of 400 ppb
improved digestibilities of dry matter, organic matter, crude protein, and crude fat (P <
0.05). Lipid peroxidation was lowered and serum vitamins C and E were increased by
supplemental CrPic (P < 0.05).
While studies on dietary CrPic in thermal stressed swine have been rare, based on
the results of poultry studies, in that supplemental CrPic moderated detrimental effects of
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thermal stress, stress alleviating effects of high dose CrPic in the pigs under thermal
stress seem warranted.

Immune stress
The immune system of swine can be chronically activated by environmental
pathogenic bacteria (Coffey and Cromwell, 1995; Williams et al., 1997). Another
technique is the direct injection of pathogenic bacteria (Turner et al., 2002; Yi et al.,
2005) or bacterial endotoxin (Yi et al., 2005). Influences of supplemental CrPic have
been investigated in pigs challenged with LPS, the most widely employed endotoxin, but
the results have been inconsistent (van Heugten and Spears, 1997; Lee et al., 2000).
The effects of 200 ppb of supplemental Cr as CrCl3, CrPic or Cr-nicotinate on the
pigs challenged with LPS have been studied by van Heugten and Spears (1997).
Supplemental Cr tended to improve weight gain and feed intake (P < 0.10) in the pigs not
challenged with LPS. However, supplementation with Cr did not moderate the depressed
growth performance due to immune challenge. In vitro cellular immune response was
increased (P < 0.10) but antibody response to ovalbumin was decreased (P < 0.05) in the
pigs fed supplemental CrPic. However, supplemental CrPic did not moderate serum
cortisol elevated by ACTH injection.
In an experiment involving specific pathogen free pigs, 400 ppb of Cr
supplementation as CrPic ameliorated the physiological responses due to immune
challenge (Lee et al., 2000). Although supplemental Cr had no effect on growth
performance of pigs challenged with LPS, plasma cortisol elevation was delayed by Cr
supplementation.
In an experiment at the University of Kentucky, supplemental CrPic (200 ppb of
Cr) had no or limited effects on immune status of pigs during the post weaning period
(van de Ligt et al., 2002c). General growth performance was unaffected by supplemental
CrPic. Total IgG was decreased in the pigs fed supplemental CrPic on d 28 (P < 0.05).
The authors suggested that CrPic had no positive effects on immunocompetence in pigs
during the post-weaning period.
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Nutritional stress
Nutrition stress includes deficiency and imbalance of essential nutrients. In a
review of supplemental CrPic in pig trials, an interaction between supplemental Cr and
dietary protein level was suggested (Lindemann, 1999) in that supplemental Cr improved
feed efficiency in pigs fed protein marginal to the requirement whereas not in pigs fed
excess protein. Indeed supplemental CrPic improved feed efficiency by 7% on average
(2.81 vs. 3.02 of feed:gain) in the experiments providing marginal protein, while feed
efficiency was unaffected by CrPic supplementation in the experiments feeding excess
protein. This concept was well demonstrated in an experiment by Ward et al. (1997).
Supplemental Cr (400 ppb as CrPic) improved weight gain and feed efficiency in pigs fed
the 80% of lysine requirement but not in the pigs fed the 120% of lysine requirement.
However, van de Ligt et al. (2002b) failed to observe effects of supplemental
CrPic in pigs fed deficient dietary protein. They observed linear increase of protein
accretion and linear decrease of lipid accretion with increasing levels of dietary protein.
However, they failed to observe major effects of supplemental CrPic on growth, carcass,
or blood measurements in the pigs fed 76, 83, or 90% of lysine requirement. No major
interactions between CrPic and dietary protein levels were observed. In another study by
van de Ligt et al. (2002a), supplemental CrPic in pigs fed various levels of energy (70, 80,
or 90% of requirement) was studied. But they failed to find the effects of supplemental
CrPic on the growth or carcass characteristics.
Although the influence of supplemental CrPic on pigs fed an insufficient amount
of nutrients has been investigated, the effects of CrPic on the pigs fed excessive energy
and/or fat have rarely been studied. The consumption of excessive amounts of dietary fat
may cause obesity in humans (Lissner and Heitmann, 1995; Shepard et al., 2001) and
rodents (Masek and Fabry, 1959; Lemonnier et al., 1975). Furthermore, the high-fat diet
may result in insulin resistance (Lavau et al., 1979; Rocchini et al., 1997; Jones et al.,
2005) and cardiovascular disease (Aguila and Mandarim-de-Lacerda, 2003; Davis et al.,
2006).
In a recent study employing obese mice induced by a high-fat diet (Bhattacharya
et al., 2006), supplemental Cr as Cr carnosinate (Carnochrome) lowered body weight
gain (3.04 vs. 7.29 g), body fat mass gain (0.95 vs. 3.13 g), and visceral fat mass gain
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(0.26 vs. 1.09 g) in the mice fed experimental diets for 14 weeks (P < 0.05). Martin et al.
(2006) studied effects of supplemental CrPic on patients with non-insulin-dependent
(Type 2) diabetes mellitus taking an antidiabetic drug (sulfonylurea). Dietary CrPic
intake for 24 weeks decreased weight gain (0.9 vs. 2.2 kg; P < 0.05), the changes of body
fat percentage (0.12 vs. 1.17 %), subcutaneous fat (P < 0.05), visceral fat (P < 0.05), and
total abdominal fat (P < 0.01) compared with the placebo group.
Overall, effects of supplemental Cr on pigs fed insufficient nutrients have been
variable, and further investigation may be needed to elucidate the effects of dietary CrPic.
Based on the recent report in mice and humans, research to elucidate effects of
supplemental CrPic on pigs fed excessive fat seems warranted.

Crowding stress
Insufficient floor space allowance induces stress and causes adverse effects in
swine (Brumm and Miller, 1996; Wolter et al., 2000). Ward et al. (1997) reported that
supplemental Cr (400 ppb as CrPic) did not moderate the adverse effects caused by
inadequate space allowance. Siberio et al. (1996a,b) also observed no effects of
supplemental Cr from Cr-yeast on growth performance, immune status, or mineral
retention in nursery pigs reared in a crowded environment.
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2.3. Diabetes mellitus and chromium (III) picolinate
2.3.1. Classification of diabetes mellitus
Diabetes mellitus (DM), a metabolic disorder, is related to the elevated blood
glucose level. Although the disease can be simply defined as hyperglycemia, it is a highly
heterogeneous disease (Bach, 1994). The causes and signs of this hyperglycemia include
a deficiency of insulin secretion, a resistance of the insulin action, or a combination of
these (Harris, 2000). The characteristic symptoms of diabetes include excessive thirst,
polyuria (frequent urination), and polydipsia (intake of a large volume of water), due to
glucosuria (the large amount of glucose excretion in urine). The meaning of DM is
“excessive excretion of sweet urine.” Other characteristic metabolic changes include
ketosis (overproduction of ketone bodies) and acidosis (Lehninger et al., 1993).
Based on the major causes, DM is classified into insulin-dependent diabetes
mellitus (IDDM) and non-insulin-dependent diabetes mellitus (NIDDM); with a lower
incidence rate, other types of DM and gestational diabetes mellitus also exist (Table 2.5).
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Table 2.5. Classification of diabetes mellitus (DM)
Causes

Results

Type 1 DM

Pancreatic β-cell destruction, often

Loss of insulin secretion and

(IDDM)

immune mediated

insulin deficiency

Type 2 DM

Genetic factors and nongenetic

Insulin resistance and insulin

(NIDDM)

factors including age, high caloric

deficiency

diet, overweight, central adiposity,
and low birth weight
Other types of

Genetic defects affecting β -cell

Type 1 and/or Type 2

DM

function or insulin action, diseases

symptoms

of the exocrine pancreas, and
drug-induced pancreatic changes
Gestational DM

Age

Insulin resistance and relative

(GDM)

insulin deficiency; delivery
complications; increased risk
of macrosomia and perinatal
mortality
(Adapted from Harris, 2000)

Type 1 diabetes mellitus (insulin-dependent diabetes mellitus; IDDM)
The IDDM, also called juvenile-onset DM, is known as a hereditary disease and is
the most common form of DM among children and adolescents. This type of DM
comprises approximately 5 to 10% of cases in the DM patients (Harris, 2000). The IDDM
patients require insulin therapy and a lifelong control of the balance between glucose
intake and insulin dose (Lehninger et al., 1993).
In IDDM patients, insulin secretion is completely inactive due to the insulinproducing β-cell destruction, which leads to absolute insulin deficiency. Two subclasses
of IDDM are an autoimmune class and an idiopathic (from an obscure or unknown cause)
class. In the autoimmune form, cellular-mediated autoimmune destruction of the β-cell
destruction occurs, and the disease continues chronically (Harris, 2000).
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Type 2 diabetes mellitus (non-insulin-dependent diabetes mellitus; NIDDM)
The NIDDM is also called adult-onset DM or type 2 DM. This type of DM
comprises approximately 90% of cases in DM patients (Harris, 2000). The NIDDM
develops more slowly and is milder compared with IDDM and often goes without
recognition due to a lack of clinical symptoms (Lehninger et al., 1993).
The causes of NIDDM are genetic factors and nongenetic factors, including age,
high caloric diet, overweight, central adiposity, and low birth weight. These factors lead
to insulin resistance in muscle, liver, and adipose tissue. Eventually, defects in insulin
secretion leading to hyperglycemia precipitate clinical onset of the disease. In many cases,
NIDDM patients alter diet or take oral agents to correct fasting hyperglycemia. However,
if this correction cannot be achieved with the diet or oral agents, exogenous insulin
therapy is required (Harris, 2000).
2.3.2. Diabetic animal model
Animal models provide important information about the pathogenic and
physiological aspects of human diseases. Animal models of DM have been widely
employed in basic and clinical research. Although these animal models do not necessarily
exhibit the same symptoms present in human DM, they are valuable tools to study human
diabetes (Young and Edwards, 2004).
Several commonly used DM animal models and their metabolic characteristics are
listed in Table 2.6. Diabetic animal models of IDDM have been generated using either
the surgical removal of the pancreas, the genetically predisposed autoimmune, or β-cell
toxic chemicals. The Bio-Breeding (BB) rat and non-obese diabetic (NOD) mouse are
examples of genetically predisposed autoimmune (spontaneous) IDDM. The features in
these animal models are very similar to human IDDM in most measurable criteria (Bach,
1994). Streptozotocin and alloxan have been used to induce diabetes in animals due to
their β-cell specific toxicity (Szkudelski, 2001). The NIDDM animal models exhibiting
spontaneous hyperphagia include transgenetic models such as the ob/ob mouse, db/db
mouse, and Zucker rat (Young and Edward, 2004).
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Table 2.6. Diabetic animal models and the characteristics
Animal model

Features

Etiology

Type1

Total insulinopenia (insulin lack)
Subtotal insulin deficiency, hyposecretion
Insulin excess, peripheral insulin resistance
Dyslipidemia, vascular disease
Severe hyperglycemia
Moderate hyperglycemia
Ketosis, hyperglucagonemia
Easy to obtain or induce
Easy to maintain or manage
Pancreatectomy

x

x

Surgical

1

BB rat

x

x

x

Autoimmune

1

NOD mouse
Streptozotocin
animal
Alloxan animal

x

x

x

Autoimmune

1

x

x

x x x Cytotoxicity via GLUT2

1

x

x

x x x Cytotoxicity via GLUT2

1

Gold thioglucose

x

x

ob/ob mouse

x

x

x x Leptin deficiency

2

db/db mouse

x

x

x x Leptin receptor deficiency

2

Zucker rat

x x

x

x x Leptin receptor deficiency

2

x Leptin receptor, secretory

2

ZDF rat

x Neurotoxic to glucosensors

x x x x

2

OLETF rat

x

x

x CCK receptor deficiency

2

LAN corpulent rat

x x

x

x Unknown

2

1

Type 1 diabetes, IDDM; type 2 diabetes mellitus, NIDDM.
(Adapted from Young and Edwards, 2004)

Diabetic animal models can be classified by the developing methods: 1) surgical
removal of pancreas, 2) administration of diabetogenic chemicals, 3) dietary strategy with
high-fat/high-sugar, 4) breeding animals, and 5) gene targeting and transgenesis. These
methods have been developed and applied in DM studies.
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Surgical removal of pancreas
One of the most straightforward methods to study diabetes in animal models is
surgically removing the pancreas. In the late nineteenth century, the surgical removal of
the pancreas from a dog caused a condition resembling human DM (Lehninger et al.,
1993). In the 1920s, Banting and Best pancreatectomised dogs in their studies on the
isolation and purification of insulin (Rees and Alcolado, 2005). Thereafter, a number of
researchers employed this method in their diabetes studies. Barnes and Bloom (1976)
used a pancreatectomised man to study glucagons in IDDM. This technique was
employed to validate the use of the implanted insulin pump (Grau and Saudek, 1987).
The artificial pancreas was applied in the clinical trials based on the in vitro studies.
Depending on the research purpose and the animals, the partial removal of the pancreas
was also used (Bonner-Weir et al., 1983; Brockenbrough et al., 1988; Hardikar et al.,
1999). Partial pancreatectomy caused moderate hyperglycemia without body weight or
circulating insulin level changes (Bonner-Weir et al., 1983). These characteristics
represent NIDDM.
In pig studies, Wilson et al. (1986) induced IDDM by pancreatectomy or by
intravenous administration of streptozotocin (150 mg/kg BW; diabetogenic agent). The
authors reported that pancreatectomised pigs were unsuitable for long-term studies
because of high morbidity and mortality whereas streptozotocin-injected pigs were
suitable for long-term studies, including transplantation of pancreatic islet tissue.
Recently, Kobayashi et al. (2004) reported that the pancreatectomised pig model was
suitable for short term studies such as 5 d, with a mean survival of 7.7 d post surgery.
The advantages of this surgical method include high reproducibility and a
similarity to human IDDM. However, the surgery requires postoperative analgesia and
antibiotics administration. Moreover, chronic pancreatic enzyme supplementation is
required for a longer period of study (Sieher and Traystman, 1993).
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Administration of diabetogenic substances
Non-surgical methods of damaging the pancreas are available using diabetogenic
agents listed in Table 2.7. These chemicals, especially alloxan and streptozotocin, have
been widely used in diabetes studies due to the convenience and simplicity (Szkudelski,
2001). The administration of these chemicals induces hyperglycemia by selectively
destroying pancreatic β-cells. Depending on the dosage level and/or the administration
method, the diabetogenic chemicals may cause either IDDM or NIDDM.
The advantage of the chemical method is that some chemicals are selectively
toxic to β-cells leaving other pancreatic cells intact and that it is relatively easy to induce
diabetes in model animals. However, the chemically induced diabetes may not be very
stable and is frequently reversible due to the regeneration of β-cells, while other
diabetogenic agents may be toxic to other organs in the body. More detailed information
on these diabetogenic agents will be discussed in the next section (2.4.3. Diabetogenic
chemicals).

Table 2.7. Diabetogenic agents in experimental animals
Name
Alloxan
Streptozotocin
Dexamethasone
Vancomycin
Dithizone
8-hydrozyquinolone
(adapted from Rees and Alcolado, 2005)

Dietary strategies to induce diabetes
Dietary modulation can trigger diabetic symptoms in animal models. This
nutritional method causes DM associated with obesity resulting from over-nutrition.
Nutritional methods induce obesity and NIDDM in specific animal models including the
Sand rat, the Spiny mouse, and the C57BL/6J mouse, as well as general animals, by
affecting the glucose-stimulated insulin secretion mechanism.
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The Sand rats (Psammonys obesus) develop obesity and DM when they consume
a high-energy diet. The initial signs are hyperphagia, obesity, hyperinsulinemia, and
glucose intolerance. In later stages of the development, these animals show insulin
deficiency with β-cell degeneration and necrosis and ultimately require insulin injection
for survival (Shafrir and Ziv, 1998; Sahfrir, 2001). Spiny mice (Acomys calirinus) secrete
low levels of insulin in their natural habitat but develop diabetes when they consume a
high-energy diet. They gain weight rapidly and show severe pancreatic β-cell hyperplasia,
hypertrophy, and increased pancreatic insulin content. This animal model accumulates
insulin in β-cells, which may produce insulin deficiency and hyperglycemia (Velasquez
et al., 1990; Srinivasan and Ramarao, 2007). The NIDDM can be induced by feeding a
high-fat diet to the C57BL/6J mouse. This mouse strain is highly susceptible to dietinduced obesity, NIDDM, and atherosclerosis (Surwit et al., 1988; Nishina et al., 1990).
The three aforementioned diabetic models are specific subspecies or strains that
are susceptible to nutrition-induced DM. A high-fat diet modulates circulating glucose
and insulin concentration in general (genetically normal) animal models as well (Kim et
al., 1995; Ahren et al., 1999).
Recently, Cerf (2007) reviewed how a high-fat diet modulates glucose sensing
and insulin secretion. Figure 2.9 shows a glucose-stimulated insulin secretion mechanism
and effects of a high-fat diet on this pathway. Glucose enters the β-cell through
membrane-bound glucose transporter isoform 2 (GLUT-2) and is phosphorylated to
glucose-6-phosphate by glucokinase. In the following glycolysis, the intracellular
ATP:ADP ratio increases, which triggers the inhibition of the ATP-sensitive K+ channels
and results in depolarization of the cell membrane. The depolarization activates voltagegated calcium channels and Ca2+ release from the intracellular store, which results in an
increased intracellular Ca2+ concentration. This electrical excitability causes exocytosis of
the insulin via the cell membrane. Adrenergic agonists are also involved in the insulin
secretion by regulating cAMP, protein kinase A, the ATP-sensitive K+ channels, and thus
insulin secretion (Kahn et al., 2006; Cerf, 2007).
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Glucose

⊕
⊝

GLUT-2

High Fat Diet
Saturated FFA

⊝

Glucose

⊝

Glucose-6-phosphate

TCA

⊕ ⊝

↑ [Ca2+]i

⊝

Oxidative
stress

⊕

Apoptosis

Pdx-1

↑ ATP:ADP ⊝
⊝

↑ cAMP

⊕

⊝

Glucokinase

⊕

KATP-channels

⊝

Ca2+-channels

Ca2+e

Insulin

Insulin
β-agonist
α-agonist

Figure 2.9. A high-fat diet regulation of glucose sensing and the glucose-stimulated
insulin secretion in the beta-cell. Ca2+e extracellular calcium, [Ca2+]i intracellular calcium
concentration, FFA free fatty acids, GLUT-2 glucose transporter isoform 2, Pdx-1
pancreatic duodenal homeobox-1, TCA tricarboxylic acid cycle. Solid arrows denote a
glucose-stimulated insulin secretion pathway; dotted arrows denote high fat diet
regulation (Adapted from Kahn et al., 2006; Cerf, 2007).
A high-fat diet and saturated free fatty acids increase circulating plasma glucose
concentration. However, they inhibit the expression of the glucose transporter (GLUT-2)
and glucokinase, which down regulates the increase of ATP:ADP ratio and subsequently
inhibits insulin secretion. In addition, a high-fat diet and saturated free fatty acids reduce
the expression of pancreatic duodenal homeobox-1. Pancreatic duodenal homeobox-1,
mainly found in the nucleus, is a crucial transcription factor regulating β-cell
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maintenance. Although this transcription factor is not directly involved in the glucosestimulated insulin secretion pathway, it may indirectly inhibit the expression of GLUT-2
and insulin genes. A high-fat diet and saturated free fatty acids induce oxidative stress
and directly or indirectly cause β-cell death (Cerf, 2007).
The advantages of using nutritional methods are that this diabetes mimics
diabesity syndrome in the human population and that the over-nutrition is relatively nontoxic to the other organs of the body. However, this strategy requires a long period of
nutritional treatment to induce DM.

Breeding animals
Spontaneously diabetic animals can be obtained by inbreeding animals with
specific selection criteria for diabetes for several generations. Depending on the selection
criteria, both IDDM and NIDDM models can be developed. The spontaneous animal
models are listed in Table 2.8. The most commonly used inbred animal models for IDDM
are non-obese diabetic (NOD) mouse and bio breeding (BB) rat. The inbred animal for
NIDDM include ob/ob mouse, db/db mouse, Zucker rat, Goto Kakizaki rat, and Kuo
Kondo mouse (Rees and Alcolado, 2005; Srinivasan and Ramarao, 2007).
The NOD mouse was developed from outbred ‘Swiss’ mice in a selection
experiment in Japan (Makino et al., 1980). The NOD mouse develops insulitis, histologic
change (edema) in the islets of Langerhans, at the age of 4 to 5 weeks and circulating
insulin concentration decreases. Apparent diabetic symptoms can be observed at 12 to 20
weeks of age. In contrast to human IDDM, ketoacidosis is not very severe and the animal
can survive with the insulin administration (Atkinson and Leiter, 1999).
The BB rat was recognized in the Bio Breeding Laboratories, a breeding company
(Nakhooda et al., 1977). At about 10 weeks of age, the animals demonstrate
hyperglycemia, hypoinsulinemia, and hyperketonemia. Similarly to human IDDM, the
ketoacidosis is severe and the animals may die unless insulin is administered (Rees and
Alcolado, 2005).
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Table 2.8. Spontaneous animal models of diabetes mellitus
IDDM
NOD (non-obese diabetic) mouse
BB (bio breeding) rat
LETL (Long Evans Tokushima lean) rat
New Zealand white rabbit
Keeshong dog
NIDDM
ob/ob mouse - monogenic model of obesity (leptin deficient)
db/db mouse - monogenic model of obesity (leptin resistant)
Zucker (fa/fa) rat - monogenic model of obesity (leptin resistant)
GK (Goto Kakizaki) rat
KK (Kuo Kondo) mouse
NSY (Nagoya-Shibata-Yasuda) mouse
OLETF (Otsuka Long-Evans Tokushima fatty) rat
(Adapted from Rees and Alcolado, 2005)

The ob/ob (obese) mouse, also called Lepob, is derived from an autosomal
recessive mutation on chromosome 6 (obese) in C57BL/6J mouse strain. Leptin, an
appetite regulating hormone, is lacking in the ob/ob mice, which results in hyperphagia,
decreased energy expenditure, and obesity. The ob/ob mouse gains weight rapidly and
may become three times heavier that the wild type mouse. Apparent obesity with
increased carcass lipid can be observed at four weeks of age. In addition, these animals
develop diabetes-like symptoms including hyperglycemia, mild glucose intolerance,
severe hyperinsulinemia, and impaired wound healing (Srinivasan and Ramarao, 2007).
These animals exhibit both hypertrophy and hyperplasia of the pancreatic islets with
obesity (Velasquez et al., 1990). The administration of leptin into the ob/ob mouse results
in decreased body weight gain, lower feed intake, and improved insulin sensitivity
(Asensio et al., 2004).
The db/db (diabetic) mouse, also called Leprdb, is derived from an autosomal
recessive mutation on chromosome 4 in the C57BL/KsJ mouse strain. In this animal
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model, lack of leptin receptor leads to hyperphagia, obesity, hyperglycemia,
hyperinsulinemia, and insulin resistance within a month of age. At the age of four months,
hypoinsulinemia and hyperglycemia can be observed. In contrast to the ob/ob mouse, the
injection of leptin does not alleviate the diabetic symptoms in the db/db mouse. The
Zucker rat, also called Leprfa, is derived from the simple autosomal recessive gene (fa) on
chromosome 5. The metabolic characteristics of this rat are similar to the db/db mouse
(Srinivasan and Ramarao, 2007).
The advantage of the spontaneous diabetic animal models is that the
characteristics of the animals resemble those of human diabetes and the genetic
homogeneity decreases the variation in the experiments. However, the availability of the
inbred model animals is limited, and the animals are costly. Moreover, the mortality due
to the severe ketosis is high and the animals may need complicated maintenance care
including exogenous insulin administration (Srinivasan and Ramarao, 2007).

Gene targeting and transgenesis
Recent progress in molecular and embryological techniques enabled gene
targeting and transgenesis. Gene targeting means the process by which a gene may be
interrupted in an embryonic stem cell followed by the transmission along the germ cell
line. This process results in ‘knockout’ animals. Transgenesis refers to the incorporation
of transgenes (modified genes) into the pronucleus of a zygote (Rees and Alcolado, 2005).
The knockout and transgenic animal models have been extensively used in diabetes
research.
The target genes used to produce animals for insulin action studies include insulin
receptor, insulin receptor substrate, glucose transporter (GLUT-4), and peroxisome
proliferated receptor-γ. The disruption of one of these genes produces animals with the
characteristics of insulin resistance, hyperglycemia, and/or ketoacidosis. The insulin
secretion related genes, such as glucokinase and GLUT-2, have also been targeted to
develop animals lacking insulin secretion in response to glucose load. As previously
demonstrated, these genes play crucial roles in the glucose-stimulated insulin secretion
mechanism (Figure 2.4.1). Targeting multiple genes results in model animals lacking
both insulin action and insulin secretion. For instance, disrupting both insulin receptor
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substrate and glucokinase produced animals with insulin resistance and β-cell dysfunction
(Kadowaki, 2000; Nandi et al., 2004; Plum et al., 2005).
The gene targeting and transgenesis approach has produced animal models
exhibiting diabetic signs and has enabled the dissection of complex genetics of diabetes.
However, this approach is sophisticated and expensive for the model production and for
animal maintenance. Moreover, the lack of a gene may influence undesired tissues and/or
unintended periods of life such as during embryogenesis. Subsequently, animals may
have abnormality in other organs not of importance for diabetes study and may die even
before birth.
The limitations of the conventional gene targeting approach have been partially
overcome by recent technical advances. A major technical invention recently developed
is tissue-specific knockout method. This technique enables researchers to study the action
of insulin in specific target tissues such as muscle, adipose, and liver in diabetic objects
and to overcome the problems in classical knockout technique (Nandi et al., 2004; Plum
et al., 2005).
2.3.3. Diabetogenic chemicals
Alloxan
The name ‘alloxan’ was made as this substance was derived from a combination
of allantoin (a product of uric acid among others excreted by the fetus into the allantois)
and oxalsaure (oxaluric acid derived from oxalic acid and urea, found in urine). The
chemical structure of alloxan is shown in Figure 2.10, and this chemical is brownish-red
crystals and strongly hydrophilic. This substance is very unstable with a half-life of a few
minutes in water at room temperature and even less stable at body temperature
(McLetchie, 2002). In order to maximize the activity of alloxan, this chemical is
administrated to the animals shortly after being dissolved in an acidic buffer. Since the
diabetogenic properties of alloxan were first reported in rabbits (Dunn et al., 1943), it has
been widely used for the induction of experimental DM (Romsos et al., 1971; Fischer et
al., 1983; Katsumata et al, 1994; Huang and Wu, 2005).
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Figure 2.10. Chemical structure of alloxan
Alloxan has been widely used to induce diabetes in experimental animals because
of its selective toxicity to the β-cells of the pancreas (Romsos et al., 1971; Weaver et al.,
1978). In rat islets maintained in a simple perfusion system, the insulin release suddenly
reached to its maximum and rapidly declined to a very low level (Weaver et al., 1978). In
the same study, the presence of glucose reversed some of the subsequent inhibition of
insulin secretion by alloxan injection, suggesting that alloxan and glucose were sharing,
and thus competing for, a common transporter on the β-cell. Kliber et al. (1996) also
reported that alloxan treatment induced a sudden, short-term release of insulin and that a
high concentration of glucose in the perfusion media inhibited the alloxan effects.
The uptake of alloxan by β-cells is followed by the production of reactive oxygen
species in the alloxan reduction process (Heikkila et al., 1976). One of the reactive
oxygen species, H2O2, was shown to induce DNA strand breaks in the β-cells (Okamoto,
1985; Takasu et al., 1991).
The β-cell-specific toxicity to alloxan is notable. If alloxan administration causes
serious damage in other tissues, the animal model generated by alloxan may not represent
only DM but other disease or malfunctioning status. This diabetogenic chemical may
cause liver and kidney damage, but at dosages generally used to induce diabetes there is
no significant damage by routine examination methods (McLetchie, 2002). In addition,
Boquist et al. (1983) showed that the uptake of alloxan was greater in endocrine pancreas
than in the other organs including liver, exocrine pancreas, and heart.
The diabetogenic action of alloxan depends on the nutritional status, the
administration route, the dosage level, and the animal species. Perhaps because alloxan
competes with glucose for a common transporter (Weaver et al., 1978; Kliber et al.,
1996), fasted animals were more susceptible to alloxan than those provided glucose
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administration (Szkudelski et al., 1998). The animals injected with glucose represent
nutritionally a post-prandial status. The effective dose of intravenous alloxan injection
ranges generally from 40 to 60 mg/kg BW in mice (Fischer et al., 1983; Huang and Wu,
2005) and rats (Matsushita et al., 1989; Diaz et al., 1996). When alloxan is administered
intramuscularly or intraperitoneally, the effective dosage levels are between 120 and 200
mg/kg BW in rats (Katsumata et al., 1994; Khandkar et al., 1995).
Compared with the rodent models, swine are more resistant to alloxan toxicity.
O’Hea and Leveille (1970) failed to induce DM by an intravenous administration of 50
mg/kg BW alloxan to 12 kg pigs. Romsos et al. (1971) observed three- to four-fold
increased blood glucose in alloxan injected pigs with 200 mg/kg BW of dosage. In the
same experiment, alloxan induced DM in pigs fasted for 48 h and in pigs provided with
NH4Cl in drinking water whereas animals fed diet continuously did not show any diabetic
signs. The continuous feeding results in an elevated level of blood glucose which is
competing with alloxan for a transporter on the β-cells. The provision of NH4Cl induces
systemic acidosis and thus may potentiate the diabetogenic action of alloxan. Emmrich et
al. (1982) observed increased glucose with very low insulin in the pigs injected with 100
mg/kg BW of alloxan whereas a 200 mg/kg BW dose resulted in only fatal outcomes. In
the case of pregnant pigs, an intravenous injection of 50 mg/kg BW of alloxan induced
gestational diabetes (Ramsay et al., 1995). The low sensitivity of pigs to alloxan may be
related to the low expression of GLUT-2 in the β-cells (Dufrane et al., 2006). Thus, the
optimum dose of alloxan for DM induction in pigs is higher than in rodent models, but it
varies depending on many factors including nutritional status, acidic condition, and the
physiological stage of the pigs.
Alloxan has been widely employed to produce diabetic animal models due to its
β-cell specific toxicity. In addition to the rodents, swine can also be used as a diabetic
model with a high dose of alloxan.

Streptozotocin
Streptozotocin is an antibiotic synthesized by Streptomycetes achromogenes. The
chemical structure of streptozotocin is shown in Figure 2.11. This chemical is structurally
a glucosamine derivative of nitrosourea. The glucose portion is responsible for the
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transport across the cell membrane via a glucose transporter (GLUT-2), and the
nitrosourea triggers toxic action in the cells (Srinivasan and Ramarao, 2007). The
diabetogenicity of streptozotocin was first reported in dogs and rats by Rakieten et al.
(1963). Like alloxan, streptozotocin induces DM by destroying pancreatic β-cells. But
this diabetogenic agent has a longer half-life (15 minutes) and lower mortality than
alloxan in diabetic animal production (Ozturk et al., 1996).
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Figure 2.11. Chemical structure of streptozotocin
The manner of diabetogenic action of streptozotocin is similar to that of alloxan,
while the toxicity is induced by a different mechanism. West et al. (1996)
intraperitoneally injected 80 mg/kg BW of streptozotocin to fasted rats. They reported
hypoglycemia associated with a high concentration of circulating insulin at 6 h after the
streptozotocin injection and subsequent hyperglycemia development related with
decreasing levels of plasma insulin. The damages of the β-cells were also observed in
histological examinations. This observation is similar to the manner of alloxan action
(Weaver et al., 1978). However, streptozotocin has been reported to induce β-cell death
mainly by alkylation of DNA (Elsner et al., 2000), while the toxicity alloxan is derived
from reactive oxygen species (Takasu et al., 1991).
The dosage level of streptozotocin varies in the literatures. In rodents, intravenous
injection doses varied from 60 to 240 mg/kg BW for diabetogenic action (Weber et al.,
1984; Almdal et al., 1986; Gorska et al., 2004), and intraperitoneal doses were between
40 and 200 mg/kg BW (Bansinath et al., 1991; Julu and Mutamba, 1991; Zhang et al.,
2002; Lau et al., 2006). The most frequently used dose of streptozotocin was between 60
to 100 mg/kg BW in both intravenous and intraperitoneal routes of administration. The
similarity in dosage levels of streptozotocin in both injection methods may be due to the
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relatively long half-life of streptozotocin. Jamal and Saggerson (1988) induced DM in
rats by subcutaneous administration of 100 mg/kg BW of streptozotocin.
In the case of pigs, Gabel et al. (1985) reported that 100 to 150 mg/kg BW of
streptozotocin induced a complete and permanent DM in a titration study. When 35
mg/kg BW of streptozotocin was injected, glucose metabolism was unaffected, but 85
mg/kg BW of the chemical resulted in transient diabetic signs. Other studies employing
swine as a model used 100 to 150 mg/kg BW as the streptozotocin dosage (Edwards et al.,
1996; Ramsay and White, 2000; Koopmans et al., 2006). In a recent study, a low dose, 50
mg/kg BW, did not affect circulating glucose whereas 150 mg/kg BW of streptozotocin
caused blood glucose elevation by 4.5-fold (Dufrane et al., 2006). In the same experiment,
a low dose of 50 mg/kg BW streptozotocin destroyed over 97% of the β-cell mass in rats
and primates, and the destructed β-cells were not regenerated at least for six months. In
contrast, pigs showed partial correction of hyperglycemia even at the high dose of 150
mg/kg BW streptozotocin, and destroyed cells were regenerated. The low sensitivity of
pigs to streptozotocin toxicity may be related to the low expression of GLUT-2 (Dufrane
et al., 2006).
Streptozotocin has been widely used to induce diabetes in model animals due to
its β-cell specific toxicity. This diabetogenic agent can more easily induce diabetes than
alloxan because of the higher stability. In pigs, the diabetogenic action of streptozotocin
may be effective for a relatively short period.

Dexamethasone
The administration of glucocorticoids reduces inflammation and immune
activation in transplantation, asthma, allergic disease, and many systemic diseases.
However, excess glucocorticoid decreases insulin sensitivity leading to the metabolic
syndromes including insulin resistance and hypertension (Schäcke et al., 2002). The
negative aspects of glucocorticoids have been applied to induce DM in animal models.
Dexamethasone is a synthetic form of glucocorticoid hormone (Figure 2.12) and has been
used as a diabetogenic agent in animal models (Ogawa et al., 1992; Ohneda et al., 1993;
Novelli et al., 1999; Bernal-Mizrachi et al., 2003).
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Figure 2.12. Chemical structure of dexamethasone
Although dexamethasone induces insulin resistance in genetically normal animal
models, the diabetogenic action of this steroid is more apparent in inbred animal models.
All the obese Zucker (fa/fa) rats (n=5) showed diabetic symptoms by a single
intraperitoneal injection of a small dose (0.4 mg/kg BW) (Ohneda et al., 1993). However,
the daily intraperitoneal administration of 5 mg/kg BW for 24 d induced DM only in 4
out of 25 normal Wistar rats (Ogawa et al., 1992). The effectiveness of dexamethasone is
also dependent upon the age of the animals. Novelli et al. (1999) reported that the
subcutaneous daily injection of dexamethasone (0.13 mg/kg BW) for 13 d increased
plasma glucose up to diabetic levels in most of 18-month-old and in all 26-month-old
Sprague-Dawley (genetically normal) rats. In 3-month-old rats, however, plasma glucose
was unaffected by dexamethasone administration.
In swine, instead of diabetogenic action of dexamethasone, studies have focused
on its positive effects such as growth promotion. The intramuscular injection of this
chemical (1 mg/kg BW) within 1 h of birth increased weaning BW by 10 to 23% (Carroll,
2001; Seaman-Bridges et al., 2003). Gaines et al. (2002) also observed 10% increased
weaning BW in pigs injected with 2 mg/kg BW of dexamethasone within 24 h of birth.
Carroll (2001) reported increased insulin-like growth factor I associated with the
increased weight gain in the suckling piglets. However, Gaines et al. (2004) failed to
demonstrate the growth promoting effect of dexamethasone in the commercial condition
perhaps due to the rather good experimental environment compared to their previous
experiment (Gaines et al., 2002).
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Dexamethasone is a less efficient diabetogenic agent compared to alloxan and
streptozotocin. But this steroid is useful for insulin resistance related studies and
glucocorticoid-induced diabetes research.
2.3.4. Chromium effects in diabetes
The essentiality of Cr in blood glucose regulation was first reported in the late
fifties (Schwarz and Mertz, 1959) and the roles of Cr have been widely studied in humans
(Ravina et al., 1999ab; Anderson et al., 1997; Cheng et al., 2004), animals (Schroeder,
1966; Raz and Havivi, 1988; Lindemann et al., 1995), and in vitro models
(Deliconstantinos et al., 1984; Chang et al., 1996). A well-known function of Cr is its
action on the insulin potentiation (Mertz et al., 1974; Vincent, 2000). Although detailed
mechanisms of Cr have not been fully understood, the effect of Cr on glucose metabolism
has been shown in diabetic animal models and human patients. The beneficial effects of
Cr have been reported mostly in NIDDM due to the direct effect of Cr on insulin action.
In the other types of DM including non-insulin-dependent, gestational, and steroidinduced DM, the disease symptoms and signs were alleviated with the supplemental Cr.
However, the diabetes alleviating effects of dietary Cr have been inconsistent in clinical
and experimental conditions (Anderson, 2000; Cefalu and Hu, 2004).

Insulin potentiation action of chromium
The major role of Cr is involved with the effects of insulin on the uptake of
glucose in the muscle and adipose tissue. Chromium has been reported to inhibit
phosphotyrosine phosphatase which decreases insulin sensitivity (Davis et al., 1996). In
other words, Cr increases insulin sensitivity. In addition, Cr has been suggested to
improve insulin binding, insulin receptor number, insulin internalization, and β-cell
sensitivity (Anderson, 1997). At the cellular level, the action of Cr for glucose and insulin
metabolism is achieved via a low-molecular-weight chromium-binding substance
(chromodulin). Vincent (2000) proposed the cellular mechanism of action for Cr and
chromodulin in response to insulin (Figure 2.13). The major carrier protein for Cr is
transferrin in the circulation system. When the insulin receptor is activated by the binding
of insulin to its receptor in the insulin-sensitive cells, the transferrin receptors migrate to
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the plasma membrane and the Cr bound to tranferrin is internalized by endocytosis. Then,
the Cr is released from transferrin and transferred to an apo (inactive) form of
chromodulin to make a holo (active) form of chromodulin, resulting in the binding of
holochromodulin to an insulin receptor. The result of this process is an increase of
insulin-dependent kinase activity and thus enhancing the function of insulin. With the
decrease of circulating insulin concentration, the holochromium is eliminated from cells.

Cr-transferrin

In

Cr3+

InR

InR

Apochromodulin

Apochromodulin

Insulin-Sensitive Cell

chromodulin

In

Insulin Receptor Activated

Lowering of insulin
concentration in blood

Holochromodulin

InR

In

InR

In

Holochromodulin

Insulin Receptor Fully Activated

Chromodulin Loaded With Cr

Figure 2.13. Proposed mechanism of action for chromium and chromodulin potentiating
the action of insulin. The inactive form of the insulin receptor (InR) is converted to the
active form by binding insulin (In). This triggers a movement of Cr (presumably in the
form of Cr-transferrin) from the blood into insulin-dependent cells, which in turn results
in the binding of Cr to apochromodulin (triangle). Finally, the holochromodulin (square)
binds to the insulin receptor, further activating the receptor kinase activity.
Apochromodulin is unable to bind to the insulin receptor and activate kinase activity.
When the insulin concentration drops, holochromodulin is released from the cell to
relieve its effects (Adapted from Vincent, 2000).
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Effects of chromium on IDDM
In a few clinical studies, beneficial effects of Cr supplementation on IDDM
patients have been observed, although most of the clinical reports on the effects of Cr
were in NIDDM patients. Ravina et al. (1995) reported that 10 d of supplemental Cr (200
μg/d) as CrPic increased insulin sensitivity in IDDM patients. These patients were able to
reduce the insulin dose by 30%. Fox and Sabovic (1998) also reported that glycosylated
hemoglobin (HbA1c) decreased from 11.3% to 7.9% in a 28-year-old female patient with
an 18 year history of IDDM by the supplemental Cr (three times of 200 μg/d) as CrPic.
The measured hemoglobin, HbA1c, represents average circulating glucose concentration
over the previous few weeks to months (Koenig et al., 1976), thus the cumulative
concentration of blood glucose.
Recently, Shindea et al. (2004) produced IDDM rats by injecting streptozotocin
intravenously (40 mg/kg BW) to adult rats. The supplementation of CrPic in the drinking
water for six weeks decreased cumulative glucose concentration (35.4 vs. 19.2 g/dL 120
min) during the first 2 h after insulin injection. This result was accompanied by increased
insulin sensitivity index in the insulin tolerance test with Cr treatment.

Effects of chromium on NIDDM
The clinical effects of Cr have been studied most frequently in NIDDM patients
and animal models. In many studies, dietary supplementation of Cr improved glucose and
insulin variables. However, others failed to demonstrate significant improvements by Cr
in NIDDM.
A number of clinical studies showed beneficial effects of Cr in NIDDM patients.
Anderson et al. (1997) investigated the effects of supplemental Cr on HbA1c, glucose,
insulin, and cholesterol in patients with NIDDM. Compared with a placebo group, the
patients receiving Cr (1 mg/d as CrPic) for four months had lower HbA1c, fasting
glucose, 2-h glucose (2 h after glucose administration), fasting insulin, 2-h insulin, and
total cholesterol. In the same study, four months of Cr supplementation relieved most of
the DM criteria, whereas two months of Cr provision improved only a few criteria. The
high dose of Cr (1 mg/d) showed quite clear improvements, but the responses to 0.2 mg/d
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of Cr supplementation were not as significant as the high dose. Ghosh et al. (2002) also
reported that the supplemental CrPic for 12 weeks reduced fasting serum glucose, postprandial serum glucose, HbA1, and fasting insulin in NIDDM patients. In elderly
(average 73 years old) NIDDM patients, Cr (0.4 mg/d as CrPic for three weeks) lowered
fasting blood glucose, HbA1c, and total cholesterol (Rabinovitz et al., 2004). The
positive effects of dietary CrPic on glucose and insulin metabolism were reported also in
NIDDM patients receiving sulfonylurea, a drug that stimulates pancreatic cells to release
insulin (Martin et al., 2006). Recently, the combination of CrPic and biotin was shown to
improve glucose management in NIDDM patients (Singer and Geohas, 2006).
In agreement with the aforementioned clinical studies, the beneficial effects of Cr
have been reported in NIDDM model animals. Yoshimoto et al. (1992) tested the effect
of Cr administration on glucose tolerance in streptozotocin-induced NIDDM rats.
Intraperitoneally administered Cr (20 μg/d/kg BW for four weeks) reduced plasma
glucose concentration after intraperitoneal glucose injection. More recently, Shindea et al.
(2004) produced NIDDM rats by intraperitoneally injecting streptozotocin (90 mg/kg
BW) to 2-d-old neonate rats and investigated the effects of CrPic in drinking water on
NIDDM. The provision of CrPic for six weeks decreased cumulative glucose
concentration during the first 2 h after insulin injection and increased insulin sensitivity
index.
However, dietary supplementation of Cr (0.1 mg/d as Cr yeast for eight weeks)
had no effects on glucose tolerance, plasma insulin, and lipoprotein in NIDDM patients
(Trow et al., 2000). Moreover, high dose of CrPic (1 mg/d) was reported to have no
effects on weight, blood pressure, HbA1c, or lipid profile compared with a placebo group
(Kleefstra et al., 2006). The lack of response in the report of Trow et al. (2000) can be
explained by the differences in the source of Cr, and the dosage level compared with
Anderson et al. (1997). However, Kleefstra et al. (2006) used the same source and dose
of Cr with Anderson et al. (1997). Kleefstra et al. (2006) postulated that the difference in
the population, thus different nutritional Cr status, resulted in the lack of Cr effects. They
used the NIDDM subjects from western population whereas NIDDM patients in
Anderson et al. (1997) were from Chinese population.
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The beneficial effects of supplemental Cr in NIDDM patients have been reported
in many papers. The lack of effects in other studies can be partially explained by the
differences in Cr source, dose, and nutritional status. However, the inconsistency of Cr
effects has not been fully understood.

Effects of chromium on gestational DM
Gestational DM refers to glucose intolerance with onset or first recognition during
pregnancy (American Diabetes Association, 2002). An insulin-resistant state increases
during pregnancy and gestational DM occurs if the maternal pancreas is unable to
increase insulin production enough to compensate for the increased needs (JovanovicPeterson and Peterson, 1996). If a woman with gestational DM is deficient in Cr, dietary
Cr may improve glucose and insulin metabolism in gestational DM patients. The
deficiency of Cr in pregnancy can often occur by an increase in urinary Cr excretion
(Saner, 1981) and an accumulation of Cr in the developing fetus (Davidson and Burt,
1973) with advancing pregnancy. Thus, it may be postulated that nutritional
supplementation of Cr to the women with gestational DM would be beneficial. However,
available data on this topic are limited and inconclusive.
Positive effects of supplemental Cr on gestational DM were reported by
Jovanovic et al. (1999). They provided 0, 4, or 8 μg/d/kg BW of Cr as CrPic for eight
weeks to the women with gestational DM. The supplemental Cr lowered fasting glucose
and insulin level compared with the placebo group. In a pregnant gilt study, Lindemann
et al. (1995) also reported that supplemental CrPic alleviated serum insulin at 2 h after
feeding, the change of serum insulin concentration from prefeeding levels, and the ratio
of insulin to glucose. However, Aharoni et al. (1992) found that the hair Cr content in the
women with gestational DM was rather higher than in normal pregnancy. They suggested
that the glucose intolerance in gestational DM may be due to impaired Cr utilization but
not because of Cr deficiency. In an animal experiment, no effect of dietary CrK(SO4)2 on
hyperglycemia or pregnancy outcome was observed in the streptozotocin-induced
diabetic pregnant rats (Spicer et al., 1998).
Although the beneficial effects of Cr in gestational DM can be logically expected,
the responses to Cr have been unclear. The inconsistency in the literature may be related
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to the dose of Cr, the form of supplemented Cr, and physiological differences among the
species.

Effects of chromium on steroid-induced DM
Steroid hormones, especially glucocorticoids oppose the action of insulin and
increase gluconeogenesis. If the insulin resistance by excessive glucocorticoid cannot be
compensated by additional insulin secretion, steroid-induced DM may occur (Andrews
and Walker, 1999). The glucocorticoids are often administered as an anti-inflammatory
and anti-immune activation agent to humans with asthma, allergic disease, on systemic
diseases or with organ transplantation (Schäcke et al., 2002). Thus steroid-induced DM
often occurs as a side effect of a glucocorticoid therapy. Because Cr improves insulin
sensitivity and alleviates stresses, it can be postulated that Cr may positively influence
steroid-induced DM.
Ravina et al. (1999a) observed an increase of daily urinary Cr excretion in the
first 3 d following corticosteroid treatment. In the same study, CrPic supplementation of
patients with steroid-induced DM decreased fasting glucose. The required amount of
hypoglycemic agents to maintain a normal glucose level was also decreased by 50% with
supplemental Cr. These results were confirmed in a follow-up study by the same group
(Ravina et al., 1999b). More recently, Kim et al. (2002) conducted an experiment to
investigate the effects of CrPic on dexamethasone-treated rats. In the insulin sensitivity
test, cumulative glucose concentration during the first 2 h after insulin injection was
decreased by CrPic treatment. The dietary treatment of CrPic also reduced fasting serum
insulin levels and insulin concentration during the first 2 h after glucose load.
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2.4. Adrenal steroid hormone physiology
2.4.1. Anatomy of adrenal gland
Gross anatomy of the mammalian adrenal gland
The adrenal glands, also called suprarenal glands, are located close to the upper
surface of each kidney (Figure 2.14). Their shapes are slightly different. The left gland is
crescentic in shape, and the right gland is pyramidal in outline and resembles ‘a cockedhat.’ The average size of adult human adrenal gland is 5.0 cm by 2.5 cm along their major
axes, and the left gland is generally 2 to 3 mm wider (Neville and O’Hare, 1982). Usually,
peri-renal fat surrounds the adrenal gland (Asif, 2004), and arterial branches vascularize
the adrenal gland from the aorta (Hadley, 1996).

Figure 2.14. Gross anatomy of adrenal gland (Pickett, 2000)
The adrenal gland can be partitioned into a head, a body, and a tail in a
macroscopic examination (Figure 2.15). The head includes a large portion of medulla,
and the depth is up to 6 mm. The body contains some medullary tissue, and the tail
consists only of cortical tissue (Neville and O’Hare, 1979).
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Figure 2.15. Adrenal gland showing the central vein (CV) surrounded by the cuff of clear
cortical cells (CF) and its relationship to the distribution of the medulla (M) (Neville and
O’Hare, 1979)
The adrenal gland is composed of chromaffin and steroidogenic tissue. The
steroidogenic tissue, which is cortical mass of the adrenal gland, surrounds the
chromaffin tissue which is the inner medullary component. In many mammals, including
humans, the steroidogenic tissue is called the adrenal cortex, which comprises almost
90% of the mass of the adrenal gland. The chromaffin tissue is called adrenal medulla
which is the center of the gland (Hadley, 1996; Ross et al., 1995). The adrenal gland and
adrenal cortex are often thought to be separate glands, because they are structurally and
functionally different in spite of their similar location.
Concerning the close anatomical coupling of the cortex and medulla, several
interaction mechanisms have been suggested. In terms of hormone flow, released
products of the cortex perfuse the medulla through the blood vessel and sphincter-like
muscles in the central adrenal vein may regulate the blood flow. Steroidogenesis is also
interrelated between these two tissues. In the chromaffin tissue, many enzymatic
reactions of the cortex can be carried out, and thus steroid intermediates are converted
into active glucocorticoids (Hadley, 1996).
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Comparative anatomy of the adrenal gland
Adrenal glands of cows, horses, and pigs are dark brown color, whereas that of a
dog is light brown. Most of the adrenal glands look flat, and the pig adrenal has a small
indent. The location of adrenal glands varies according to the species. The adrenal of the
horse is attached to the inner side of the kidney. Ruminants, pigs, and dogs have the
adrenal gland more on the cranial side of the kidney compared to horses. The left adrenal
gland of a dog is a little apart from the kidney, and the rabbit adrenal gland is positioned
quite far from the kidney (Yoon, 1996).

Microscopic anatomy of the adrenal gland
The adrenal cortex can be partitioned into three morphologically and functionally
different layers: zona glomerulosa, zona fasciculata, and zona reticularis (Figure 2.16).
The narrow outer zona glomerulosa, the thick middle zona fasciculate, and the inner
reticularis constitute 15%, 80%, and 5 to 7% of the cortical volume, respectively (Ross et
al., 1995).

Figure 2.16. Three cortical zones and medula of adrenal gland (Austgen et al., 1998)
The blood is supplied to the adrenal glands through the superior, middle, and
inferior adrenal arteries (Figure 2.17). These blood vessels branch out and make many
small arteries when the vessels enter the capsule. Cortical arteries and arterioles branch

63

into capillary beds inside the cortical region, and these vessels merge into veins at the
corticomedullary junction. Medullary arteries and arterioles, which penetrate the cortical
region without branching and splitting, form capillary beds in the medulla (Ross et al.,
1995; Austgen et al., 1998).
A number of preganglionic sympathetic nerve fibers are linked to parenchymal
cells of the adrenal medulla. Because catecholamine-secreting medullary cells respond to
nerve impulses delivered through the sympathetic fibers, medullary cells are considered
postganglionic neuron equivalents (Ross et al., 1995).

Figure 2.17. Vasculature of adrenal gland (Austgen et al., 1998)
From an experimental point of view, three different zones of the adrenal cortex
are not easy to culture together and represent the steroidogenesis pathway (described in
the next section). The H295R adrenocortical carcinoma would be a good model for
studying the metabolism of adrenocortical steroid synthesis because the pluri-potent cells
synthesize three major adrenal steroids: aldosterone, cortisol and dehydroepiandrosterone
(Rainey et al., 1994). In addition, the H295R cells are useful in molecular level research
(Bassett et al., 2004a; Metzeler et al., 2004).
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2.4.2. Chemistry and biochemistry of adrenal steroids
Chemical nature of a steroid
One of the most important chemical characteristics of a steroid is the fact that it is
mostly lipid soluble. Until 1929, scientists failed to demonstrate the effect of adrenal
cortex extract in adrenalectomized animals because they assumed that the compound in
question was water soluble (Samuels and Uchikawa, 1967).
A steroid is an organic molecule, and its structure is composed of the tetracyclic
ring system (Figure 2.18). All the steroids produced from the adrenal cortex contain the
cyclopentanoperhydrophenanthrene nucleus (Hadley, 1996). The four rings are named A,
B, C, and D from lower left, and the carbon atom numbers start from the A ring. At room
temperature, cyclohexane rings are conformationally mobile. In a steroid, however,
cyclohexane ring-flips are constrained by rigid conformations of three cyclohexane rings
which adopt an energy-minimizing chair conformation (McMurry, 1994).
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Figure 2.18. A steroid

Adrenal steroids
Adrenal cortex cells produce various kinds of steroids from cholesterol. The
major adrenal steroids are shown in Figure 2.19. In early in vivo studies, scientists
compared the steroid concentration difference between adrenal venous blood and arterial
blood. The steroids present in higher concentration in venous blood than in arterial blood
were considered to be released from the adrenal gland (Samuels and Uchikawa, 1967).
The adrenal steroid hormones are grouped into three categories by their effects.
The names of these categories were also according to their biological effects:
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mineralocorticoids, glucocorticoids, and gonadocorticoids. Aldosterone secreted from the
zona glomerulosa is a main mineralocorticoid hormone and regulates electrolyte
homeostasis. Cortisol secreted from the zona fasciculata is a main glucocorticoid
hormone. Glucose metabolism regulation is one of the functions of cortisol. Adrenal
gonadocorticoids, which are not significant in quantity, function as sex steroids (Ross et
al., 1995; Hadley, 1996).

Biochemical pathways of adrenal steroidogenesis
Major pathways and enzymes in adrenal steroidogenesis are shown in Figure 2.19.
Cholesterol is the precursor for adrenal steroid hormone biosynthesis. Cholesterol is
converted to pregnenolone by the enzyme desmolase, which is required to cleave the
terminal six carbons of the side chain of cholesterol (Hadley, 1996).
Pregnenolone is a common precursor of numerous steroidogenic pathways.
Pregnenolone can be converted either to progesterone or 17α-hydroxy pregnenolone by
different enzymes. The enzyme 3β-hydroxysteroid dehydrogenase converts pregnenolone
to progesterone by oxidizing the hydroxyl group at C3. The enzyme 17α-hydroxylase
converts pregnenolone to 17α-hydroxy pregnenolone by hydroxylation of C17. For the
synthesis of aldosterone and cortisol, the action of 3β-hydroxysteroid dehydrogenase is
indispensable. The more 3β-hydroxysteroid dehydrogenase expresses, the less
dehydroepiandrosterone (DHEA) is synthesized (Mason et al., 1993). The 17αhydroxylase has been suggested to compete with the 3β-hydroxysteroid dehydrogenase
(Conley and Bird, 1997). The competition between these two enzymes influences the
production of aldosterone versus cortisol and DHEA.
In the zona fasciculata, pregnenolone is transformed into progesterone, and
hydroxyls are successively added at C17 and C21. The resultant 11-deoxycortisol is
hydroxylated in C11. Aldosterone is secreted exclusively in the zona glomerulosa. The
last step of hydroxylation by 11β-hydroxylase is essential in synthesizing glucocorticoid.
Deoxycorticosterone is synthesized by similar steps as in the zona fasciculata. However
the critical last step to synthesize aldosterone is catalyzed by 18-hydroxylase and 18-OHdehydrogenase (Bern and Levy, 2000)
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Figure 2.19. Major pathways in adrenal steroidogenesis (Adapted from Hadley, 1996)
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2.4.3. Secretion
Hypothalamic-pituitary-adrenal axis
Hypothalamic corticotrophin-releasing hormone (CRH) controls the release of
pituitary adrenocorticotropic hormone (ACTH). The pituitary ACTH modulates cortisol
release by the cells of the fasciculata zone. Blood concentration of cortisol regulates CRH
secretion from the hypothalamus and ACTH secretion from the anterior pituitary by
feedback mechanism (Figure 2.20). In addition, physiological actions induced by
corticosteroids can also inhibit further corticosteroid secretion through the negative
feedback on the adrenal cortex, the anterior pituitary, the hypothalamus, and the higher
brain centers (Ross et al., 1995). Homeostasis of cortisol secretion is modulated by this
negative feedback mechanism of cortisol and physiological action induced by
corticosteroids.

Hypothalamus
(―)
CRH (Corticotropin-Releasing Hormone)

Anterior Pituitary
(―)
ACTH (Adrenocorticotropic Hormone)

Adrenal Cortex

Cortisol

Figure 2.20. Hypothalamus-pituitary-adrenal axis
Adrenal corticosteroids negatively regulate mRNA and peptide expression of
CRH in parvocellular neurosecretory neurons; whereas, many stressors positively
regulate CRH (Sawchenko et al., 1993). In adrenalectomized rats, antisera to ovine CRH
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lowered the ACTH level, which showed the stimulatory effect of CRH on ACTH
secretion (Chrousos, 1992).
A suggested mechanism of ACTH on adrenal steroidogenesis is illustrated in
Figure 2.21. ACTH interacts with the plasmalemma of the zona fasciculata cells,
resulting in increased intracellular cAMP and Ca2+ which ultimately activates the enzyme
system of cortisol biosynthesis. After ACTH binds to the melanocortin 2 receptor (Liakos
et al., 1998), ACTH activates cAMP production through adenylyl cyclases, and Ca2+
enters the cell through ionic channels. Calcium ion and protein kinase A (PKA) activated
by cAMP stimulate the expression of enzymes and transcription factors (Gallo-Payet and
Payet, 2003). Recently, nerve growth factor-induced clone B (NGFIB) was suggested to
play an important role in regulating 3β-hydroxysteroid dehydrogenase (Bassett et al.,
2004b).

ACTH
Melanocortin 2 receptor
Ca2+

cAMP

(ionic channels)

(adenylyl cyclases)

PKA
(phosphodiesterases, phosphatases)

P450/3β-HSD

Steroid release

Transcription factors

Steroid synthesis

Figure 2.21. Proposed mechanism of ACTH on adrenal cortex (adapted from Gallo-Payet
and Payet, 2003)
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The interactions between secretagogues, such as CRH and arginine-vasopressin
(AVP), and inhibitors, such as cortisol, were studied by Evans et al. (1996). They
reported that CRH may protect the ACTH response to pulses of AVP in the presence of
cortisol. In other words, background CRH can allow an increase in ACTH in response to
AVP released by a new stress, in spite of the presence of an elevated cortisol level.
Livesey et al. (2000), the same author group as Evans et al. (1996), further elucidated the
interaction using dispersed equine anterior pituitary cells. They suggested that when the
CRH level is physiologically high, it “permissively” prevented the cortisol-induced
inhibition of the ACTH response to AVP. A basal level of cortisol “permissively” primed
the HPA axis to maximally respond to stimulated levels of CRH and AVP.

Cortisol patterns in blood
The activity of the HPA system cyclicly changes over a 24-h diurnal period. The
blood level of cortisol peaks between 3 and 8 am with a nadir at 18 to midnight. A similar
pattern of pituitary ACTH secretion results in a diurnal rhythm of cortisol secretion
(Jones, 1979). The detailed mechanism of ACTH on cortisol secretion is shown in Figure
2.21. The cortisol rhythm is mainly regulated by the autonomic nervous system (Buijs
and Kalsbeek, 2001). The diurnal rhythm of blood ACTH and cortisol is not present in
patients with Cushing’s disease because of the high level of ACTH and cortisol secretion
(Jones, 1979).
2.4.4. Transport of adrenal steroid hormones
Steroid hormones circulation – steroid binding protein
The adrenal steroids are secreted into the blood, followed by the circulation to all
parts of the body through the blood vessels. Most steroid hormones are transported to
their target tissues by plasma proteins. Albumin nonspecifically binds most steroids.
However, the affinities of albumin to cortisol, testosterone, and estradiol are low. These
steroids are bound to specific binding proteins such as sex hormone binding globulin and
cortisol binding globulin with higher affinity (Table 2.9). The concentration of the
specific binding proteins is relatively low; whereas, the non-specific binding proteins are
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present in high concentrations and thus have high capacity to bind steroids (Brooks,
1979).

Table 2.9. Steroid binding proteins in the plasma
Parameter

Albumin

Sex hormone
binding globulin

Cortisol binding
globulin

Concentration (moles/liter)

5.0 × 10-4

3.9 × 10-8

6.0 × 10-7

Association constant [(moles/liter)-1] at 37°C
Cortisol

0.3 × 104

3.0 × 107

Progesterone

12.0 × 104

9.5 × 107

Aldosterone

0.3 × 104

6.5 × 108

Testosterone

3.6 × 104

1.9 × 109

Estradiol

6.0 × 104

6.0 × 108

1.4 × 106

(Brooks, 1979)
The transcortin or corticosteroid-binding globulin (CBG) is a major cortisol
binding protein, and with a lower affinity α-2 globulin also binds cortisol. Over 90% of
cortisol is transported as bound to protein, and only about 6% of cortisol as unbound form
(Hadley, 1996). Cortisol has a higher association constant (affinity) with CBG than with
albumin (Table 2.9). Therefore, the binding to cortisol to albumin occurs only when CBG
is limiting. The concentration of estrogen influences the CBG level as well as sex
hormone binding globulin concentration (Vinson et al., 1992).

Physiological significance of CBG
The steroids bound to a binding protein are not utilized at target tissues, and only
free hormones can enter cells and metabolize inside the cells (‘free hormone hypothesis’;
Mendel, 1989). According to this hypothesis, the major role of CBG is to control the
availability of corticosteroids (Westphal, 1983). Although many scientists agree that free

71

hormone may be the primary regulator of the action of hormone, more complex action of
CBG has been reported (Breuner and Orchinik, 2002).
In normal conditions, CBG provides a reservoir of cortisol. Different
physiological or environmental conditions increase the level of unbound cortisol
available to tissues by lowering the total CBG capacity. Tinnikov (1993) reported that
starvation or immobilization decreased the total CBG capacity. Social stress (Alexander
and Irvine, 1998; Spencer et al., 1996) and electric shock on the tail (Fleshner et al.,
1995) also decreased the capacity of CBG.
The cell membrane CBG receptor may uptake CBG-corticosteroid complex
across the membrane. Endocytosis is another possibility for CBG complex internalization.
In the cell, cortisol would be cleaved from CBG as an active form of unbound cortisol.
The membrane binding sites for CBG have been identified in human (Hryb et al., 1986)
and rat (Maitra et al., 1993) livers.
The cellular cAMP stimulating effect of CBG has also been reported (Nakhla et
al., 1988; Strel’chyonok and Avvakumov, 1991). In both studies, unbound CBG showed
no effect. Meanwhile the CBG-cortisol complex bound to the cell membrane receptor and
increased the intracellular cAMP level. Therefore, the CBG molecule has its own
biological activity as well as storage and delivery functions.
2.4.5. Action of glucocorticoid
Hormone receptors
Hormones are delivered to all parts of the body through the blood vessel.
However, they regulate only specific target tissues, not all cells. Different tissues express
different types of proteins. A major protein contributing to allow hormone specificity is a
hormone receptor. Receptors may be membrane bound, cytosolic, or nuclear elements
(Hadley, 1996).
The importance of hormone receptors may be explained by abnormal receptor
expressions as suggested by Hadley (1996). If a cortisol receptor is absent in a tissue, the
tissue would be irresponsive to cortisol secreted to play important roles. If cortisol
receptors were concentrated in the left fingers’ muscle cells, stress would make the left
fingers atrophic and weak, and there would be insufficient cortisol for normal purposes.
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Furthermore, if all the tissues have non-specific hormone receptors, all the tissues will
respond to a single hormone. Therefore, the existence, specificity and normal quantity of
hormone receptors in tissues are important in hormone action in the body.
The specificity of hormone receptors can be applied in medical therapy. For
example, abnormally high levels of a certain hormone secretion might be treated by
administration of a drug which binds to the hormone receptor but lacks intrinsic
biological activity (Hadley, 1996).

Steroid hormone – receptor interaction
Steroid hormones freely diffuse into cells due to their hydrophobicity. In a
classical model of steroid hormone action, steroid receptors in the cell change their
conformation in response to hormones and act as transcription factors. A stepwise
mechanism is described as follows (Figure 2.22). The steroid hormone binds to its
cytoplasmic or nuclear hormone receptor specifically with high affinity. The receptor is
activated into DNA-binding form. The hormone-receptor complex binds to hormone
response elements in the promoter region of genes. Then, mRNA is translated into cellspecific protein synthesis (Hadley, 1996).

Figure 2.22. Steroid hormone – receptor interaction (Kimball, 2005)
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Besides the receptor mediated action of steroid hormones, direct membrane
actions of steroid hormones also exist. The receptor-independent fast action of steroid
hormones in the neuronal membrane has been reported by Orchinik et al. (1991). The
rapid signal transduction through neuronal membrane receptors were suggested to be
mediated by guanine nucleotide-binding proteins (Orchinik et al., 1992).

Glucocorticoid receptor
The glucocorticoid receptor (GR) is present in almost every tissue. In humans,
two types of highly homologous GR isoforms exist. Alternative splicing of the two
terminal exons of the encoding gene in chromosome 5 generates these two isoforms
(Figure 2.23). The classic form, GRα mediates most of the well known effects of cortisol;
while, the role of GRβ has not yet been elucidated (Beato et al., 1995; Bamberger et al.,
1995; Tliba et al., 2006).

Human Glucocorticoid Receptor
ATG
1

TGA, α
2

3
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TGA, β
9α

9β

Chromosome 5
GRα cDNA

1

2

3 4 5 6 7 8

GRβ cDNA

1

2

3 4 5 6 7 8

GRα

Immunogenic Domain

9α

9β

DBD

HR

LBD

Figure 2.23. Genomic, complementary DNA, and protein structures of the human
glucocorticoid receptor (GR). The human GR gene, located on chromosome 5, consists of
10 exons. Exon 1 is untranslated, exon 2 encodes for the immunogenic domain, exons 3
and 4 for the DNA binding domain (DBD), and exons 5–9 for the hinge region (HR) and
the ligand binding domain (LBD). The GR gene contains two terminal exons, 9α and 9β,
alternatively spliced to generate two isoforms, the classic GRα and the nonligand-binding
GRβ (Manoli et al., 2004).
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The GRα mechanism is shown in Figure 2.24. In the unliganded state, most of
GRα exists in the cytoplasm. Cytoplasmic GRα is complexed with other proteins such as
the heat-shock protein (Hsp) 90, 70, and 50; the immunophilin FKBP52; the cyclophilin
Cyp40; the p23 protein; and their related molecules (hip, hop). When glucorticoid binds
to the specific ligand binding domain (LBD) of GRα, the receptor changes its
conformation, is separated from the oligomeric complex, and forms the free cortisolreceptor subunit in the DNA-binding form. The activated receptor couples as a
homodimer and enters into the nucleus through the nucleopore. Inside the nucleus, the
receptor complex binds to specific glucocorticoid responsive elements (GRE) located in
the promoter region of responsive genes and changes their transcriptional activity
(Manoli et al., 2004).

75

cyp

cyp

p23
protein
hip

hsp 50

hop

p23
protein
hip

hop

hsp 50

cyp
p23
protein
hip

hop

hsp 50

Figure 2.24. Schematic illustration of the glucocorticoid receptor cell tracking and
signaling (adapted from Sigma-Aldrich, 2005)
The GR binding site of regulatory regions can be categorized by five different
binding types and two different effects (Figure 2.25). GR can activate gene transcription
by direct binding to so-called simple GRE (Figure 2.25.a). In many genes, the
glucocorticoid response depends on other transcription factors close to the binding sites
as well as GR binding to a GRE. Because these response elements are spatially and
functionally clustered, they are called glucocorticoid responsive units (Figure 2.25.b).
76

Besides homodimer binding to GREs, GR can also bind the DNA as a monomer, which is
called GRE half-sites (Figure 2.25.c). Occasionally, GR is recruited to DNA-bound
transcription factors in a regulatory complex instead of binding directly to the DNA
(Figure 2.25.d and g). The GRE that has negative influence on gene expression of
responsive genes is called a negative GRE (nGRE) (Figure 2.25.e). In the competition
model, GR binding to the nGRE inhibits other transcription factors from binding to their
response elements, causing a negative response (Figure 2.25.f) (Schoneveld et al., 2004).

Figure 2.25. Mechanisms of GR interactions with regulatory elements (Schoneveld et al.,
2004)
Selected modulators of the glucocorticoid receptor activity are shown in Table
2.10. The GR can also interact with other transcription factors, such as nuclear factor-κB
(NF-κB), activator protein-1 (AP1), and signal transducers and activators of transcription
(STATs). Many molecules and compounds have been suggested to regulate the activity
of GR (Manoli et al., 2004).
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Table 2.10. Selected known modulators of the glucocorticoid receptor activity
Function
Modulator
Ligand binding
Agonists/modulators

Steroids, ursodeoxycolic acid, cortivazol, thioredoxin

Antagonists

RU 486

GR trafficking

Hsps, RAP46, FKBPs, 14-3-3s

Transcription regulators

Coactivators: BRG1 (SWI/SNF), p/CAF (ADA/SAGA),
CBP/p300, p160, TIF2/GRIP1, AIB1, DRIP
(TRAP/ARC), PGC-1, L7/SPA, ASC-2, PNRC, AIB1;
viral proteins: E1A (adenovirus), Vpr (HIV-1), FLASH
Corepressors: NCoR, SMRT

Transcription factors

NF-κB, COUP-TFII, AP-1, STATs, CREB, C/EBP, Nur77,
HNF-6, p53, GATA-1, Sp-1, Oct-1, NF-1

Abbreviations: Hsps, heat-shock proteins; RAP46, receptor-associating protein of .46 kDa;
FKBPs, FK506-binding proteins; BRG1, Brahma-related gene 1; SWI, mating-type switching;
SNF, sucrose nonfermenting; p/CAF, p300/CBP associated factor; ADA, alteration/deficiency
in activation; SAGA, Spt-Ada-Gcn5-acetyltransferase; CBP, CREB-binding protein (cAMP
response element binding protein); TIF2, transcriptional intermediary factor 2; GRIP1, GR
interacting protein-1; AIB1, amplified in breast cancer; DRIP, vit D receptor interacting
protein; TRAP, thyroid hormone receptor associated protein; PGC-1, peroxisome proliferatoractivated receptor γ–coactivator; L7/SPA, ribosomal protein L7/switch protein for antagonists;
ASC-2, activating signal cointegrator 2; FLASH, FLICE associated huge protein; NCoR,
nuclear receptor corepressor; SMRT, silencing mediator of retinoid and thyroid hormone
receptor; NF-κB, nuclear factor κB; COUP-TFII, chicken ovalbumin upstream promoter
transcription factor II; AP-1, activator protein 1; STATs, signal transducers and activators of
transcription; CREB, cAMP-responsive element binding protein; C/EBP, CCAAT/enhancer
binding protein; HNF-6, hepatocyte nuclear factor-6; GATA-1, erythroid transcription factor;
Oct-1, octamer factor-1; NF1, nuclear factor-1.
(Manoli et al., 2004)
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2.5. Conclusion
In swine production system various stress sources exist including thermal stress,
immune stress, social stress, and dietary stress. These stressors may cause growth
retardation, changes in hormone release, increased disease susceptibility, and/or
behavioral changes. Many scientists have suggested that Cr may ameliorate negative
effects associated with stress. Dietary supplementation of Cr has alleviated the negative
effects of thermal stress in poultry and transport stress in calves. Supplemental Cr has
favorably affected obese mice fed fat-enriched diet.
However, studies on dietary Cr for pigs kept in stressful thermal environment
have been sparse. The effects of dietary Cr on immune-challenged animals have been
inconclusive in pigs. The influence of Cr on pigs fed fat-enriched diets has not been
tested. In addition, effects of Cr on adrenocortical steroidogenesis have not been reported.
Therefore, the objective of the current research is to investigate the effects of
dietary Cr supplementation on pigs under thermoneutral or thermal stress environment in
Chapter 3, pigs challenged with an endotoxin in Chapter 4, and pigs fed high-fat diets in
Chapter 5. Additionally, effects of Cr on adrenocortical steroids secretion from H295R
adrenocortical cells stimulated with an agonist are studied in Chapter 6.

Copyright © Beob Gyun Kim 2007
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CHAPTER 3. The Effects of Dietary Chromium (III) Picolinate on Growth
Performance, Blood Measurements, and Respiratory Rate in High and Low
Ambient Temperature
Abstract
Three experiments were conducted to investigate the effects of thermal stress and
dietary chromium (Cr) on growth performance and physiological variables in weanling
pigs. In Exp. 1, a total of 54 pigs (BW of 5.95 ± 0.84 kg) were allotted to a 2 × 3 factorial
arrangement using two ambient temperatures (23.7 or 40.5°C during d 14 to 28 postweaning) and three dietary levels of Cr (0, 1,000, or 2,000 ppb) as Cr (III) picolinate. In
Exp. 2, a total of 54 pigs (BW of 5.94 ± 1.29 kg) were allotted in the same treatment
arrangement but with different ambient temperatures (26.5 or 16.0°C during d 14 to 26
post-weaning). In Exp. 3, a total of 36 pigs (BW of 6.40 ± 0.72 kg) were allotted in the
same treatment arrangement with ambient temperatures of 25.9 or 13.8°C during d 14 to
28 post-weaning. During d 0 to 14 of all experiments, a neutral ambient temperature (NT)
was maintained. In Exp. 1, pigs in high ambient temperature (HT) gained less weight
(575 vs. 663 g/d; P < 0.001), and consumed less feed (926 vs. 1,074 g/d; P < 0.01) than
pigs in NT during d 14 to 28. However, feed:gain was unaffected by ambient temperature
(1.61 vs. 1.62; P = 0.79). Dietary Cr had no effect on growth performance. Pigs in HT
had lower plasma cortisol on d 18 (44.3 vs. 56.9 ng/ml; P = 0.05), and on d 27 (37.4 vs.
52.5 ng/ml; P < 0.01). Respiratory rate of pigs in HT was higher compared to the pigs in
NT (114.6 vs. 65.0 breath/min; P < 0.001) on d 27. In Exp. 2 and 3 (pooled), pigs in low
ambient temperature (LT) had higher ADFI (1,026 vs. 942 g/d; P < 0.01) and feed:gain
(1.57 vs. 1.51; P < 0.01) during d 14 to 26 (28). Plasma cortisol was minimally affected
by thermal temperature. Dietary Cr supplementation had no effects on blood
measurements. In Exp. 3, the respiratory rate measured on d 22 and 27 was lower (43.2
vs. 54.2 breath/min and 42.2 vs. 57.0 breath/min, respectively; P < 0.001) in the pigs in
LT than the pigs in NT with no effects of dietary Cr supplementation. These results
indicate that growth performance is affected by thermal stress and plasma cortisol is
decreased by heat stress, but these effects are not moderated by dietary CrPic.
Key Words: Thermal stress, Chromium, Pigs
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3.1. Introduction
Trivalent chromium (Cr) is an essential micro element for animals (Anderson,
1987; Offenbacher and Pi-Sunyer, 1988). Since the first report on the essentiality of Cr in
rats (Schwarz and Mertz, 1959), the metabolic roles of Cr have been widely studied in
humans and animals. In addition to the insulin potentiation (Mertz et al., 1974; Vincent,
2000), Cr has been suggested to alleviate stress in animals and humans (Chang and
Mowat, 1992; Anderson, 1994; NRC, 1997). The stressors existing in swine production
systems would include cold/hot (relative to thermoneutrality) environmental temperature
(Stahly and Cromwell, 1979; Schenck et al., 1992ab), microbial infection (Webel et al.,
1997), insufficient space allowance (Brumm and Miller, 1996; Wolter et al., 2000), social
mixing (Barnett et al., 1993; Marchant et al., 1995), and nutritional deficiency or
imbalance (NRC, 1998). These stressors may cause growth retardation, changes in
hormone release, increased disease susceptibility, and/or behavioral changes.
Dietary supplementation of Cr alleviated the detrimental effects of cold stress
(Sahin et al., 2001; Sahin et al., 2002c; Onderci et al., 2003) and heat stress (Sahin et al.,
2002ab; Onderci et al., 2005; Sahin et al., 2005) in poultry studies. However, studies on
the dietary Cr in thermal stressed swine have been rare. Therefore, the purpose of the
current research was to determine the effects of supplemental Cr on the pigs in
thermoneutral or thermal stress environment.
3.2. Experimental procedures
Three experiments were carried out in environmentally controlled rooms at the
University of Kentucky. The experiments were conducted under protocols approved by
the Institutional Animal Care and Use Committee of the University of Kentucky.
3.2.1. Experiment 1 (heat stress) - Animals and treatments
In a 28-d experiment, a total of 54 crossbred weanling pigs with an average initial
BW of 5.95 ± 0.84 kg were used. Animals were allotted to a 2 × 3 factorial arrangement
using two ambient temperatures (23.7 or 40.5°C during d 14 to 28) and three
supplemental levels of dietary Cr (0, 1,000, or 2,000 ppb). Piglets were grouped into
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three blocks by initial BW and randomly allotted to six treatment groups with three
animals per pen, with balanced sex and ancestry using Experimental Animal Allotment
Program (Kim and Lindemann, 2007). Two males and one female were housed in each
plastic woven floored 1.2 m × 1.2 m pen. Each pen was equipped with a four-hole,
stainless steel feeder and a nipple waterer. The height of each nipple was adjusted weekly.
Pigs had ad libitum access to feed and water.
The ambient temperature during d 0 to 14 was maintained in the thermoneutral
zone. On d 14 the ambient temperature was changed to induce thermal stress, and the
high temperature was maintained until the end of the experiment (Figure 3.1). The
medians of maximum and minimum temperatures were calculated for each day, and the
averages of daily median temperature of neutral and hot rooms during d 14 to 28 were
23.7 and 40.5°C, respectively.
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45
40
35
30
25
20
15

Neutral (23.7 °C)

10

Hot (40.5 °C)
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Figure 3.1. Daily median ambient temperature in the neutral (squares) and hot (circles)
rooms (Exp. 1). The ambient temperature during d 0 to 14 was maintained in the
thermoneutral zone; on d 14 the ambient temperature of hot room was changed to induce
thermal stress, and the high temperature was maintained until the end of the experiment.
The medians of maximum and minimum temperatures were calculated for each day, and
the average of daily median temperature of neutral and hot rooms during d 14 to 28 were
23.7 and 40.5°C, respectively.
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One male fed no supplemental Cr in neutral ambient temperature died during the
first week. Two males in neutral temperature (NT) – 1,000 ppb Cr treatment were
considered as outliers and removed from the data set because they gained less than 43%
of their pen mates during the first two weeks and during the last week, respectively. The
feed intake of the remaining animals was estimated using the model suggested by
Lindemann and Kim (2007).
3.2.2. Experiment 2 and 3 (cold stress) - Animals and treatments
In Exp. 2, a total of 54 pigs (initial BW of 5.95 ± 0.84 kg) were housed in groups
of three pigs per pen for a 26-d experimental period. In Exp. 3, a total of 36 pigs (initial
BW of 6.40 ± 0.72 kg) were housed in groups of two pigs per pen for a 28-d period. The
treatment structure and other procedures of Exp. 2 and 3 were the same as Exp. 1.
During the first 14 d of the experiments, the environment was maintained
thermoneutral. The average ambient temperatures of neutral and cold rooms were 26.5
and 16.0°C, respectively, during d 14 to 26 in Exp. 2 (Figure 3.2). The average ambient
temperatures of neutral and cold rooms were 25.9 and 13.8°C, respectively, during d 14
to 28 in Exp. 3 (Figure 3.3).
In Exp. 2, one female in low ambient temperature – 2,000 ppb Cr treatment was
considered as an outlier and removed from the data because this animal gained less than
48% of its pen mates throughout the experimental period.
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Figure 3.2. Daily median ambient temperature in the neutral (squares) and cold (triangles)
rooms (Exp. 2). The ambient temperature during d 0 to 14 was maintained in the
thermoneutral zone; on d 14 the ambient temperature of cold room was changed to induce
thermal stress, and the low temperature was maintained until the end of the experiment.
The medians of maximum and minimum temperatures were calculated for each day, and
the average of daily median temperature of neutral and cold rooms during d 14 to 26 were
26.5 and 16.0°C, respectively.

84

Ambient temperature, °C

35
30
25
20
15
10

Neutral (25.9 °C)

5

Cold (13.8 °C)

0
0

5

10

15

20

25

Day

Figure 3.3. Daily ambient temperature in the neutral (squares) and cold (triangles) rooms
(Exp. 3). The ambient temperature during d 0 to 14 was maintained in the thermoneutral
zone; on d 14 the ambient temperature of cold room was changed to induce thermal stress,
and the low temperature was maintained until the end of the experiment. The medians of
maximum and minimum temperatures were calculated for each day, and the averages of
daily median temperatures of neutral and cold rooms during d 14 to 28 were 25.9 and
13.8°C, respectively.
3.2.3. Experimental diets
The diets, based primarily on corn, soybean meal, and dried whey, were
calculated to contain 3,406 kcal/kg ME, 21.7% CP, 1.36% Lys, and 0.31% Met for d 0 to
14; 3,600 kcal/kg ME, 19.9% CP, 1.19% Lys, and 0.30% Met for d 14 to 28 (Table 3.1).
Minerals and vitamins were added to meet or exceed NRC (1998). Antibacterial agents
and antioxidants were also included in the diets. To minimize potential variation that can
occur with multiple diet mixings, a single batch of basal diet was prepared.
Approximately the first 5% and last 5% (as manufacture sequence) of the basal diet was
excluded in the treatment diet manufacturing. In Exp. 1 and 2, the treatment diets were
made by adding Cr (0, 1,000, or 2,000 ppb) in the form of Cr (III) picolinate (CrPic) to
the basal diet. In Exp. 3, a commercial product of CrPic (CHROMAX, Prince Agri
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Products, Inc., Quincy, IL; limestone ) was added to the basal diet at the expense of
limestone, a carrier in CHROMAX. The organic form of trivalent Cr, CrPic, was used
based on previous reports suggesting that Cr is more available as an organic chelate (Page
et al., 1993).

Table 3.1. Percentage composition of the basal diet (as-fed basis)
Item
Ingredients
Corn
Soybean meal, 48% CP
Dried whey
Spray dried animal plasma
Lactose
Corn oil
Dicalcium phosphate
Limestone
Salt
Vitamin premix1
Trace-mineral premix2
Mecadox-103
Santoquin4
Calculated nutrient composition
ME, kcal/kg
CP, %
Lysine, %
Calcium, %
Phosphorus, %

D 0 to 14 (Phase I)
48.055
26.00
12.00
5.00
4.00
2.00
1.00
1.10
0.40
0.10
0.075
0.25
0.02
3,406
21.70
1.36
0.81
0.65

1

D 14 to 28 (Phase II)
57.255
25.50
10.00
2.00
2.50
1.00
0.90
0.40
0.10
0.075
0.25
0.02
3,600
19.91
1.19
0.72
0.60

Supplied per kg of diet: vitamin A, 6,600 IU; vitamin D3, 880 IU; vitamin E, 44 IU; vitamin K
(as menadione sodium bisulfite complex), 6.4 mg; thiamin, 4.0 mg; riboflavin, 8.8 mg;
pyridoxine, 4.4 mg; vitamin B12, 33 µg; folic acid, 1.3 mg; niacin, 44 mg; pantothenic acid, 22
mg; D-biotin, 0.22 mg.
2
Supplied per kg of diet: Zn, 131 mg as ZnO; Fe, 131 mg as FeSO4·H2O; Mn 45 mg, as MnO;
Cu, 13 mg as CuSO4·5H2O; I, 1.5 mg as CaI2O6; Co, 0.23 mg as CoCO3; Se, 0.28 mg as
NaSeO3.
3
Supplied 55 mg carbadox per kg of diet.
4
Supplied 130 mg ethoxyquin per kg of basal diet.
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3.2.4. Data and sample collection
Animal weights and feed intake were measured weekly. Wasted feed and orts
were collected and weighed to measure accurate feed intake. Blood samples were
collected from two pigs per pen (one male and one female) via the jugular vein on d 15,
18, and 27 (25 in Exp. 2). These blood sampling dates were 1, 4, and 13 (11 in Exp. 2) d
after the change of ambient temperature. The collected blood samples were kept on ice
for approximately 1 to 2 h until the plasma was obtained by centrifugation of the blood at
800 × g and 4°C for 20 min. Plasma samples were stored at -20°C until the chemical
assays. Respiratory rate was visually measured by counting flank movements over a
period of 1 min in resting pigs. To facilitate the counting respiration in resting pigs,
respiratory rate was determined between 19:30 and 22:00. In Exp. 1 the respiratory rate
was counted once for every pig by a single panelist; in Exp. 3 three panelists
independently counted the respiratory rate, and mean counts of the three panelists were
used for analysis.
3.2.5. Laboratory analysis
The frozen plasma samples were allowed to thaw at room temperature for the
chemical analysis. The glucose concentration in the plasma was analyzed using a glucose
autoanalyzer (YSI 2300 STAT PLUS, Yellow Springs Instrument Co., Yellow Springs,
OH). Samples were analyzed in duplicate, and the calibration was automatically
performed every 30 min.
The cortisol concentrations in the plasma samples were determined using coated
tube radioimmunoassays from Diagnostic Products Corporation (Los Angeles, CA).
Standards and plasma samples were added to antibody-coated tubes. Radiolabeled
cortisol (125I) was added to tubes and incubated for 45 minutes at 37°C using a waterbath.
Then, all moisture in the tube was thoroughly removed and the radioactivity was
measured using a Packard Cobra Auto-gamma counter (Packard Instrument Co., Meriden,
CT). Standards and samples were analyzed in triplicate and duplicate, respectively. A
new set of standards was prepared and analyzed for each separate analysis.
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3.2.6. Statistical analysis
The experimental data were analyzed using GLM procedures of SAS (SAS Inst.
Inc., Cary, NC). The model for Exp. 1 (heat stress) included two main effects and
interaction as follows:
Yijk = k + bi + Tempj + Crk + (Temp × Cr)jk + eijk
In this equation, the parameters represent:
Y = response variables (ADG, ADFI, feed:gain, plasma cortisol, plasma glucose,
and respiratory rate)
k = a constant
bi = block effect
Tempj = ambient temperature effect
Crk = supplemental Cr effect
(Temp × Cr)jk = ambient temperature × supplemental Cr interaction
eijk = error term of the model
The model for analyzing data pooled from Exp. 2 and Exp. 3 (cold stress) included
experiment × treatments interactions as follows:
Yijk = k + exph + bi(exph) + Tempj + Crk + (Temp × Cr)jk + (exp × Temp)hj + (exp
× Cr)hk + (exp × Temp × Cr)hjk + ehijk
In this equation, the parameters represent:
Y = response variables (ADG, ADFI, feed:gain, plasma cortisol, and plasma
glucose)
k = a constant
exph = experiment effect
bi = block effect
Tempj = ambient temperature effect
Crk = supplemental Cr effect
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(Temp × Cr)jk = ambient temperature × supplemental Cr interaction
(exp × Temp)hj = experiment × ambient temperature
(exp × Cr)hk = experiment × supplemental Cr interaction
(exp × Temp × Cr)hjk = experiment × ambient temperature × supplemental Cr
interaction
ehijk = error term of the model
In cold stress experiments, respiratory rates were measured only in Exp. 3 not in Exp. 2.
Thus the model for Exp. 1 was used for the analysis of respiratory rate of cold stress
study. Each pen was considered as an experimental unit for average daily gain (ADG),
average daily feed intake (ADFI), and feed:gain ratio; individual animals served as the
experimental unit for other measurements. The alpha level used for determination of
statistical significance was 0.05.
3.3. Results
3.3.1. Experiment 1: Heat stress
Growth performance was affected by the high ambient temperature, but not by
supplemental Cr (Table 3.2). The BW of the animals were unaffected by the treatments
on d 7 and 14 (P > 0.20). The ambient temperature was changed on d 14 to induce
thermal stress. During d 14 to 21, pigs in high ambient temperature (HT) gained less
weight (550 vs. 657 g/d; P < 0.001) and consumed less feed (858 vs. 1,017 g/d; P =
0.001) than pigs in NT. However, feed:gain was unaffected by the thermal stress. During
d 21 to 28, pigs in HT had lower ADG (600 vs. 669 g/d; P = 0.020) and lower ADFI (994
vs. 1,132 g/d; P = 0.009) than pigs in NT with no difference in feed:gain. During d 14 to
28, accordingly, HT resulted in decreased ADG (575 vs. 663 g/d; P = 0.001) and ADFI
(926 vs. 1,074 g/d; P < 0.001) compared with NT, but feed:gain was again unaffected by
heat stress (1.61 vs. 1.62; P = 0.793). The BW on d 21 and 28 were also lower (P < 0.01)
in HT than in NT. No effect of supplemental Cr on the growth performance was observed
(P > 0.10) nor were there any interactions of supplemental Cr and temperature (P > 0.10).
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Table 3.2. Effects of high ambient temperature (Temp) and dietary chromium (III)
picolinate (CrPic) supplementation on body weight, feed intake and feed:gain of pigs
(Exp. 1)1
Temp2: Neutral (23.7°C)
Hot (40.5°C)
Temp effect CrPic effect
Interaction
Cr, ppb: 0 1,000 2,000
0 1,000 2,000
Pr SEM Pr SEM
Pr
SEM
Body weight, kg
D0
5.98 5.87 5.94 5.93 5.93 5.93 0.921 0.18 0.231 0.02 0.257 0.03
D7
8.18 8.15 8.22 8.28 8.30 8.22 0.488 0.83 0.996 0.10 0.890 0.14
D 14
11.90 12.13 11.99 11.78 12.15 11.85 0.612 0.11 0.289 0.13 0.890 0.18
D 21
16.70 16.65 16.45 15.65 16.13 15.55 0.004 0.16 0.391 0.19 0.614 0.27
D 28
21.49 21.40 21.08 19.83 20.50 19.59 0.003 0.25 0.386 0.30 0.655 0.43
D 0 to 7
ADG, g
315 326 325 336 339 328 0.424 10.5 0.917 12.9 0.880 18.3
ADFI, g
410 398 424 405 421 425 0.668 10.6 0.618 13.0 0.722 18.3
Feed:gain 1.31 1.22 1.31 1.21 1.25 1.31 0.494 0.02 0.192 0.03 0.317 0.04
D 7 to 14
ADG, g
531 567 539 500 550 518 0.164 11.0 0.113 13.4 0.938 19.0
ADFI, g
759 795 777 695 746 723 0.072 19.5 0.461 23.9 0.975 33.7
Feed:gain 1.42 1.40 1.44 1.40 1.36 1.39 0.448 0.04 0.821 0.04 0.986 0.03
D 14 to 21
ADG, g
685 646 638 553 569 529 < 0.001 13.3 0.336 16.3 0.515 23.1
ADFI, g 1053 987 1009 832 912 830 0.001 24.6 0.772 30.1 0.258 42.6
Feed:gain 1.54 1.53 1.58 1.50 1.61 1.56 0.864 0.02 0.382 0.03 0.396 0.04
D 21 to 28
ADG, g
685 662 661 598 625 576 0.020 17.8 0.683 21.8 0.664 30.8
ADFI, g 1149 1124 1122 960 1085 937 0.009 30.0 0.375 36.7 0.298 51.9
Feed:gain 1.68 1.70 1.70 1.60 1.74 1.63 0.585 0.04 0.501 0.05 0.651 0.07
D 0 to 14
ADG, g
423 447 432 418 444 423 0.590 6.9 0.143 8.4
0.955 11.9
ADFI, g
584 596 600 550 584 574 0.187 12.1 0.524 14.9 0.873 21.0
Feed:gain 1.38 1.33 1.39 1.32 1.31 1.36 0.222 0.02 0.386 0.03 0.859 0.04
D 14 to 28
ADG, g
685 654 650 575 597 553 0.001 13.1 0.422 16.0 0.526 22.7
ADFI, g 1101 1056 1066 896 999 883 < 0.001 23.5 0.464 28.8 0.197 40.7
Feed:gain 1.61 1.61 1.64 1.56 1.68 1.60 0.793 0.03 0.372 0.03 0.370 0.04
1
Each mean represents three pens of three pigs/pen.
2
Ambient temperatures during d 14 to 28. The ambient temperature before d 14 was maintained
in the thermoneutral zone. On d 14 the ambient temperature was changed to induce thermal
stress, and the high temperature was maintained until the end of the experiment.
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As shown in Table 3.3, pigs in HT had lower plasma cortisol concentration on d
18 (44.3 vs. 56.9 ng/ml; P = 0.054) and d 27 (37.4 vs. 52.5 ng/ml; P = 0.009). On d 15,
circulating cortisol was affected by supplemental Cr with the highest cortisol
concentration at 1,000 ppb Cr supplementation (P = 0.008), and ambient temperature ×
supplemental Cr interaction was significant for plasma cortisol concentration (P = 0.012).
Plasma glucose concentration tended to be lower in pigs in HT than the animals in NT on
d 15 (6.57 vs. 6.90 mmol/L; P = 0.074) and d 27 (6.62 vs. 6.98 mmol/L; P = 0.054). On d
18, there was a tendency for plasma glucose to be reduced by supplemental Cr (P =
0.089).
Table 3.3. Effects of high ambient temperature (Temp) and dietary chromium (III)
picolinate (CrPic) supplementation on plasma cortisol and glucose concentration of pigs
(Exp. 1)1
Temp2: Neutral (23.7°C)
Cr, ppb:

0

1,000 2,000

Hot (40.5°C)
0

1,000 2,000

Temp effect CrPic effect Interaction

Pr SEM

Pr SEM

Pr SEM

Cortisol, ng/mL
D 15 (1)3 55.1 57.7 42.7

34.9 65.2 32.9 0.209 4.1

0.008 5.1 0.167 7.2

D 18 (4) 63.4 47.5 59.8

31.1 62.6 39.3 0.054 4.4

0.589 5.4 0.012 7.7

D 27 (13) 59.5 45.8 52.1

33.7 45.4 33.2 0.009 3.8

0.825 4.7 0.155 6.6

Glucose, mmol/L
D 15 (1) 6.85 6.80 7.04

6.43 6.67 6.62 0.074 0.12 0.672 0.15 0.730 0.21

D 18 (4) 7.07 7.03 6.89

7.25 6.58 6.71 0.306 0.10 0.089 0.13 0.239 0.18

D 27 (13) 6.92 7.08 6.92

6.73 6.61 6.53 0.054 0.12 0.840 0.15 0.801 0.22

1

Each mean represents six pigs.
Ambient temperatures during d 14 to 28. The ambient temperature before d 14 was maintained
in the thermoneutral zone. On d 14 the ambient temperature was changed to induce thermal
stress, and the high temperature was maintained until the end of the experiment.
3
The numbers in the parenthesis represent the days after the thermal stress.
2

The respiratory rate measured on d 27 was higher (114.6 vs. 65.0 breath/min; P <
0.001) in the pigs in HT than the pigs in the thermoneutral environment with no effects of
dietary Cr supplementation (Table 3.4).
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Table 3.4. Effects of high ambient temperature (Temp) and dietary chromium (III)
picolinate (CrPic) supplementation on respiratory rate of pigs (Exp. 1)1
Temp2: Neutral (23.7°C)
Cr, ppb:

0

1,000 2,000

Hot (40.5°C)
0

1,000 2,000

Temp effect CrPic effect Interaction

Pr SEM

Pr SEM

Pr SEM

Respiratory rate, breath/min
D 27 (13)3 66.8 64.5 63.7 116.9 112.4 114.3 <0.001 3.3

0.816 4.0 0.969 5.7

1

Each least squares mean represents nine pigs.
Ambient temperatures during d 14 to 28. The ambient temperature before d 14 was maintained
in the thermoneutral zone. On d 14 the ambient temperature was changed to induce thermal
stress, and the high temperature was maintained until the end of the experiment.
3
The numbers in the parenthesis represent the days after the thermal stress.
2

3.3.2. Experiment 2 and 3: Cold stress
Data from Exp. 2 and 3 are combined for the analysis (Table 3.5). Result tables
for each experiment are shown in Appendix 1. The cold stress affected growth
performance, but dietary Cr treatment had no effect on the growth of pigs. Pigs in low
ambient temperature (LT) had higher feed:gain (1.54 vs. 1.44; P < 0.001) than pigs in NT
during d 14 to 21. Pigs in LT had higher ADG (711 vs. 625 g/d; P = 0.006) and ADFI
(1,143 vs. 991 g/d; P < 0.001) than pigs in NT during d 21 to 26 (28). During d 14 to 26
(28), pigs in LT had higher ADFI (1,026 vs. 942 g/d; P = 0.008) and feed:gain (1.57 vs.
1.51; P = 0.002) than pigs in NT. However, dietary treatments of Cr had no effects on
ADG, ADFI, or feed:gain.
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Table 3.5. Effects of low ambient temperature (Temp) and dietary chromium (III)
picolinate (CrPic) supplementation on body weight, feed intake and feed:gain of pigs
(pooled data of Exp. 2 and 3)1
Temp2:
Neutral
Cold
Temp effect CrPic effect
Interaction
Cr, ppb: 0 1,000 2,000
0 1,000 2,000
Pr SEM Pr SEM
Pr
SEM
Body weight, kg
D0
6.18 6.19 6.19 6.18 6.18 6.18 0.837 0.02 0.992 0.03 0.990 0.04
D7
7.59 7.59 7.55 7.59 7.59 7.70 0.409 0.04 0.847 0.05 0.540 0.08
D 14
10.71 10.63 10.57 10.27 10.55 10.89 0.712 0.13 0.576 0.16 0.270 0.23
D 21
15.29 14.80 14.77 14.31 14.72 15.30 0.561 0.21 0.717 0.26 0.143 0.37
D 26 (28) 19.10 18.68 18.56 18.52 19.02 19.59 0.498 0.27 0.827 0.33 0.243 0.46
D 0 to 7
ADG, g
200 199 195 201 201 217 0.337 5.9 0.814 7.3 0.507 10.3
ADFI, g
234 228 251 231 268 252 0.275 7.9 0.356 9.6 0.246 13.6
Feed:gain 1.18 1.16 1.29 1.16 1.32 1.17 0.908 0.04 0.536 0.05 0.106 0.07
D 7 to 14
ADG, g
447 435 432 383 423 456 0.459 16.2 0.597 19.8 0.313 28.0
ADFI, g
567 519 559 483 527 539 0.213 17.6 0.645 21.5 0.320 30.4
Feed:gain 1.27 1.21 1.30 1.27 1.26 1.22 0.822 0.03 0.708 0.03 0.329 0.05
D 14 to 21
ADG, g
654 595 600 577 596 630 0.521 16.6 0.727 20.3 0.182 28.7
ADFI, g
936 872 854 896 900 967 0.296 22.2 0.711 27.2 0.161 38.5
Feed:gain 1.43 1.47 1.43 1.56 1.52 1.54 <0.001 0.01 0.869 0.02 0.294 0.03
D 21 to 26 (28)
ADG, g
620 638 616 703 719 712 0.006 20.1 0.871 24.6 0.973 34.8
ADFI, g 1000 974 998 1124 1149 1157 <0.001 24.0 0.908 29.4 0.824 41.5
Feed:gain 1.63 1.54 1.62 1.60 1.60 1.62 0.766 0.03 0.483 0.03 0.556 0.05
D 0 to 14
ADG, g
323 317 313 292 312 336 0.734 9.3 0.569 11.3 0.261 16.0
ADFI, g
401 374 405 357 397 396 0.546 11.2 0.538 13.7 0.243 19.4
Feed:gain 1.24 1.18 1.29 1.23 1.27 1.19 0.818 0.02 0.810 0.02 0.014 0.03
D 14 to 26 (28)
ADG, g
641 620 612 634 649 668 0.231 15.0 0.980 18.3 0.486 25.9
ADFI, g
971 928 927 1003 1015 1058 0.008 20.1 0.820 24.6 0.381 34.8
Feed:gain 1.52 1.50 1.52 1.58 1.56 1.58 0.002 0.01 0.647 0.02 0.990 0.02
1
Each mean represents six pens of three (Exp. 2) or two (Exp. 3) pigs/pen. The durations of Exp.
2 and 3 were 26 and 28 d, respectively.
2
The ambient temperature before d 14 was maintained in the thermoneutral zone. On d 14 the
ambient temperature was changed to induce thermal stress, and the low temperature was
maintained until the end of the experiment. The average ambient temperatures of neutral and
cold rooms were 26.5 and 16.0°C, respectively, during d 14 to 26 in Exp. 2; 25.6 and 13.8°C,
respectively, during d 14 to 28 in Exp. 3.
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Plasma cortisol concentration tended to be lower in the pigs in LT (54.2 vs. 65.8
ng/mL; P = 0.091) on d 15 but tended to be higher in LT (64.3 vs. 53.6 ng/mL; P = 0.083)
on d 18 than the pigs in NT (Table 3.6). Other blood measure measurements were
unaffected by the ambient temperature or the dietary Cr treatments. A tendency of
ambient temperature × supplemental Cr interaction on plasma glucose concentration was
observed on d 15 (P = 0.077) and d 18 (P = 0.063).
Table 3.6. Effects of low ambient temperature (Temp) and dietary chromium (III)
picolinate (CrPic) supplementation on plasma cortisol and glucose concentration of pigs
(pooled data of Exp. 2 and 3)1
Temp2:
Cr, ppb:

Neutral
0

1,000 2,000

Cold
0

1,000 2,000

Temp effect CrPic effect Interaction

Pr SEM

Pr SEM

Pr SEM

Cortisol, ng/mL
D 15 (1)3 63.2 74.5 59.7

50.7 54.3 57.6 0.091 4.8

0.644 5.9 0.556 8.3

D 18 (4) 52.0 62.5 46.4

67.2 60.4 65.3 0.083 4.3

0.739 5.2 0.322 7.4

D 25 (11) 61.1 61.8 80.1

77.6 64.6 64.1 0.868 4.7

0.531 5.7 0.137 8.1

Glucose, mmol/L
D 15 (1) 7.08 7.31 6.83

6.96 6.71 6.96 0.139 0.09 0.688 0.11 0.077 0.16

D 18 (4) 7.17 6.71 6.64

6.94 6.80 7.48 0.213 0.13 0.300 0.16 0.063 0.23

D 25 (11) 6.99 6.92 6.78

7.05 6.99 6.97 0.579 0.14 0.837 0.17 0.958 0.24

1

Each mean represents twelve pigs.
The ambient temperature before d 14 was maintained in the thermoneutral zone. On d 14 the
ambient temperature was changed to induce thermal stress, and the low temperature was
maintained until the end of the experiment. The average ambient temperatures of neutral and
cold rooms were 26.5 and 16.0°C, respectively, during d 14 to 26 in Exp. 2; 25.6 and 13.8°C,
respectively, during d 14 to 28 in Exp. 3.
3
The numbers in the parenthesis represent the days after the thermal stress. The blood collection
d in Exp. 3 were d 15, 18, and 27.
2

In Exp. 3, the respiratory rate measured on d 22 and 27 was lower (43.2 vs. 54.2
breath/min and 42.2 vs. 57.0 breath/min, respectively; P < 0.001) in the pigs in LT than
the pigs in NT with no effects of dietary Cr supplementation (Table 3.7).
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Table 3.7. Effects of low ambient temperature (Temp) and dietary chromium (III)
picolinate (CrPic) supplementation on respiratory rate of pigs (Exp. 3)1
Temp2: Neutral (25.9°C)
Cr, ppb:

0

Cold (13.8°C)

1,000 2,000

0

1,000 2,000

Temp effect CrPic effect Interaction

Pr SEM

Pr SEM

Pr SEM

Respiratory rate, breath/min
D 22 (8)3

52.8 54.2 55.4

42.6 45.6 41.6 <0.001 1.7

0.764 2.1 0.683 3.0

D 27 (13)

53.6 60.9 56.4

41.5 41.7 43.6 <0.001 1.3

0.259 1.6 0.234 2.3

1

Each least squares mean represents six pigs. The respiratory rate was measured by three
independent panels and means of three observations were used for statistical analysis.
2
Ambient temperatures during d 14 to 28. The ambient temperature before d 14 was maintained
in the thermoneutral zone. On d 14 the ambient temperature was changed to induce thermal
stress, and the low temperature was maintained until the end of the experiment.
3
The numbers in the parenthesis represent the days after the thermal stress.

3.4. Discussion
3.4.1. Experiment 1: Heat stress
Pigs in high ambient temperature generally consume less feed in efforts to reduce
body heat production from digestive and metabolic processes (Quiniou et al., 2000; Le
Bellego et al., 2002). The depression of weight gain is largely attributed to the decreased
feed intake. In the current study, feed intake reduction and growth retardation by heat
stress were clearly demonstrated in agreement with previous reports (Stahly and
Cromwell, 1979; Stahly et al., 1979; Schenck et al., 1992ab; Kerr et al., 2003). In the
present study, weight gain depression and feed intake reduction in pigs in HT were 13.8%
and 13.3%, respectively. Stahly and Cromwell (1979) observed an 18.2% reduction of
feed intake and a 25.7% depression of weight gain depression in growing pigs reared in
hot environment (35°C) compared with pigs in thermoneutral environment (23°C). The
relatively large reduction of weight gain and feed intake may be related to the length of
the experiment and BW of the pigs. In our study, the heat stress (40.5°C) lasted for 14 d
with pigs of 12.0 kg initial BW whereas the Stahly and Cromwell (1979) maintained the
high environmental temperature for 42 d with pigs of 27.5 kg initial BW. Thus the
temperature of 35°C was more stressful to the pigs at the end of the experiment compared
with the pigs at the beginning based on the BW of the pigs. This postulation is supported
in the finishing pig trial at the same temperature (35°C). Weight gain depression and feed
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intake reduction were 36.8% and 42.0%, respectively, in the pigs of 68.2 kg initial BW.
Quiniou et al. (2000) also suggested that heavier pigs are more sensitive to hot ambient
temperature than lighter pigs.
Feed efficiency was unaffected by high ambient temperature in the present study.
In agreement, others have reported minor increases (< 1.5%) of feed:gain in pigs housed
in high environmental temperature (Stahly et al., 1979; Schenck et al., 1992a). However,
Stahly and Cromwell (1979) observed 10.1% increase of feed:gain in growing pigs
housed in the 35°C compared with the pigs in 23°C. The degree of heat stress may
partially explain these discrepancies as feed:gain increased by 17.9% in finishing pigs in
35°C environment compared to the 23°C environment. The changes of feed:gain in
response to elevated environmental temperature may also be related to the degree of feed
intake reduction (Kerr et al., 2003). The lower the feed intake, the more serious the
nutrient deficiencies that may occur and feed:gain increases.
In multiple poultry trials, dietary supplementation of Cr ameliorated the
detrimental effects of heat stress on growth and egg production performance (Sahin et al.,
2002a; Onderci et al., 2005; Sahin et al., 2005). Dietary supplementation of Cr at
concentrations of 200 to 1,200 ppb linearly increased feed intake, weight gain, feed
efficiency, and egg production rate of laying quail reared in high ambient temperature
(Sahin et al., 2002a), and 400 ppb of dietary Cr supplementation increased weight gain
and feed efficiency of heat stressed quail by 4.2% and 2.4%, respectively (Sahin et al.,
2005). In the present study, however, we failed to find any effect of dietary Cr
supplementation on the growth performance of pigs either in high ambient temperature or
in thermoneutral environment.
Circulating cortisol concentration was 22.1% lower in pigs housed in HT for 4 d
compared with pigs in NT. The exposure to HT for 13 d resulted in 28.8% lower cortisol
concentration. In agreement, Marple et al. (1972) observed decreased plasma cortisol
concentration in gilts exposed to heat stress (32°C) for 8 d. Similarly, Hicks et al. (1998)
reported numerically decreased plasma cortisol concentrations in pigs exposed to heat
stress. Low plasma cortisol in heat stressed pigs has been confirmed in recent studies
(Heo et al., 2005; Sutherland et al., 2006). The low cortisol concentration in HT may be
attributed to an increased turnover of plasma cortisol and/or decreased adrenal
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responsiveness to ACTH (Marple et al., 1972). Although the acute response of cortisol
secretion was not assessed in the current study, Minton and Blecha (1990) reported that
cortisol secretion was increased for 6 h in response to heat stress (35°C) and the secretion
was returned to normal within 12 h in lambs. In an earlier report, an exposure to severe
heat (45°C) and high humidity acutely (4 h) resulted in a rise of plasma corticosteroids
and ACTH in pigs (Blatchford et al., 1972). Thus the potential changes of cortisol
turnover rate and adrenal responsiveness to ACTH may be rather acute than chronic. In
the present study, heat stress tended to decrease plasma glucose concentration on d 13
post temperature change. The reduction of glucose concentration in the heat stressed
group is supported by low cortisol concentration in the same treatment group as
circulating cortisol stimulates glucose release from body reserve.
Dietary supplementation of Cr (200 to 1,200 ppb) as CrPic linearly decreased
serum corticosterone concentration in heat stressed laying quail (Sahin et al., 2002b). In
the present study, however, supplemental Cr had no effects on plasma cortisol
concentration on d 4 or 13 post ambient temperature change. Further, plasma cortisol was
numerically increased in the pigs fed 1,000 ppb of supplemental Cr on d 1 post thermal
change. In heat stressed poultry, supplemental Cr decreased serum glucose concentration
(Sahin et al., 2002b; Onderci et al., 2005; Sahin et al., 2005).
In the current study, the respiratory rate was clearly elevated by heat stress. The
increased respiratory rate of pigs in hot environment has been demonstrated by many
researchers (Schoenherr et al., 1989; Quiniou and Noblet, 1999; Renaudeau et al., 2001).
The evaporative heat loss via respiration in the high ambient temperature is important for
the maintenance of animal body temperature. The respiratory evaporation is even more
important for swine which have a limited capacity of cutaneous evaporation (Ingram,
1965).
Pigs in a hot environment generally exhibit more recumbent behavior with
increased respiratory rate, and thus fewer feeding and standing periods in response to
chronic (Morrow-Tesch et al., 1994) and acute (Hicks et al., 1998) heat stress treatments.
The respiratory rate has been demonstrated to be higher (124 vs. 26 breaths/min) in the
pregnant sow exposed to heat stress (29°C) compared with those in a thermoneutral
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environment (18°C) (Quiniou and Noblet, 1999). A similar result was reported later by
the same group (Renaudeau et al., 2001).
3.4.2. Experiment 2 and 3: Cold stress
Pigs in low ambient temperature generally show increased feed intake and
diminished feed efficiency (Stahly and Cromwell, 1979; Stahly et al., 1979; Frank et al.,
2003). In the present study, ADFI and feed:gain were higher in pigs housed in LT than in
NT. This is in agreement with Stahly and Cromwell (1979) who reported that growing
pigs (28 to 60 kg BW) in a low ambient temperature (10°C) consumed 15% more feed
and had 19% higher feed:gain compared with pigs in a thermoneutral environment. A
similar response was observed in weanling pigs (8.6 to 10.2 kg BW) by Frank et al.
(2003). The increased feed consumption is used to compensate for the elevated
maintenance needs for metabolic activity (Holmes and Close, 1977). Accordingly, ADG
was unaffected by the low ambient temperature in the present study and other reports
(Stahly and Cromwell, 1979; Stahly et al., 1979; Frank et al., 2003). However, at an
extremely low ambient temperature (below the lower critical temperature), BW gain may
be retarded by cold stress (Le Dividich, 1981).
Dietary supplementation of Cr as CrPic increased weight gain, egg production,
and feed efficiency of poultry in a low ambient temperature (Sahin et al., 2001; Sahin et
al., 2002c). In the present study, however, we failed to observe beneficial effects of
supplemental Cr on pigs in cold stress. This discrepancy may be attributed to the
physiological differences between these species and/or the degree of cold stress.
Although the ambient temperature was below the thermoneutral zone, and the feed intake
was increased by the cold stress, it may be that the degree of cold stress was affordable to
the pigs by increasing feed intake. The low ambient temperature (16.0 and 13.8°C in
Experiment 2 and 3, respectively) used to induce cold stress was higher than the
temperature (6.8°C) used in the poultry trials (Sahin et al., 2001; Sahin et al., 2002c).
In a severe cold stress (-5 and -15°C), pigs had elevated plasma corticosteroids
(Blatchford et al., 1972). Frank et al. (2003) also reported that cold stress increased
circulating cortisol concentrations in pigs. Pigs of 8.6 kg BW in cold environment
(15.6°C) had higher (P < 0.001) serum ACTH (85.1 vs. 61.3 pg/mL) and cortisol (39.1 vs.
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24.1 ng/mL) than those in thermoneutral environment (26.7°C). In the present study,
however, plasma cortisol was only minimally affected and plasma glucose concentrations
were unaffected by cold stress (16.0 and 13.8°C in Experiment 2 and 3, respectively).
The low temperature in Experiment 3 (13.8°C) resulted in a decrease of
respiratory rate in the pigs in LT than those in NT. Although the cold stress in this study
induced changes in growth performance and respiratory rate, the stress was perhaps not
enough to induce changes in plasma cortisol or glucose. In laying hens kept in low
ambient temperature (6.8 or 6.9°C), supplemental Cr decreased plasma corticosteroid
concentration (Sahin et al., 2001; Sahin et al., 2002c). It may be that the degree of stress
in the present study was not severe enough to adequately test the degree to which it may
be ameliorated by dietary Cr supplementation.
In conclusion, heat stress reduced feed intake, weight gain, and plasma cortisol,
but increased respiratory rate. Cold stressed pigs increased their feed intake and feed:gain,
but decreased respiration frequency. However, stress alleviating effects of dietary Cr
were not observed with either type of temperature stress.
3.5. Implications
The thermal stress in the current study induced marked changes in some growth
and physiological parameters consistent with previous research. However, stress
alleviating effects of dietary Cr supplementation were not observed. Further research to
assess effects and mechanism of Cr on pigs in severely hot or cold environment seems
warranted.
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CHAPTER 4. The Effects of Dietary Chromium (III) Picolinate on Growth
Performance, Vital Signs, and Blood Measurements of Pigs during Immune Stress
Abstract
This experiment investigated the effects of dietary chromium (Cr) on growth,
rectal temperature, respiratory rate, plasma cortisol, and plasma glucose in pigs
challenged with lipopolysaccharide (LPS). Twenty four pigs (BW: 26.0 ± 2.8 kg) were
assigned to one of four treatments with two pigs per pen. Treatments were 1) phosphate
buffered saline (PBS) injection, no supplemental Cr; 2) LPS injection, no supplemental
Cr; 3) LPS injection, 1,000 ppb supplemental Cr; and 4) LPS injection, 2,000 ppb
supplemental Cr. The supplemental Cr levels, in the form of Cr (III) picolinate, were fed
for 35 d before PBS or LPS injection and continued until the end of the experiment. At 0
h, PBS or LPS was injected intraperitoneally in each pig. During the first 12 h post
injection, pigs challenged with LPS lost 951 g, while the PBS group gained 170 g (P <
0.001). This weight loss began to be recovered after 12 h and the weight gain of the LPS
group tended to be higher (1,014 vs. 723 g; P = 0.09) than the PBS group during 24 to 48
h. However, cumulative weight gain of the LPS group still remained lower at 96 h (1,729
vs. 2,545 g; P < 0.05). Compared to the PBS group, LPS challenged pigs had lower feed
intake (FI; 874 vs. 2,197 g; P < 0.01), similar FI (1,876 vs. 1,795 g; P = 0.81), and higher
FI (4,834 vs. 3,924; P < 0.05) during 0 to 24 h, 24 to 48 h, and 48 to 96 h, respectively.
Dietary Cr had no effect on weight gain or FI. Rectal temperature was higher in the LPS
vs. the PBS group at 2 h (40.2 vs. 39.5°C; P < 0.01) and 4 h (40.2 vs. 39.5°C; P < 0.05).
Respiratory rate was also higher in the LPS vs. the PBS group at 1.3 h (83.4 vs. 58.0
breath/min; P < 0.05) and at 8.5 h (55.1 vs. 43.0 breath/min; P < 0.05). Plasma collected
at 3 h had higher cortisol (178 vs. 29 ng/ml; P < 0.001) and lower glucose (5.87 vs. 6.88
mmol/l; P < 0.05) concentrations in the LPS group than the PBS group. Dietary Cr did
not affect rectal temperature, respiratory rate, plasma cortisol, or plasma glucose. These
results demonstrate that LPS challenge affects weight gain, FI, body temperature,
respiratory rate, plasma cortisol, and plasma glucose but dietary Cr is unable to moderate
the stress related effects due to an LPS challenge.
Key Words: Immune stress, Chromium, Pigs
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4.1. Introduction
Since the first report on the essentiality of chromium (Cr) as an active component
in the glucose tolerance factor (Schwarz and Mertz, 1959), the roles of Cr have been
widely studied in humans and animals. Generally Cr has been shown to potentiate the
action of insulin (Mertz et al., 1974; Vincent, 2000) and accordingly to modulate
carbohydrate, protein, and lipid metabolism (Davis and Vincent, 1997; Cefalu et al.,
2002; Bernao et al., 2004). In domestic animals, Cr has been recognized as an essential
trace mineral (Anderson, 1987; Offenbacher and Pi-Sunyer, 1988) and suggested to
alleviate stress associated effects (Chang and Mowat, 1992; Anderson, 1994; NRC, 1997).
In swine production systems, stress sources include cold/hot (relative to
thermoneutrality) environmental temperature (Stahly and Cromwell, 1979; Schenck et al.,
1992), microbial infection (Webel et al., 1997), insufficient space allowance (Brumm and
Miller, 1996; Wolter et al., 2000), social mixing (Barnett et al., 1993; Marchant et al.,
1995), and nutritional deficiency or imbalance (NRC, 1998). These stressors may cause
growth retardation, changes in hormone secretion, increased disease susceptibility, and/or
behavioral changes. Dietary supplementation of Cr alleviated the detrimental effects of
thermal stress in poultry (Sahin et al., 2001; Sahin et al., 2002b; Onderci et al., 2003;
Onderci et al., 2005), and transport stress in calves (Chang and Mowat, 1992; MoonsierShageer and Mowat, 1993).
However, the effects of dietary Cr on immune responses in animals have been
inconsistent in cattle (Burton et al., 1993; Burton et al., 1996; Chang et al., 1996) and in
pigs (van Heugten and Spears, 1997; Lee et al., 2000; van de Ligt et al., 2002c).
Therefore, the objective of the present research was to determine the effects of dietary Cr
supplementation on growth performance, body temperature, respiratory rate, plasma
cortisol, and plasma glucose in pigs challenged with an immune stressor.
4.2. Experimental procedures
This experiment was carried out in environmentally controlled rooms at the
University of Kentucky. The experiments were conducted under protocols approved by
the Institutional Animal Care and Use Committee of the University of Kentucky.
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4.2.1. Animals, treatments, and diets
Twenty four crossbred weanling pigs with an average initial BW of 26.0 ± 2.8 kg
were assigned to one of four treatments. Treatments included: 1) phosphate buffered
saline (PBS) injection, no supplemental Cr; 2) LPS injection, no supplemental Cr; 3) LPS
injection, 1,000 ppb of supplemental Cr; 4) LPS injection, 2,000 ppb of supplemental Cr.
Pigs were grouped into three blocks by initial BW, four treatment groups, and two pigs
per pen with mixed sex. One male and one female were housed in each plastic woven
wire floored 1.2 m × 1.2 m pen. Each pen was equipped with a four-hole, stainless steel
feeder and a nipple waterer. Pigs had ad libitum access to feed and water.
The diets, based primarily on corn, soybean meal, and dried whey, were
formulated to contain 3,600 kcal/kg ME, 19.9% CP, and 1.19% Lys (Table 4.1). Minerals
and vitamins were added to meet or exceed NRC (1998). Antibacterial agents and
antioxidants were also included in the diets. To minimize potential variation that can
occur with multiple diet mixings, a single batch of basal diet was prepared.
Approximately first 5% and last 5% (as manufacture sequence) of the basal diet was
excluded in the specific treatment diet manufacturing. The treatment diets were made by
adding Cr (0, 1,000, or 2,000 ppb) as Cr (III) picolinate (CrPic) to the basal diet. The
specific organic form of trivalent Cr, CrPic, was used based on previous reports
suggesting that Cr is more available as an organic chelate (Page et al., 1993). The
supplemental Cr levels were fed for 35 d before the challenge and continued until the end
of the experiment. The animals in the present study were used for heat stress study of
Chapter 3 (Experiment 1) during d 0 to 28. The animals for LPS challenge were kept in
the thermoneutral environment during the entire period; the animals for PBS injection
were reared under high ambient temperature (40.5°C) during d 14 to 28. Body weight and
ADG of these animal during 35 d before the challenge are shown in Appendix 2.
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Table 4.1. Percentage composition of the basal diet (as-fed basis)
Item
Ingredients
Corn
Soybean meal, 48% CP
Dried whey
Spray dried animal plasma
Lactose
Corn oil
Dicalcium phosphate
Limestone
Salt
Vitamin premix1
Trace-mineral premix2
Mecadox-103
Antioxidant4
Calculated nutrient composition
ME, kcal/kg
CP, %
Lysine, %
Calcium, %
Phosphorus, %
1

57.255
25.50
10.00
2.00
2.50
1.00
0.90
0.40
0.10
0.075
0.25
0.02
3,600
19.91
1.19
0.72
0.60

Supplied per kg of diet: vitamin A, 6,600 IU; vitamin D3, 880 IU; vitamin E, 44 IU; vitamin K
(as menadione sodium bisulfite complex), 6.4 mg; thiamin, 4.0 mg; riboflavin, 8.8 mg;
pyridoxine, 4.4 mg; vitamin B12, 33 µg; folic acid, 1.3 mg; niacin, 44 mg; pantothenic acid, 22
mg; D-biotin, 0.22 mg.

2

Supplied per kg of diet: Zn, 131 mg as ZnO; Fe, 131 mg as FeSO4·H2O; Mn 45 mg, as MnO;
Cu, 13 mg as CuSO4·5H2O; I, 1.5 mg as CaI2O6; Co, 0.23 mg as CoCO3; Se, 0.28 mg as
NaSeO3.

3

Supplied 55 mg carbadox per kg of diet.

4

Supplied 130 mg ethoxyquin per kg of basal diet.
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4.2.2. Lipopolysaccharide challenge
At 0 h (09:00), animals were weighed and given an intraperitoneal injection of
either PBS or LPS (50 μg/kg BW). The LPS (Escherichia coli serotype 0111:B4 phenol
extract; Sigma L-2630, Sigma-Aldrich, Inc., St. Louis, MO) was dissolved in PBS
solution (P-4417, Sigma-Aldrich, Inc., St. Louis, MO) to make 0.4 mg/ml LPS solution.
A volume of 5 ml was made for each pig by combining PBS with the appropriate amount
of LPS solution. Animals were suspended by the rear legs, and the solution was injected
into the peritoneal cavity, three nipples down from the caudal end and approximately 3
cm lateral to the nipple of the left side of the pig.
4.2.3. Data and sample collection
Animal weight and feed intake were measured at 0, 2, 4, 6, 12, 24, 48, and 96 h.
Wasted feed and orts were collected and weighed to measure accurate feed intake. Rectal
temperature was measured at 0, 2, 4, 6, 8, 10, 12, 24, and 48 h. Respiratory rate was
visually measured by counting flank movements over a period of 1 min in resting pigs at 1, 1.3, 3.7, 6, 8.5, 12, and 23 h. At 3 h, blood samples were collected via the jugular vein
from pigs restrained in dorsal recumbency using a V-trough. The time point of blood
collection was decided based on previous studies (Warren et al., 1997; Webel et al., 1997;
Sakumoto et al., 2003). The collected blood samples were kept on ice until the plasma
was obtained by centrifugation of the blood at 800 × g and 4°C for 20 min. Plasma
samples were stored at -20°C until the chemical assays.
4.2.4. Laboratory analysis
The frozen plasma samples were allowed to thaw at room temperature for the
chemical analysis. The cortisol concentrations in the plasma samples were determined
using coated tube radioimmunoassays from Diagnostic Products Corporation (Los
Angeles, CA). Standards and plasma samples were added to antibody-coated tubes.
Radiolabeled cortisol (125I) was added to tubes and incubated for 45 minutes at 37°C
using a waterbath. Then, all moisture in the tube was thoroughly removed and the
radioactivity was measured using a Packard Cobra Auto-gamma counter (Packard
Instrument Co., Meriden, CT). Standards and samples were analyzed in triplicate and

104

duplicate, respectively. A new set of standards was prepared and analyzed for each
separate analysis. The glucose concentration in the plasma was analyzed using a glucose
autoanalyzer (YSI 2300 STAT PLUS, Yellow Springs Instrument Co., Yellow Springs,
OH). Samples were analyzed in duplicate, and the calibration was automatically
performed every 30 min.
4.2.5. Statistical analysis
The experimental data were analyzed using GLM procedures of SAS (SAS Inst.
Inc., Cary, NC). The model included two main effects and interaction as follows:
Yijk = k + bi + tj + eij
In this equation, the parameters represent:
Y = response variables (growth performance, vital signs, and blood parameters)
k = a constant
bi = block effect
tj = treatment effect
eijk = error term of the model
Orthogonal polynomials were used to determine the linear and quadratic effects of the
dietary Cr supplementation. Each pen was considered as an experimental unit for feed
intake; individual animals served as the experimental unit for other measurements. The
alpha level used for determination of statistical significance was 0.05.
4.3. Results
4.3.1. Growth performance
The LPS injection clearly affected BW changes of pigs (Table 4.2). All pigs
injected with LPS lost weight during the first 2 h post injection. During the first 12 h post
injection, pigs challenged with LPS lost 951 g, while the PBS injected pigs gained 170 g
(P < 0.001). This weight loss began to be recovered after 12 h, and the weight gain of the
LPS group tended to be higher than the PBS group during 24 to 48 h (1,014 vs. 723 g; P
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= 0.09). In a cumulative basis, the weight gain of LPS challenged pigs was still negative
at 24 h (-746 vs. 492 g; P < 0.001), and the weight gain of the LPS group still remained
lower than the PBS group at 96 h (1,729 vs. 2,545 g; P < 0.05). Weight gain of pigs
challenged with LPS was linearly decreased as dietary Cr supplementation increased
during 6 to 12 h (P < 0.05). During 48 to 96 h, pigs fed diets supplemented with Cr
gained less weight than pigs fed no supplemental Cr in a linear trend (P = 0.06). However,
cumulative weight gains of pigs were not affected by dietary Cr supplementation during
any of the periods or over the entire period.
Pigs challenged with LPS consumed less feed during the first 2 h post injection,
during 2 to 4 h, and during 12 to 24 h (P < 0.05; Table 4.3). Feed intake of the LPS group
was higher than the PBS group during 48 to 96 h (4,834 vs. 3,924 g; P < 0.05). On a
cumulative basis, pigs challenged with LPS had less feed consumption during 0 to 24 h
(874 vs. 2,179 g; P < 0.01), but cumulative feed intake was similar in pigs injected with
LPS or PBS at 96 h post injection (7,810 vs. 7,917 g; P = 0.88). The supplementation of
dietary Cr had no effects on feed intake of pigs challenged with LPS during any of the
periods or over the entire experiment.
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Table 4.2. Effects of dietary chromium (III) picolinate (CrPic) supplementation on body
weight of lipopolysaccharide (LPS) challenged pigs1
Injection2: PBS
Cr, ppb:

0

LPS
0

1,000 2,000

SEM

P-values3
PBS vs. LPS

LPS

Linear Quadratic

Body weight, kg
0h

24.0

26.5

26.2

27.3

0.8

0.007

0.033

0.510

0.555

2h

24.1

26.2

25.9

26.9

0.7

0.016

0.061

0.534

0.553

4h

24.0

25.8

25.7

26.6

0.7

0.023

0.088

0.494

0.610

6h

24.0

25.7

25.6

26.4

0.7

0.029

0.106

0.509

0.651

12 h

24.1

25.6

25.5

26.1

0.7

0.070

0.161

0.677

0.709

24 h

24.5

25.8

25.5

26.5

0.8

0.116

0.235

0.575

0.540

48 h

25.2

26.7

26.5

27.5

0.8

0.083

0.200

0.542

0.577

28.4

28.8

28.8

0.7

0.017

0.073

0.723

0.739

-299

-318

-371

70

<0.001

0.001

0.397

0.814

96 h
26.5
Body weight gain,
g
0 to 2 h
91
2 to 4 h

-61

-352

-220

-314

86

0.030

0.028

0.760

0.300

4 to 6 h

-11

-148

-102

-186

47

0.023

0.054

0.389

0.104

6 to 12 h

152

-64

-125

-352

109

0.017

0.179

0.039

0.457

12 to 24 h 322

189

8

417

146

0.494

0.528

0.292

0.123

24 to 48 h 723

947

1019

1076

141

0.091

0.276

0.521

0.965

48 to 96 h 1330

1667

1300

1212

157

0.727

0.138

0.056

0.572

Cumulative body weight gain, g
0 to 2 h

91

-299

-318

-371

70

<0.001

0.001

0.397

0.814

0 to 4 h

30

-652

-538

-686

112

<0.001

<0.001

0.845

0.394

0 to 6 h

19

-799

-640

-871

131

<0.001

<0.001

0.702

0.243

0 to 12 h

170

-864

-765 -1223

207

<0.001

0.002

0.210

0.260

0 to 24 h

492

-674

-758

-807

241

<0.001

0.003

0.733

0.960

0 to 48 h 1216

273

261

269

275

0.008

0.026

0.993

0.979

0 to 96 h 2545
1939 1765 1481
317
0.036
0.183
0.242
0.744
Each least squares mean represents six pigs.
2
At 0 h, phosphate buffered saline (PBS) or lipopolysaccharide (LPS) was intraperitoneally
injected. The volume of LPS solution was determined to deliver 50 μg/kg BW, and PBS was
filled to make 5 ml.
3
P-values are from single degree of freedom contrast. PBS vs. LPS represents the contrast
between pigs injected with PBS and pigs injected with LPS and fed 0, 1,000, or 2,000 ppb of
supplemental Cr; LPS represents the contrast between pigs injected with PBS and pigs injected
with LPS and fed 0 ppb of supplemental Cr. Linear and quadratic effects of dietary CrPic were
tested within the LPS challenged groups.
1
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Table 4.3. Effects of dietary chromium (III) picolinate (CrPic) supplementation on feed
intake of lipopolysaccharide (LPS) challenged pigs1
Injection2: PBS
Cr, ppb:

0

LPS
0

1,000 2,000

SEM

P-values3
PBS vs. LPS

LPS

Linear Quadratic

Feed intake, g
0 to 2 h

250

15

30

23

23

<0.001

<0.001

0.643

0.435

2 to 4 h

167

38

30

30

47

0.048

0.100

0.840

0.907

4 to 6 h

152

45

30

-

64

0.139

0.287

0.325

0.840

6 to 12 h

523

265

106

129

156

0.096

0.288

0.483

0.584

12 to 24 h 1,106

636

576

667

109

0.009

0.022

0.878

0.661

24 to 48 h 1,795

1,826 1,735 2,068

271

0.805

0.940

0.592

0.589

48 to 96 h 3,924

5,061 4,783 4,659

254

0.023

0.020

0.060

0.668

Cumulative feed intake, g
0 to 2 h

250

15

30

23

23

<0.001

<0.001

0.643

0.435

0 to 4 h

417

53

61

53

39

<0.001

<0.001

1.000

0.742

0 to 6 h

568

98

91

53

82

0.002

0.007

0.520

0.800

0 to 12 h

1,091

364

197

182

193

0.009

0.038

0.490

0.733

0 to 24 h

2,197

1,000

773

848

259

0.005

0.017

0.724

0.685

0 to 48 h

3,992

2,826 2,508 2,917

480

0.066

0.136

0.915

0.628

0 to 96 h 7,917
7,886 7,967 7,576 586
0.876
0.970
0.506
0.292
Each least squares mean represents three pens of two pigs/pen.
2
At 0 h, phosphate buffered saline (PBS) or lipopolysaccharide (LPS) was intraperitoneally
injected. The volume of LPS solution was determined to deliver 50 μg/kg BW, and PBS was
filled to make 5 ml.
3
P-values are from single degree of freedom contrast. PBS vs. LPS represents the contrast
between pigs injected with PBS and pigs injected with LPS and fed 0, 1,000, or 2,000 ppb of
supplemental Cr; LPS represents the contrast between pigs injected with PBS and pigs injected
with LPS and fed 0 ppb of supplemental Cr. Linear and quadratic effects of dietary CrPic were
tested within the LPS challenged groups.
1
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Effects of PBS or LPS challenge on cumulative BW gain and feed intake of pigs
fed no supplemental Cr are demonstrated in Figure 4.1.
(a)
3,000
Cumulative BW gain, g

2,500

PBS

LPS

2,000
1,500
1,000
500
0
-500 0

20

40

60

80

1 00

-1,000
-1,500
Hours post PBS or LPS challe nge

(b)
Cumulative feed intake, g

9,000
8,000
PBS

7,000

LPS

6,000
5,000
4,000
3,000
2,000
1,000
0
0

20

40

60

80

1 00

Hours post PBS or LPS challe nge

Figure 4.1. Effects of phosphate buffered saline (PBS) or lipopolysaccharide (LPS)
challenge on cumulative BW gain (a; n = 6 pigs) and cumulative feed intake (b; n = 3
pens) of pigs fed no supplemental Cr. At 0 h, LPS or PBS was intraperitoneally injected.
The volume of LPS solution was determined to deliver 50 μg/kg BW, and PBS was filled
to make 5 ml.
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4.3.2. Vital signs
Table 4.4 and 4.5 demonstrate rectal temperature and respiratory rate responses.
Rectal temperature was higher in the LPS group compared with the PBS group at 2 h
(40.2 vs. 39.5°C; P < 0.01) and 4 h (40.2 vs. 39.5°C; P < 0.05). Rectal temperature was
not different between the LPS and the PBS group at 6 h and after. Respiratory rate was
also higher in the LPS compared with the PBS group at 1.3 h (83.4 vs. 58.0 breath/min; P
< 0.05) and at 8.5 h (55.1 vs. 43.0 breath/min; P < 0.05). The dietary Cr had no effects on
body temperature or respiratory rate at any time point of the experiment.

Table 4.4. Effects of dietary chromium (III) picolinate (CrPic) supplementation on rectal
temperature of lipopolysaccharide (LPS) challenged pigs1
Injection2: PBS
Cr, ppb:

0

LPS
0

1,000 2,000

SEM

P-values3
PBS vs. LPS

LPS

Linear Quadratic

Rectal temperature, °C
0h

39.8

39.8

40.1

39.9

0.13

0.313

0.920

0.666

0.163

2h

39.5

40.1

40.2

40.4

0.16

0.001

0.021

0.346

0.937

4h

39.5

39.9

39.9

40.8

0.25

0.038

0.330

0.044

0.202

6h

39.6

39.9

39.5

40.2

0.33

0.375

0.437

0.566

0.257

8h

39.7

39.7

39.3

39.8

0.24

0.667

0.916

0.682

0.152

10 h

39.5

39.3

39.3

39.4

0.16

0.343

0.307

0.643

0.983

12 h

39.8

39.6

39.6

39.9

0.19

0.766

0.552

0.312

0.554

24 h

39.5

39.3

39.1

39.4

0.13

0.298

0.536

0.700

0.122

48 h
39.5
39.4 39.1 39.6 0.16
0.383
0.584
0.498
0.107
Each least squares mean represents six pigs.
2
At 0 h, phosphate buffered saline (PBS) or lipopolysaccharide (LPS) was intraperitoneally
injected. The volume of LPS solution was determined to deliver 50 μg/kg BW, and PBS was
filled to make 5 ml.
3
P-values are from single degree of freedom contrast. PBS vs. LPS represents the contrast
between pigs injected with PBS and pigs injected with LPS and fed 0, 1,000, or 2,000 ppb of
supplemental Cr; LPS represents the contrast between pigs injected with PBS and pigs injected
with LPS and fed 0 ppb of supplemental Cr. Linear and quadratic effects of dietary CrPic were
tested within the LPS challenged groups.
1
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Table 4.5. Effects of dietary chromium (III) picolinate (CrPic) supplementation on
respiratory rate of lipopolysaccharide (LPS) challenged pigs1
Injection2: PBS
Cr, ppb:

0

LPS
0

1,000 2,000

SEM

P-values3
PBS vs. LPS

LPS

Linear

Quadratic

Respiratory rate, breath/min
-1.0 h

63.2

52.0

53.8

55.3

3.99

0.055

0.063

0.547

0.972

1.3 h

58.0

75.0

83.8

91.5 10.03

0.041

0.246

0.316

0.967

3.7 h

65.5

81.7

80.8

81.5 11.45

0.247

0.331

0.993

0.964

6.0 h

54.8

68.5

62.3

63.2

5.05

0.109

0.072

0.472

0.584

8.5 h

43.0

58.5

58.0

48.7

4.50

0.032

0.026

0.127

0.413

12.0 h

54.5

54.0

58.3

49.3

7.63

0.946

0.964

0.708

0.538

23.0 h
42.0
40.5 39.5 45.5 2.83
0.960
0.712
0.246
0.344
Each least squares mean represents six pigs.
2
At 0 h, phosphate buffered saline (PBS) or lipopolysaccharide (LPS) was intraperitoneally
injected. The volume of LPS solution was determined to deliver 50 μg/kg BW, and PBS was
filled to make 5 ml.
3
P-values are from single degree of freedom contrast. PBS vs. LPS represents the contrast between
pigs injected with PBS and pigs injected with LPS and fed 0, 1,000, or 2,000 ppb of supplemental
Cr; LPS represents the contrast between pigs injected with PBS and pigs injected with LPS and
fed 0 ppb of supplemental Cr. Linear and quadratic effects of dietary CrPic were tested within the
LPS challenged groups.
1
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Effects of PBS or LPS challenge on rectal temperature and respiratory rate of pigs
fed no supplemental Cr are shown in Figure 4.2.
(a)

Rectal temperature, °C

40.4
40.2

PBS

40.0

LPS

39.8
39.6
39.4
39.2
39.0
0
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20
30
40
Hours post PBS or LPS challe nge

50

(b)
Respiratory rate, breath/min

100
90
PBS

80

LPS

70
60
50
40
30
-5

0

5
10
15
20
Hours post PBS or LPS challe nge

25

Figure 4.2. Effects of phosphate buffered saline (PBS) or lipopolysaccharide (LPS)
challenge on rectal temperature (a) and respiratory rate (b) of pigs fed no supplemental Cr
(n = 6). At 0 h, LPS or PBS was intraperitoneally injected. The volume of LPS solution
was determined to deliver 50 μg/kg BW, and PBS was filled to make 5 ml.
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4.3.3. Blood variables
Plasma collected at 3 h had higher cortisol (178 vs. 29 ng/ml; P < 0.001) and
lower glucose (5.87 vs. 6.88 mmol/l; P < 0.05) concentrations in the LPS group than the
PBS group (Table 4.6). However, plasma measurements were unaffected by dietary Cr
supplementation.
Table 4.6. Effects of dietary chromium (III) picolinate (CrPic) supplementation on
plasma cortisol and glucose of lipopolysaccharide (LPS) challenged pigs1
Injection2: PBS
Cr, ppb: 0

LPS
0

1,000 2,000

SEM

P-values3
PBS vs. LPS LPS Linear Quadratic

Cortisol, ng/ml

29.1

166.9 163.3 203.5 19.8

<0.001

<0.001 0.278

0.447

Glucose, mmol/l

6.88

6.03

0.021

0.100 0.967

0.362

5.57

6.01

0.35

1

Each least squares mean represents six pigs.
At 0 h, phosphate buffered saline (PBS) or lipopolysaccharide (LPS) was intraperitoneally
injected. The volume of LPS solution was determined to deliver 50 μg/kg BW, and PBS was
filled to make 5 ml.
3
P-values are from single degree of freedom contrast. PBS vs. LPS represents the contrast
between pigs injected with PBS and pigs injected with LPS and fed 0, 1,000, or 2,000 ppb of
supplemental Cr; LPS represents the contrast between pigs injected with PBS and pigs injected
with LPS and fed 0 ppb of supplemental Cr. Linear and quadratic effects of dietary CrPic were
tested within the LPS challenged groups.
2

4.4. Discussion
Effects of dietary CrPic supplementation on the immune responses in pigs have
been inconsistent (van Heugten and Spears, 1997; Lee et al., 2000; van de Ligt et al.,
2002c). At a dose of 200 ppb Cr, supplemental CrPic resulted in no or minimal effects on
pigs challenged with ACTH (van Heugten and Spears, 1997), whereas 400 ppb of Cr as
CrPic modulated cortisol response in pigs challenged with LPS (Lee et al., 2000). The
supplemental Cr levels were fed for 7 d before the initial immune challenge in the former
study; for 21 d in the latter study. The discrepancy of dietary Cr effects on immune
stressed pigs may be attributed to supplemental Cr levels and/or pre-feeding periods.
Immune systems may require greater than 200 ppb of supplemental Cr due to high
proliferation rate, as suggested by van Heugten and Spears (1997). In addition, dietary
supplementation of Cr as CrPic at the concentrations of 200, 400, 800, and 1,200 ppb
linearly increased feed intake, weight gain, feed efficiency, and egg production, and
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linearly decreased serum corticosterone concentration in heat stressed laying quail (Sahin
et al., 2002b). In the present study, thus, Cr levels of 1,000 and 2,000 ppb and 35 d of
pre-feeding period were employed.
4.4.1. Growth performance
Weight gain responded acutely to LPS challenge. During 0 to 2 h, all pigs
challenged with LPS lost weight, and the weight loss continued until 12 h. The acute
weight loss may be due to increased defecation, increased urination, and reduced feed
intake (Johnson and von Borell, 1994; Warren et al., 1997; Sakumoto et al., 2003). On a
cumulative basis, weight gain of the LPS group was still negative at 24 h and was not
fully recovered at the end of the experiment (96 h). In agreement, Mao et al. (2005)
reported growth retardation in pigs challenged with LPS during the first 7 d post injection.
In a longer term, however, weight gain may be recovered by the elevated compensatory
feed intake observed in the present study and other experiments depending on the LPS
dose (Johnson and von Borell, 1994; Warren et al., 1997).
Although behavioral activities were not quantified in the present study, all pigs
injected with LPS instantly showed depressed behavior and very rarely accessed the
feeder during 0 to 6 h, whereas the PBS group was more active and often accessed the
feeder. Similar to our observation, depressed behavior increased with a higher dose of
LPS (intraperitoneal) and decreased time-dependently after an acute peak at between 0
and 3 h in a previous study (Warren et al., 1997). However, Sakumoto et al. (2003)
reported that intravenous administration of LPS actually increased the activity of Chinese
Meishan pigs. The discrepancy among the studies may be related to the LPS injection
methods, dose levels, pig breeds, and/or experimental conditions.
According to the reduction of behavioral activity by immune stress, the present
study confirmed the feed intake reduction by immune stress during 0 to 24 h. In
agreement, acute decrease of feed intake by LPS challenge was reported in a number of
previous studies (Johnson and von Borell, 1994; Warren et al., 1997; Sakumoto et al.,
2003; Frank et al., 2005). In our study, relatively low feed intake in the PBS group during
2 to 4 h was perhaps due to the stress inevitably caused in blood collection procedures
without catheter settings. Compensatory increase in feed intake was observed in the LPS
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group during 48 to 96 h. Similarly, Johnson and von Borell (1994) reported that pigs
injected with a low dose (0.5 μg/kg BW) of LPS showed a compensatory elevation of
feed intake during 4 to 8 h post challenge. Although feed intake after 8 h was not
demonstrated herein, a compensation of feed intake may occur later with a higher dose (5
or 50 μg/kg BW) of LPS.
We failed to observe ameliorating effects of dietary Cr on weight gain or feed
intake of pigs challenged with immune stress, in agreement with other studies (van
Heugten and Spears, 1997; Lee et al., 2000).
4.4.2. Vital signs
In the present study, the endotoxin-induced elevation of body temperature was
consistent with previous research (Johnson and von Borell, 1994; Warren et al., 1997;
Sakumoto et al., 2003). However, supplemental Cr did not affect body temperature of
pigs under immune stress. Similarly, Lee et al. (2000) reported that rectal temperature
was elevated by LPS but dietary Cr had no effects on rectal temperature in pigs under
immune stress.
Respiratory rate was also higher in pigs under immune stress. Respiratory rate has
been often assessed to measure other types of stress such as heat stress (Morrow-Tesch et
al., 1994; Hicks et al., 1998). However, respiratory rate has been rarely measured in
immune stressed animal models. Although respiratory rate in this study was measured
once for each time by a single panelist, immune stress significantly affected the
measurement at two time points, and all LPS treatment means were greater than PBS
means through 8.5 h. Employing multiple panels system will potentially make respiratory
rate a good criterion in immune stress research.
4.4.3. Blood variables
The administration of LPS is generally known to activate macrophages and to
trigger the release of proinflammatory cytokines including tumor necrosis factor-α,
interleukin-1, and interleukin-6, which activate the hypothalamus-pituitary-adrenal axis
causing increased corticosteroid secretion from the adrenal cortex (Webel et al., 1997). In
the present study, plasma cortisol concentration was elevated 6.1-fold by LPS challenge
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consistent with previous studies (Warren et al., 1997; Webel et al., 1997; Sakumoto et al.,
2003). However, dietary Cr supplementation did not affect circulating cortisol
concentration in the pigs under immune stress. van Heugten and Spears (1997) also failed
to detect effects of Cr on serum cortisol concentrations in pigs stressed with ACTH. In
contrast, Lee et al. (2000) reported that dietary Cr decreased plasma cortisol
concentration at 2 h post LPS challenge on d 35 of the experiment. But, it should be
noted that dietary Cr did not affect cortisol concentrations in the first LPS injection on d
21, and supplemental Cr even increased plasma cortisol concentration at 4 h post
injection on d 35.
In the present study, plasma glucose concentration was 15% lower in the LPS
group than in the PBS group. Myers et al. (1997) also reported that blood glucose
concentration was decreased at 6 to 8 h post LPS challenge. The low glucose
concentration in the pigs challenged with LPS may be attributed to the low feed intake
during the first few hours. If the elevated cortisol concentration continues for a longer
term, gluconeogenesis may be enhanced and circulating glucose concentration may be
increased (McMahon et al., 1988). With a single injection of LPS, elevated cortisol
concentration generally lasted no more than 24 h (Webel et al., 1997). Multiple
challenges with endotoxin may result in high glucose concentration and potentially
glucose intolerance.
Taken together, an LPS challenge acutely caused growth retardation, feed intake
reduction, body temperature elevation, respiration rate increase, plasma cortisol elevation,
and plasma glucose reduction. However, dietary Cr had minimal effects on the pigs under
immune stress.
4.5. Implications
The present research indicated that pigs challenged with acute immune stress
consumed less feed, gained less weight, but had higher body temperature and respiratory
rate compared with those challenged with saline. The immune stress by endotoxin
challenge

increased

circulating

cortisol

concentration

but

decreased

glucose

concentration. However, supplemental Cr as CrPic added to the diet failed to ameliorate
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the effects of immune stress in pigs. Further research to assess effects and mechanism of
Cr on the pigs under other types of stress may be needed.

Copyright © Beob Gyun Kim 2007

117

CHAPTER 5. The Effects of Dietary Chromium (III) Picolinate on Growth
Performance, Respiratory Rate, Plasma Variables, and Carcass Traits of Pigs Fed
High-fat Diets
Abstract
The present experiment investigated the effects of dietary chromium (Cr) as Cr
(III) picolinate on growth, respiration, plasma variables, and carcass traits of pigs fed the
high-fat diets (HFD). A total of 32 crossbred weanling pigs (BW of 9.56 ± 1.64 kg) were
grouped into four blocks by initial BW, and randomly assigned to four treatment groups
with two pigs per pen. Dietary treatments included: 1) low-fat diet (LFD) with no
supplemental Cr, 2) HFD with no supplemental Cr, 3) HFD with 1,000 ppb supplemental
Cr, and 4) HFD with 2,000 ppb supplemental Cr. Crude fat contents in LFD and HFD
were less than 3.5% and more than 30.0%, respectively. During d 0 to 56, pigs fed the
HFD gained faster (800 vs. 727 g/d; P = 0.024), consumed less feed (1,130 vs. 1,397 g/d;
P < 0.001), and had lower feed:gain (1.41 vs. 1.92; P < 0.001). Dietary Cr
supplementation caused an increase in feed:gain of pigs fed the HFD (1.43 vs. 1.38; P =
0.035) in a quadratic manner (P = 0.033). Pigs fed the HFD had more frequent respiration
than pigs fed the LFD on d 13 (64.5 vs. 57.3 breath/min; P = 0.080), d 41 (75.9 vs. 61.9
breath/min; P < 0.001) and d 55 (43.3 vs. 35.6 breath/min; P = 0.061). However, the
supplemental Cr had no effect on respiratory rate. Plasma cortisol concentration on d 42
tended to be higher in the pigs fed HFD than the pigs fed LFD (47.8 vs. 34.3 ng/ml; P =
0.081). Plasma insulin concentration on d 14 decreased with dietary Cr supplementation
(2.84 vs. 5.71 μIU/ml; P = 0.024) in a linear manner (P = 0.050). Consumption of the
HFD resulted in increases of slaughter weight (62.5 vs. 57.7 kg; P < 0.001), hot carcass
weight (45.8 vs. 37.8 kg; P < 0.001), perirenal fat (496 vs. 261 g; P < 0.001), first rib fat
(2.97 vs. 1.98 cm; P < 0.001), last rib fat (1.69 vs. 1.17 cm; P = 0.006), last lumbar fat
(2.23 vs. 1.30 cm; P < 0.001), average backfat (2.30 vs. 1.49 cm; P< 0.001), and tenth rib
fat (1.79 vs. 1.06 cm; P < 0.001) compared with the LFD group. Estimated carcass fatfree lean percentages were lower in pigs fed the HFD than in the LFD group (52.8 vs.
59.9 %; P < 0.001). The supplemental levels of Cr resulted in linear reductions of hot
carcass weight (P = 0.083), cold carcass weight (P = 0.106), the last rib fat (P = 0.070),
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the last lumbar fat (P = 0.004) and average backfat (P = 0.036). The effects of Cr on
carcass fat measurements were more significant in barrows than in gilts. These results
indicate that dietary Cr supplementation attenuates some effects of HFD, mainly on body
fat accretion of pigs, especially in barrows.
Key Words: High-fat diet, Chromium, Pigs
5.1. Introduction
Since chromium (Cr) was identified as an essential component in the glucose
tolerance factor (Schwarz and Mertz, 1959), the roles of Cr have been widely studied in
humans and animals. Generally Cr has been shown to potentiate the action of insulin
(Mertz et al., 1974; Vincent, 2000) and accordingly to modulate carbohydrate, protein,
and lipid metabolism (Davis and Vincent, 1997; Cefalu et al., 2002; Bernao et al., 2004).
In animals, Cr has been recognized as an essential trace mineral (Anderson, 1987;
Offenbacher and Pi-Sunyer, 1988) and suggested to ameliorate stress related effects
(Chang and Mowat, 1992; Anderson, 1994; NRC, 1997). The effects of Cr have been
investigated in various stress situations of animals including thermal stress (Sahin et al.,
2002b; Onderci et al., 2003), immune stress (van Heugten and Spears, 1997; Lee et al.,
2000), and transportation stress (Chang and Mowat, 1992; Moonsier-Shageer and Mowat,
1993). However, studies on dietary Cr in animals under nutritional stress of high-fat diets
(HFD) have been rare and limited only to rodent models (Striffler et al., 1998;
Bhattacharya et al., 2006).
The consumption of HFD has been reported to cause obesity in humans (Lissner
and Heitmann, 1995; Shepard et al., 2001) and rodents (Masek and Fabry, 1959;
Lemonnier et al., 1975). And animals with obesity induced by HFD have been widely
used as experimental models in studies of human obesity (Inoue et al., 1977; Hansen et
al., 1997; Han et al., 2000; Jones et al., 2005; Kishino et al., 2006). Furthermore, dietary
high-fat may result in insulin resistance (Lavau et al., 1979; Rocchini et al., 1997; Jones
et al., 2005) and cardiovascular disease (Aguila and Mandarim-de-Lacerda, 2003; Davis
et al., 2006). Pigs, perhaps rather than rodents, would be excellent experimental animal
models for human nutrition studies, because of the anatomical and physiological
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similarities between swine and human digestive systems (Miller and Ullrey, 1987;
Nafikov and Beitz, 2007).
Supplemental Cr as Cr (III) picolinate (CrPic) has been reported to increase
leanness and/or decrease fat deposition of pigs in some studies (Page et al., 1993;
Lindemann et al., 1995; Mooney and Cromwell, 1995; Lien et al., 2001) but not in others
(Evock-Clover et al., 1993; Mooney and Cromwell, 1999; Matthews et al., 2001). In a
commercial environment, dietary CrPic has been suggested to be more effective in
animals with high propensity for body fat deposition (Lindemann and Purser, 1997). But
the influence of Cr on pigs fed fat-enriched diets has not been tested. Therefore, the
objective of the present study was to determine the effect of supplemental Cr on growth,
respiratory rate, plasma variables, and carcass traits of pigs fed HFD.
5.2. Experimental procedures
The growth trial was carried out at the University of Kentucky. The animal
slaughter and carcass traits assessment were performed at the meat laboratory of the same
institution. The experiments were conducted under protocols approved by the
Institutional Animal Care and Use Committee of the University of Kentucky.
5.2.1. Animals and dietary treatments
In a 56-d experiment, a total of 32 crossbred weanling pigs with an average initial
BW of 9.56 ± 1.64 kg were used. Animals were grouped into four blocks by initial BW
and randomly assigned to four treatment groups with two animals per pen, with balanced
gender and ancestry using the Experimental Animal Allotment Program (Kim and
Lindemann, 2007). One barrow and one gilt were housed in each plastic woven wire
floored 1.2 m × 1.2 m pen. Each pen was equipped with a stainless steel feeder and a
nipple waterer. Pigs had ad libitum access to feed and water.
Dietary treatments included: 1) a low-fat diet (LFD) with no supplemental Cr, 2) a
HFD with no supplemental Cr, 3) the HFD with 1,000 ppb supplemental Cr, and 4) the
HFD with 2,000 ppb supplemental Cr. The experimental diets for d 0 to 14 were
formulated to contain 3.29% crude fat, 22.17% crude protein, and 1.38% Lys for the lowfat treatment group and 30.07% crude fat, 20.66% crude protein, and 1.38% Lys for the
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high-fat treatment groups (Table 5.1). The experimental diets for d 14 to 56 were
formulated to contain 3.48% crude fat, 21.79% crude protein, and 1.22% Lys for the lowfat treatment group and 30.11% crude fat, 20.43% crude protein, and 1.25% Lys for the
high-fat treatment groups (Table 5.2). A dried fat product (SOWEENA Dry Fat 4-80,
Merrick Animal Nutrition, Inc., Middleton, WI) containing 80% crude fat, 4.4% crude
protein, and less than 3.5% ash was used to achieve the high fat contents. Analysed fatty
acid profile of treatment diets is shown in Table 5.3. Dietary Cr was supplemented as
CrPic (CHROMAX, Prince Agri Products, Inc., Quincy, IL) at the expense of limestone,
the carrier of CrPic in CHROMAX. The organic form of trivalent Cr, CrPic, was used
based on previous reports suggesting that Cr is more available as an organic chelate (Page
et al., 1993). Minerals and vitamins were added to meet or exceed NRC (1998).
Antibacterial agents and antioxidants were also included in the diets.
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Table 5.1. Percentage composition of experimental diets for starting pigs (d 0 to 14; asfed basis)
Dietary fat:
Low
High
Cr, ppb:
0
0
1,000
2,000
Ingredients
Corn
58.635
28.535
28.535
28.535
Soybean meal, 48% CP
30.00
30.00
30.00
30.00
Whey dried
5.00
Spray dried animal plasma
3.00
3.00
3.00
3.00
Dried fat 4-801
35.00
35.00
35.00
L-Lysine·HCl
0.10
0.09
0.09
0.09
DL-Methionine
0.02
0.09
0.09
0.09
L-Threonine
0.04
0.04
0.04
Dicalcium phosphate
1.30
1.30
1.30
1.30
Limestone
1.10
1.10
0.85
0.60
2
0.25
0.50
CHROMAX
Iodized salt
0.40
0.40
0.40
0.40
3
Vitamin premix
0.10
0.10
0.10
0.10
4
Trace mineral premix
0.075
0.075
0.075
0.075
Antibiotic5
0.25
0.25
0.25
0.25
Antioxidant6
0.02
0.02
0.02
0.02
Calculated nutrient composition
ME, kcal/kg
3,296
4,576
4,576
4,576
Crude fat, %
3.29
30.07
30.07
30.07
Crude protein, %
22.17
20.66
20.66
20.66
Lysine, %
1.38
1.38
1.38
1.38
Calcium, %
0.84
0.89
0.89
0.89
Phosphorus, %
0.69
0.66
0.66
0.66
Available phosphorus, %
0.38
0.42
0.42
0.42
1

A homogeneous, co-dried product (SOWEENA Dry Fat 4-80, Merrick Animal Nutrition, Inc.,
Middleton, WI) containing micro-encapsulated lard, tallow, and whey proteins. This product
contains 7,054 kcal/kg ME, 80% crude fat, 4.4% crude protein, 0.36% lysine, 0.17%
methionine + cystine, 0.20% threonine, 0.27% calcium, 0.26% phosphorus, and 0.25%
available phosphorus (calcium and phosphorus contents are estimated assuming that the ratios
of these contents to crude protein are the same as in dried whey).
2
Supplied 0, 1,000, or 2,000 ppb Cr as chromium (III) picolinate (CHROMAX, Prince Agri
Products, Inc., Quincy, IL).
3
Supplied per kg of diet: vitamin A, 6,600 IU; vitamin D3, 880 IU; vitamin E, 44 IU; vitamin K
(as menadione sodium bisulfite complex), 6.4 mg; thiamin, 4.0 mg; riboflavin, 8.8 mg;
pyridoxine, 4.4 mg; vitamin B12, 33 µg; folic acid, 1.3 mg; niacin, 44 mg; pantothenic acid, 22
mg; D-biotin, 0.22 mg.
4
Supplied per kg of diet: Zn, 131 mg as ZnO; Fe, 131 mg as FeSO4·H2O; Mn 45 mg, as MnO; Cu,
13 mg as CuSO4·5H2O; I, 1.5 mg as CaI2O6; Co, 0.23 mg as CoCO3; Se, 0.28 mg as NaSeO3.
5
Mecadox-10 (Phibro Animal Health, Fairfield, NJ) supplied 55 mg carbadox per kg of diet.
6
Santoquin (Monsanto, St. Louis, MO) supplied 130 mg ethoxyquin per kg of diet.
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Table 5.2. Percentage composition of experimental diets for growing pigs (d 14 to 56; asfed basis)
Dietary fat:
Low
High
Cr, ppb:
0
0
1,000
2,000
Ingredients
Corn
62.255
27.255
27.255
27.255
Soybean meal, 48% CP
35.00
35.00
35.00
35.00
Dried fat 4-801
35.00
35.00
35.00
Dicalcium phosphate
1.10
1.10
1.10
1.10
Limestone
1.00
1.00
0.75
0.50
CHROMAX2
0.25
0.50
Iodized salt
0.40
0.40
0.40
0.40
0.10
0.10
0.10
0.10
Vitamin premix3
Trace mineral premix4
0.075
0.075
0.075
0.075
5
Antibiotic
0.05
0.05
0.05
0.05
Antioxidant6
0.02
0.02
0.02
0.02
Calculated nutrient composition
ME, kcal/kg
3,312
4,584
4,584
4,584
Crude fat, %
3.48
30.11
30.11
30.11
Crude protein, %
21.79
20.43
20.43
20.43
Lysine, %
1.22
1.25
1.25
1.25
Calcium, %
0.74
0.82
0.82
0.82
Phosphorus, %
0.62
0.61
0.61
0.61
Available phosphorus, %
0.28
0.36
0.36
0.36
1

A homogeneous, co-dried product (SOWEENA Dry Fat 4-80, Merrick Animal Nutrition, Inc.,
Middleton, WI) containing micro-encapsulated lard, tallow, and whey proteins. This product
contains 7,054 kcal/kg ME, 80% crude fat, 4.4% crude protein, 0.36% lysine, 0.17%
methionine + cystine, 0.20% threonine, 0.27% calcium, 0.26% phosphorus, and 0.25%
available phosphorus (calcium and phosphorus contents are estimated assuming that the ratios
of these contents to crude protein are the same as in dried whey).
2
Supplied 0, 1,000, or 2,000 ppb Cr as chromium (III) picolinate (CHROMAX, Prince Agri
Products, Inc., Quincy, IL).
3
Supplied per kg of diet: vitamin A, 6,600 IU; vitamin D3, 880 IU; vitamin E, 44 IU; vitamin K
(as menadione sodium bisulfite complex), 6.4 mg; thiamin, 4.0 mg; riboflavin, 8.8 mg;
pyridoxine, 4.4 mg; vitamin B12, 33 µg; folic acid, 1.3 mg; niacin, 44 mg; pantothenic acid, 22
mg; D-biotin, 0.22 mg.
4
Supplied per kg of diet: Zn, 131 mg as ZnO; Fe, 131 mg as FeSO4·H2O; Mn 45 mg, as MnO;
Cu, 13 mg as CuSO4·5H2O; I, 1.5 mg as CaI2O6; Co, 0.23 mg as CoCO3; Se, 0.28 mg as
NaSeO3.
5
Tylan 40 Sulfa-G (Elanco Animal Health, Indianapolis, IN) supplied 110 mg of tylosin and 110
mg of sulfamethazine per kg of diet.
6
Santoquin (Monsanto, St. Louis, MO) supplied 130 mg ethoxyquin per kg of diet.
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Table 5.3. Analysed fatty acid profile of the dietary treatments
Experimental period:

D 0 to 14

Dietary fat:
Crude fat

D 14 to 56

Low

High

Low

High

2.58

25.98

2.17

26.45

Fatty acid profile, % of total fat1
C14:0

-2

2.12

-

2.14

C16:0

12.61

22.04

12.36

21.98

C16:1

-

2.72

-

2.74

C17:0

-

0.92

-

0.93

C17:1

-

0.62

-

0.64

C18:0

2.55

C18:1t-9

-

2.55

-

2.61

C18:1n-9

21.99

38.67

23.58

38.98

C18:2

57.08

12.17

55.81

11.37

C18:3

3.93

0.93

3.15

0.77

Saturated fatty acid

15.16

38.36

15.13

38.50

Polyunsaturated fatty acid

61.01

13.10

58.96

12.14

13.28

2.77

13.45

4.02
0.34
3.90
0.32
PUFA:SFA3
1
Fatty acids lower than 0.5% are removed from the list.
2
Not detectable.
3
PUFA and SFA represent polyunsaturated fatty acid and saturated fatty acid,
respectively.
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5.2.2. Data and sample collection
Animal weights and feed intake were measured biweekly. Blood samples were
collected from all pigs via the jugular vein on d 14, 28, 42, and 56. Animals were fasted
for 16 h before the blood collection on d 42 and 56. The collected blood samples were
kept on ice for approximately 1 to 2 h, and the plasma samples were then obtained by
centrifugation of the blood at 800 × g and 4°C for 20 min. Plasma samples were stored at
-20°C until the chemical assays.
Respiratory rate was visually measured on d 13, 27, 41, and 55 by counting flank
movements over a period of 1 min in resting pigs. To facilitate the counting of respiration
in resting pigs, respiratory rate was determined between 20:30 and 24:30. The respiratory
rate was measured by three independent panelists, and means of three observations were
used for analysis.
Growth data were recorded until d 56, and the treatments diets continued to be fed
until the animals were slaughtered on d 58 or 65 for determination of body fat measures.
After fasting for 16 to 20 h, animals were humanely slaughtered using conventional
methods. One pig died before slaughter, and carcass data of this pig were not collected.
The perirenal fat (leaf fat) surrounding the kidney was removed from the carcass and
weighed. The head was removed, and the carcass was split along the dorsal midline. The
hot carcass was weighed, and carcass traits were measured after chilling the carcass at
1°C for 72 h. The midline backfat was measured at the first rib, the last rib, and the last
lumbar vertebrae. The tenth-rib fat thickness was measured at three-fourths of the
distance across the longissimus muscle, and the longissimus muscle area (LMA) was
determined by assessing the surface area at primal cuts of tenth rib following the methods
described by NPPC (2000).
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5.2.3. Carcass fat-free lean estimation and carcass data adjustment
From the carcass data, initial fat-free lean (FFL) weight, carcass FFL weight, FFL
gain, daily FFL gain, and the percentage FFL in carcass were estimated using the
equations (NPPC, 2000) adapted to metric units as follows:
Initial fat-free lean weight, kg = (0.418 × initial BW, kg) – 1.825
Carcass fat-free lean = 3.899 + (0.465 × hot carcass weight, kg) – (3.914 ×
tenth rib fat, cm) + (0.2115 × longissimus muscle area, cm2)
Fat-free lean gain, kg = carcass fat-free lean, kg – initial fat-free lean, kg
Daily fat-free lean gain, kg/d = fat-free lean gain, kg ÷ days on test
Percentage fat-free lean in carcass, % = carcass fat-free lean, kg ÷ hot
carcass weight, kg
Backfat depth and LMA were adjusted to 41.6 kg cold carcass weight (the mean
weight). Adjustment equations for backfat depth and LMA are available (NPPC, 2000)
but applicable only to the pigs of 107 to 120 kg BW. Thus, considering different
dimensional parameters, the following adjustment equations were used:
Adjusted fat depth, cm = actual fat depth, cm × (41.61/3 ÷ cold carcass
weight1/3, kg)
Adjusted longissimus muscle area, cm2 = actual longissimus muscle area,
cm2 × (41.62/3 ÷ cold carcass weight2/3, kg).
5.2.4. Laboratory analysis
Crude fat contents of diet samples were analysed by a solvent extraction method
(AOAC, 1995) using a Soxtec System HT (Tecator AB, Hoganas, Sweden). Fatty acid
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profiles of treatment diets were determined (AOAC, 1995) at Experiment Station
Chemical Laboratory (University of Missouri, Columbia).
The frozen plasma samples were allowed to thaw at room temperature for the
chemical analysis. The cortisol and insulin concentrations in the plasma samples were
determined using coated tube radioimmunoassays (Diagnostic Products Corporation, Los
Angeles, CA). The radioactivity was measured using a Packard Cobra Auto-gamma
counter (Packard Instrument Co., Meriden, CT). Standards and samples were analyzed in
triplicate and duplicate, respectively. A new set of standards was prepared and analyzed
for each separate analysis.
5.2.5. Statistical analysis
The experimental unit for the growth performance responses was the pen and data
were analyzed using GLM procedures of SAS (SAS Inst. Inc., Cary, NC). The model
included two main effects and interaction as follows:
Yij = k + bi + tj + eij
In this equation, the parameters represent:
Y = response variables
k = a constant
bi = block effect
tj = treatment effect
eij = error term of the model
For other data including respiratory rate, plasma hormones, and carcass measurements,
the individual pig was considered as the experimental unit. Respiratory rates and plasma
hormone concentrations were analyzed using MIXED procedure of SAS for repeated
measures (Littell et al., 1998). For the analysis of carcass measurements the model
included block effect, treatment effect, sex effect, and treatment × sex interaction.
Orthogonal polynomials were used to determine the effects of dietary high-fat inclusion
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and the linear and quadratic effects of the dietary Cr supplementation in the HFD
treatments.
5.3. Results
5.3.1. Growth performance
The growth performance was affected by dietary fat inclusion levels but
minimally by supplemental Cr (Table 5.4 and 5.5). During d 0 to 14, pigs fed the HFD
gained 16% more weight (671 vs. 579 g/d; P = 0.025), had 19% lower feed:gain (1.24 vs.
1.53; P < 0.001), consumed more energy (3.80 vs. 2.94 Mcal ME/d; P = 0.001), and had
higher ME:gain (5.65 vs. 5.06; P = 0.023) than pigs fed the LFD. During d 14 to 56, pigs
in the HFD groups gained 9 % more weight (843 vs. 776 g/d; P = 0.064), consumed 21%
less feed (1,231 vs. 1,566 g/d; P < 0.001), and had 28% lower feed:gain (1.46 vs. 2.02; P
< 0.001) with no discernible difference in energy intake or ME:gain. Over the entire
experimental period, the HFD group gained 10% faster (800 vs. 727 g/d; P = 0.024),
consumed 19% less feed (1,130 vs. 1,397 g/d; P < 0.001) but 12% more energy (5.18 vs.
4.62 Mcal ME/d; P = 0.028), and showed 26% lower feed:gain (1.41 vs. 1.92; P < 0.001)
with no detectable changes in ME:gain (P = 0.291). Dietary Cr supplementation had no
effect on the growth performance of the pigs fed the HFD except that feed:gain was 3.3%
increased (1.43 vs. 1.38; P = 0.035) in a quadratic manner (P = 0.033) by Cr
supplementation for the overall period.
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Table 5.4. Effects of dietary chromium supplementation on biweekly body weight,
average daily gain (ADG, g/d), average daily feed intake (ADFI, g/d), and feed:gain of
pigs fed the experimental diets1
Dietary fat: Low
High
P-values2
SEM
Cr, ppb:
0
0
1,000
2,000
Fat1 Fat2
Cr Linear Quad.
Body weight, kg
D0
9.6
9.4
9.6
9.6
0.13 0.752 0.382 0.213 0.320 0.398
D 14
17.7
18.8
19.1
18.9
0.43 0.033 0.094 0.798 0.882 0.798
D 28
28.3
29.8
28.7
29.1
0.85 0.400 0.252 0.441 0.611 0.498
D 42
38.1
42.6
40.2
40.5
1.28 0.070 0.033 0.244 0.341 0.459
D 56
50.3
55.5
53.8
53.8
1.38 0.031 0.025 0.399 0.461 0.666
D 0 to 14
ADG
579
672
673
668
29
0.025 0.053 0.967 0.926 0.939
ADFI
891
811
852
826
34
0.152 0.130 0.574 0.790 0.506
Feed:gain
1.53
1.21
1.26
1.24 0.05 <0.001 0.001 0.348 0.520 0.427
D 14 to 28
ADG
760
785
688
728
46
0.636 0.713 0.146 0.327 0.186
ADFI
1299
1054
1004
1013
58
0.003 0.015 0.375 0.482 0.559
Feed:gain
1.71
1.34
1.46
1.39 0.03 <0.001 <0.001 0.095 0.331 0.077
D 28 to 42
ADG
697
915
822
814
60
0.054 0.030 0.304 0.350 0.640
ADFI
1509
1304
1260
1228
80
0.027 0.104 0.571 0.536 0.955
Feed:gain
2.17
1.43
1.57
1.51 0.08 <0.001 <0.001 0.163 0.343 0.210
D 42 to 56
920
968
944
44
0.183 0.450 0.512 0.702 0.510
ADG
870
ADFI
1891
1384
1438
1392
55
<0.001 <0.001 0.664 0.918 0.493
Feed:gain
2.18
1.51
1.50
1.47 0.06 <0.001 <0.001 0.738 0.659 0.922
D 0 to 14
ADG
579
672
673
668
29
0.025 0.053 0.967 0.926 0.939
ADFI
891
811
852
826
34
0.152 0.130 0.574 0.790 0.506
Feed:gain
1.53
1.21
1.26
1.24
0.05 <0.001 0.001 0.348 0.520 0.427
D 14 to 56
ADG
776
873
826
829
28
0.064 0.034 0.252 0.328 0.518
ADFI
1566
1247
1234
1211
55
<0.001 0.003 0.688 0.612 0.937
Feed:gain
2.02
1.43
1.49
1.46
0.03 <0.001 <0.001 0.088 0.295 0.081
Overall
ADG
727
823
788
789
23
0.024 0.018 0.342 0.411 0.615
ADFI
1397
1138
1138
1115
46
<0.001 0.003 0.834 0.713 0.827
Feed:gain
1.92
1.38
1.44
1.41 0.02 <0.001 <0.001 0.035 0.173 0.033
1
Each least squares mean represents four pens of two pigs/pen.
2
P-values are from single degree of freedom contrast. Fat1 represents the comparison between low- and
high-fat diets. Fat2 represents the comparison between low- and high-fat diets with no supplemental
Cr. Cr represents the comparison of Cr added vs. non-added within pigs fed the high-fat diet. Linear
and quadratic effects of dietary Cr were tested within pigs fed the high-fat diet.
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Table 5.5. Effects of dietary chromium supplementation on body weight, average daily
gain (ADG, g/d), average daily feed intake (ADFI, g/d), feed:gain, average daily ME
intake (ADMEI, Mcal/d), and ME:gain (kcal/g gain) of pigs fed the experimental diets1
Dietary fat: Low
High
P-values2
SEM
Cr, ppb:
0
0
1,000
2,000
Fat1 Fat2
Cr Linear Quad.
Body weight, kg
D0
9.6
9.4
9.6
9.6
0.13 0.752 0.382 0.213 0.320 0.398
D 14
17.7
18.8
19.1
18.9
0.43 0.033 0.094 0.798 0.882 0.798
D 56
50.3
55.5
53.8
53.8
1.38 0.031 0.025 0.399 0.461 0.666
D 0 to 14
ADG
579
672
673
668
29
0.025 0.053 0.967 0.926 0.939
ADFI
891
811
852
826
34
0.152 0.130 0.574 0.790 0.506
Feed:gain
1.53
1.21
1.26
1.24
0.05 <0.001 0.001 0.348 0.520 0.427
ADMEI
2.94
3.71
3.90
3.78
0.16 0.001 0.007 0.574 0.790 0.506
ME:gain
5.06
5.53
5.76
5.67
0.19 0.023 0.111 0.348 0.520 0.427
D 14 to 56
ADG
776
873
826
829
28
0.064 0.034 0.252 0.328 0.518
ADFI
1566
1247
1234
1211
55
<0.001 0.003 0.688 0.612 0.937
Feed:gain
2.02
1.43
1.49
1.46
0.03 <0.001 <0.001 0.088 0.295 0.081
ADMEI
5.19
5.72
5.66
5.55
0.22 0.105 0.120 0.688 0.612 0.937
ME:gain
6.69
6.55
6.85
6.69
0.11 0.946 0.368 0.088 0.295 0.081
Overall
727
823
788
789
23
0.024 0.018 0.342 0.411 0.615
ADG
ADFI
1397
1138
1138
1115
46
<0.001 0.003 0.833 0.713 0.827
Feed:gain
1.92
1.38
1.44
1.41
0.02 <0.001 <0.001 0.035 0.173 0.033
ADMEI
4.62
5.22
5.22
5.11
0.18 0.028 0.050 0.833 0.713 0.827
ME:gain
6.36
6.34
6.62
6.48
0.09 0.291 0.883 0.035 0.173 0.033
1
Each least squares mean represents four pens of two pigs/pen.
2
P-values are from single degree of freedom contrast. Fat1 represents the comparison between low- and
high-fat diets. Fat2 represents the comparison between low- and high-fat diets with no supplemental
Cr. Cr represents the comparison of Cr added vs. non-added within pigs fed the high-fat diet. Linear
and quadratic effects of dietary Cr were tested within pigs fed the high-fat diet.

5.3.2. Respiratory rate
Respiratory rate (Table 5.6) was numerically higher in pigs fed the HFD than pigs
fed a LFD on d 13 (65.4 vs. 57.3 breath/min; P = 0.080; 24.6°C ambient temperature), d
27 (50.0 vs. 44.1 breath/min; P = 0.147; 23.7°C ambient temperature), and d 55 (43.3 vs.
35.6 breath/min; P = 0.061; 22.3°C ambient temperature). The frequency of respiration
was markedly higher in pigs fed the HFD than in pigs fed the LFD on d 41 (75.9 vs. 61.9
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breath/min; P < 0.001; 27.1°C ambient temperature). Dietary Cr supplementation did not
affect respiration rate.

Table 5.6. Effects of dietary chromium supplementation on respiratory rate of pigs fed
the experimental diets1
Dietary fat: Low
High
P-values2
SEM
Cr, ppb:
0
0
1,000 2,000
Fat1 Fat2 Cr Linear Quad.
Respiratory rate, breath/min
D 13
57.3
65.3
63.2
65.0
3.3 0.080 0.112 0.782 0.960 0.642
D 27
44.1
51.8
45.2
53.2
3.7 0.147 0.127 0.552 0.772 0.093
3
D 41
61.9
73.4
74.9
79.3
3.8 <0.001 0.023 0.395 0.239 0.731
D 55
35.6
43.8
42.3
43.8
2.7 0.061 0.103 0.865 0.993 0.724
1

Each least squares mean represents eight pigs (four animals for each sex). The respiratory rate
was measured by three independent panelists (two panelists on d 27) and means of these three
observations were used for statistical analysis.
2
P-values are from single degree of freedom contrast. Fat1 represents the comparison between
low- and high-fat diets. Fat2 represents the comparison between low- and high-fat diets with
no supplemental Cr. Cr represents the comparison of Cr added vs. non-added within pigs fed
the high-fat diet. Linear and quadratic effects of dietary Cr were tested within pigs fed the
high-fat diet. In the analysis of repeated measures, treatment effects (P = 0.003) and time
effects (P < 0.001) were significant, but no interaction between treatment and time existed (P
= 0.829).
3
The ambient temperature on d 41 was unintentionally high (27.1°C), while the temperature was
maintained as thermoneutral on d 13 (24.6°C), 27 (23.7°C), and 55 (22.3°C).

5.3.3. Plasma cortisol and insulin
As shown in Table 5.7, plasma cortisol concentration on d 42 tended to be higher
in the pigs fed HFD than the pigs fed LFD (47.8 vs. 34.3 ng/ml; P = 0.081). Plasma
insulin concentration on d 14 was decreased by dietary Cr supplementation (P = 0.024) in
a linear manner (P = 0.050).
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Table 5.7. Effects of dietary chromium supplementation on plasma cortisol and insulin of
pigs fed the experimental diets1
Dietary fat: Low
High
P-values2
SEM
Cr, ppb:
0
0
1,000 2,000
Fat1 Fat2 Cr Linear Quad.
Cortisol, ng/ml
D 14
60.8
57.8
67.2
56.4
8.6 0.965 0.745 0.618 0.884 0.213
D 28
33.2
41.8
42.8
46.1
7.3 0.177 0.358 0.747 0.652 0.891
D 42
34.3
52.5
48.0
42.8
5.8 0.081 0.055 0.386 0.305 0.964
D 56
31.7
39.8
32.0
31.7
4.8 0.711 0.386 0.328 0.387 0.646
Insulin, μIU/ml3
D 14
4.78
5.71
2.83
2.84 1.44 0.404 0.522 0.024 0.050 0.252
D 28
5.38
5.31
6.86
4.94 1.06 0.786 0.958 0.636 0.801 0.169
D 42
3.41
2.60
4.28
3.43 0.77 0.984 0.578 0.322 0.569 0.318
D 56
2.66
3.64
2.31
2.76 0.64 0.837 0.499 0.380 0.546 0.477
1

Each least squares mean represents eight pigs (four animals for each sex).
P-values are from single degree of freedom contrast. Fat1 represents the comparison between
low- and high-fat diets. Fat2 represents the comparison between low- and high-fat diets with no
supplemental Cr. Cr represents the comparison of Cr added vs. non-added within pigs fed the
high-fat diet. Linear and quadratic effects of dietary Cr were tested within pigs fed the high-fat
diet. In the analysis of repeated measures data of cortisol, time effects (P < 0.001) were
significant, but treatment effects (P = 0.524) nor interaction between treatment and time (P =
0.676) existed. For insulin, similarly, time effects (P = 0.002) were observed whereas treatment
effects (P = 0.713) and the interaction (P = 0.452) were insignificant.
3
One IU of insulin is the biological equivalent of about 45.5 μg pure crystalline insulin (1 μIU =
45.5 pg pure crystalline insulin).
2

5.3.4. Carcass traits
Feeding the HFD caused increases of slaughter weight, carcass weight, and
carcass fat measures. Carcass weights and some of the fat parameters increased by the
HFD were reversed by dietary Cr supplementation (Table 5.8). Feeding the HFD caused
increases of slaughter weight (62.5 vs. 57.7 kg; P < 0.001), and hot carcass weight (45.8
vs. 37.8 kg; P < 0.001). Consumption of the HFD resulted in 90% greater perirenal fat
(496 vs. 261 g; P < 0.001) compared with the LFD group. Pigs provided with the HFD
had deeper first rib fat (2.97 vs. 1.98 cm; P < 0.001), last rib fat (1.69 vs. 1.17 cm; P =
0.006), last lumbar fat (2.23 vs. 1.30 cm; P < 0.001), average backfat (2.30 vs. 1.49 cm; P
< 0.001), and tenth rib fat (1.79 vs. 1.06 cm; P < 0.001) by 50, 44, 72, 55, and 69%,
respectively, compared with the LFD group. The greater fat deposition by dietary fat was
similarly observed in adjusted carcass fat traits. The tenth rib LMA was unaffected by
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dietary fat inclusion (P = 0.485) whereas the tenth rib LMA adjusted to 41.6 kg cold
carcass weight was 11% smaller (25.2 vs. 28.5 cm2; P = 0.035). Estimated carcass FFL
percentages were lower in pigs fed the HFD than in the LFD group (52.8 vs. 59.9 %; P <
0.001). But, carcass FFL (P = 0.504), and daily FFL gain (P = 0.442) were not influenced
by dietary fat levels.
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Table 5.8. Effects of dietary chromium supplementation on carcass traits of pigs fed the
experimental diets1
Dietary fat: Low
High
P-values2
SEM
Cr, ppb: 0
0 1,000 2,000
Fat1 Fat2 Cr Linear Quad.
Measurements3
Initial BW, kg
9.6
9.5
9.6
9.6 0.2 0.947 0.821 0.702 0.780 0.762
BW at slaughter, kg 57.7
65.5 61.1 60.8 2.0 0.036 0.009 0.102 0.132 0.430
Hot carcass, kg
40.3
48.1 44.7 44.5 1.3 <0.001 <0.001 0.058 0.083 0.341
Cold carcass, kg
37.8
45.1 42.2 42.1 1.2 <0.001 <0.001 0.077 0.106 0.378
Perirenal fat, g
261
560
466
462
48
<0.001 <0.001 0.170 0.214 0.496
First rib fat, cm
1.98
2.94 3.08 2.89 0.18 <0.001 0.001 0.613 0.956 0.256
Last rib fat, cm
1.17
1.97 1.57 1.54 0.16 0.006 0.001 0.050 0.070 0.344
Last lumbar fat, cm
1.30
2.57 2.19 1.94 0.16 <0.001 <0.001 0.008 0.004 0.747
Average backfat, cm
1.49
2.49 2.28 2.12 0.14 <0.001 <0.001 0.064 0.036 0.938
10th rib fat, cm
1.06
1.97 1.73 1.68 0.16 <0.001 <0.001 0.263 0.280 0.674
2
10th rib LMA, cm
26.8
27.2 25.0 25.2 1.3 0.485 0.829 0.244 0.323 0.485
4
Estimations
Initial FFL, kg
2.19
2.16 2.20 2.18 0.10 0.947 0.821 0.702 0.780 0.762
Carcass FFL, kg
24.1
24.3 23.2 23.3 0.7 0.504 0.839 0.272 0.362 0.490
FFL gain, kg
21.9
22.2 21.0 21.1 0.6 0.477 0.799 0.220 0.310 0.433
Daily FFL gain, kg/d 365
368
349
351
10
0.442 0.833 0.217 0.307 0.429
Carcass FFL, %
59.9
50.7 52.2 52.5 1.6 <0.001 <0.001 0.478 0.488 0.802
Adjusted carcass traits5
First rib fat, cm
2.05
2.86 3.07 2.88 0.18 <0.001 0.003 0.332 0.739 0.156
Last rib fat, cm
1.21
1.91 1.57 1.53 0.15 0.010 0.003 0.069 0.090 0.396
Last lumbar fat, cm
1.34
2.50 2.18 1.93 0.15 <0.001 <0.001 0.011 0.005 0.882
Average backfat, cm
1.53
2.43 2.27 2.11 0.13 <0.001 <0.001 0.100 0.049 0.874
10th rib fat, cm
1.10
1.91 1.72 1.68 0.14 <0.001 <0.001 0.320 0.333 0.718
2
10th rib LMA, cm
28.5
25.8 24.9 25.0 1.4 0.035 0.154 0.678 0.747 0.768
1
Each least squares mean represents eight pigs (four animals for each sex).
2
P-values are from single degree of freedom contrast. Fat1 represents the comparison between low- and
high-fat diets. Fat2 represents the comparison between low- and high-fat diets with no supplemental
Cr. Cr represents the comparison of Cr added vs. non-added within pigs fed the high-fat diet. Linear
and quadratic effects of dietary Cr were tested within pigs fed the high-fat diet.
3
The midline fat depth was measured at the first rib, the last rib, and the last lumbar vertebrae. Average
backfat depth was calculated as a mean of three fat depth values at the first rib, the last rib, and the
last lumbar vertebrae. The off-midline fat depth and longissimus muscle area (LMA) were assessed
at primal cuts of 10th rib.
4
Fat-free lean (FFL) values were estimated using the equations in Pork Composition & Quality
Assessment Procedures (NPPC, 2000): Initial FFL, kg = (0.418 × initial BW, kg) – 1.825; Carcass
FFL = 3.899 + (0.465 × hot carcass weight, kg) – (3.914 × 10th rib fat, cm) + (0.2115 × LMA, cm2);
FFL gain, kg = carcass FFL, kg – initial FFL, kg; Daily FFL gain, kg/d = FFL gain, kg ÷ days on test
(60.5 d on average); Carcass FFL, % = carcass FFL, kg ÷ hot carcass weight, kg.
5
Backfat depth and LMA were adjusted to 41.6 kg cold carcass weight using the equations: Adjusted
fat depth, cm = actual fat depth, cm × (41.61/3 ÷ cold carcass weight1/3, kg); Adjusted LMA, cm2 =
actual LMA, cm2 × (41.62/3 ÷ cold carcass weight2/3, kg).
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The increased carcass fat measures caused by the HFD were moderated by
feeding supplemental Cr (Table 5.8). The supplemental levels of Cr resulted in linear
reductions of hot carcass weight (P = 0.083), cold carcass weight (P = 0.106), the last rib
fat (P = 0.070), the last lumbar fat (P = 0.004) and average backfat (P = 0.036). Adjusted
backfat depths were also similarly responded to supplemental Cr. The interactions (or
trends) of dietary Cr × sex were observed in the last lumbar fat (P = 0.014; not shown)
and average backfat (P = 0.090; not shown). In barrows, the last lumbar fat (P = 0.002)
and average backfat (P = 0.037) were linearly reduced by increasing levels of
supplemental Cr (Table 5.9). In gilts, however, the effects of dietary Cr on carcass fat
measurement were not observed (P > 0.20; Table 5.10). In addition, the perirenal fat
weight also tended to linearly decrease with supplemental Cr in barrows (675, 521, and
423 g; P = 0.147; Table 5.9), but not in gilts (449, 412, and 501 g; P = 0.394; Table 5.10).
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Table 5.9. Effects of dietary chromium supplementation on carcass traits of barrows fed
the experimental diets1
Dietary fat: Low
High
P-values2
SEM
Cr, ppb: 0
0 1,000 2,000
Fat1 Fat2 Cr Linear Quad.
Measurements3
Initial BW, kg
9.2
9.2
9.2
9.7
BW at slaughter, kg 57.6
67.6 61.7 59.3
Hot carcass, kg
39.7
49.8 44.6 43.2
Cold carcass, kg
37.3
46.5 42.2 40.9
Perirenal fat, g
295
675
521
423
First rib fat, cm
2.19
3.14 3.30 2.86
Last rib fat, cm
1.46
2.30 1.65 1.56
Last lumbar fat, cm
1.27
3.14 2.19 1.84
Average backfat, cm
1.64
2.86 2.38 2.08
10th rib fat, cm
1.14
2.25 1.87 1.59
2
25.2
26.0 23.4 26.3
10th rib LMA, cm
4
Estimations
Initial FFL, kg
2.01
2.03 2.03 2.21
Carcass FFL, kg
23.2
23.7 22.2 23.3
FFL gain, kg
21.2
21.7 20.2 21.1
Daily FFL gain, kg/d 353
360
337
351
Carcass FFL, %
58.5
47.6 50.5 54.1
5
Adjusted carcass traits
First rib fat, cm
2.27
3.02 3.29 2.88
Last rib fat, cm
1.51
2.22 1.65 1.56
Last lumbar fat, cm
1.31
3.03 2.18 1.85
Average backfat, cm 1.70
2.76 2.37 2.10
10th rib fat, cm
1.19
2.17 1.86 1.60
2
27.1
24.1 23.5 26.7
10th rib LMA, cm
1

0.3 0.563 0.939
4.2 0.238 0.105
2.7 0.050 0.021
2.4 0.038 0.019
96
0.031 0.016
0.25 0.006 0.020
0.28 0.211 0.051
0.21 <0.001<0.001
0.21 0.005 0.002
0.28 0.024 0.016
1.7 0.966 0.703

0.486
0.328
0.210
0.230
0.194
1.000
0.123
0.003
0.056
0.241
0.389

0.300
0.302
0.207
0.220
0.147
0.582
0.134
0.002
0.037
0.181
0.780

0.651
0.803
0.642
0.688
0.899
0.324
0.466
0.187
0.802
0.956
0.046

0.13
1.1
1.0
16
2.5

0.939
0.729
0.719
0.733
0.011

0.486
0.539
0.446
0.466
0.213

0.300
0.827
0.699
0.720
0.126

0.651
0.348
0.332
0.345
0.819

0.21 0.006 0.028
0.27 0.279 0.073
0.19 <0.001<0.001
0.18 0.004 0.002
0.25 0.022 0.016
1.7 0.195 0.212

0.712
0.152
0.003
0.064
0.257
0.418

0.785
0.164
0.003
0.040
0.189
0.072

0.220
0.506
0.225
0.911
0.991
0.073

0.563
0.901
0.834
0.831
0.014

Each least squares mean represents four barrows.
P-values are from single degree of freedom contrast. Fat1 represents the comparison between low- and
high-fat diets. Fat2 represents the comparison between low- and high-fat diets with no supplemental Cr.
Cr represents the comparison of Cr added vs. non-added within pigs fed the high-fat diets. Linear and
quadratic effects of dietary Cr were tested within pigs fed the high-fat diets.
3
The midline fat depth was measured at the first rib, the last rib, and the last lumbar vertebrae. Average
backfat depth was calculated as a mean of three fat depth values at the first rib, the last rib, and the last
lumbar vertebrae. The off-midline fat depth and longissimus muscle area (LMA) were assessed at primal
cuts of 10th rib.
4
Fat-free lean (FFL) values were estimated using the equations in Pork Composition & Quality Assessment
Procedures (NPPC, 2000): Initial FFL, kg = (0.418 × initial BW, kg) – 1.825; Carcass FFL = 3.899 +
(0.465 × hot carcass weight, kg) – (3.914 × 10th rib fat, cm) + (0.2115 × LMA, cm2); FFL gain, kg =
carcass FFL, kg – initial FFL, kg; Daily FFL gain, kg/d = FFL gain, kg ÷ days on test (60.5 d on
average); Carcass FFL, % = carcass FFL, kg ÷ hot carcass weight, kg.
5
Backfat depth and LMA were adjusted to 41.6 kg cold carcass weight using the equations: Adjusted fat
depth, cm = actual fat depth, cm × (41.61/3 ÷ cold carcass weight1/3, kg); Adjusted LMA, cm2 = actual
LMA, cm2 × (41.62/3 ÷ cold carcass weight2/3, kg).
2
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Table 5.10. Effects of dietary chromium supplementation on carcass traits of gilts fed the
experimental diets1
Dietary fat: Low
High
P-values2
SEM
Cr, ppb: 0
0 1,000 2,000
Fat1 Fat2 Cr Linear Quad.

Measurements3
Initial BW, kg
BW at slaughter, kg
Hot carcass, kg
Cold carcass, kg
Perirenal fat, g
First rib fat, cm
Last rib fat, cm
Last lumbar fat, cm
Average backfat, cm
10th rib fat, cm
10th rib LMA, cm2
Estimations4
Initial FFL, kg
Carcass FFL, kg
FFL gain, kg
Daily FFL gain, kg/d
Carcass FFL, %
Adjusted carcass traits5
First rib fat, cm
Last rib fat, cm
Last lumbar fat, cm
Average backfat, cm
10th rib fat, cm
10th rib LMA, cm2

10.0
10.1
57.8
64.1
40.8
46.9
38.3
44.2
227
449
1.78
2.73
0.89
1.65
1.33
2.06
1.33
2.15
0.98
1.65
28.4
28.2

10.0
60.6
44.8
42.3
412
2.86
1.49
2.19
2.18
1.59
26.6

9.5
62.3
45.8
43.3
501
2.92
1.52
2.03
2.16
1.78
24.0

0.2 0.583
1.5 0.027
1.2 0.004
1.1 0.004
39 <0.001
0.28 0.010
0.19 0.015
0.25 0.028
0.21 0.008
0.17 0.007
1.8 0.349

0.813
0.014
0.005
0.005
0.003
0.041
0.021
0.071
0.023
0.021
0.952

0.334
0.217
0.324
0.358
0.884
0.299
0.550
0.861
0.911
0.899
0.153

0.146
0.447
0.545
0.594
0.394
0.282
0.643
0.919
0.962
0.662
0.087

0.458
0.225
0.341
0.349
0.247
0.828
0.688
0.603
0.889
0.614
0.795

2.36
25.0
22.6
376
61.3

2.37
24.2
21.8
361
53.9

2.16
23.3
21.2
351
51.0

0.08
0.8
0.8
13
1.8

0.583
0.426
0.439
0.404
0.003

0.813
0.861
0.876
0.919
0.017

0.334
0.127
0.136
0.137
0.605

0.146
0.095
0.115
0.120
0.374

0.458
0.908
0.809
0.778
0.589

2.68 2.84 2.88
1.62 1.48 1.50
2.02 2.18 2.00
2.10 2.17 2.13
1.62 1.58 1.75
27.1 26.3 23.4

0.28
0.19
0.24
0.20
0.16
1.8

0.014
0.018
0.034
0.009
0.008
0.067

0.059
0.025
0.089
0.030
0.027
0.297

0.192
0.576
0.785
0.804
0.832
0.285

0.210
0.650
0.951
0.908
0.615
0.149

0.632
0.734
0.520
0.768
0.652
0.621

1.82
0.91
1.37
1.37
1.01
29.9

2.39
25.2
22.8
378
53.8

1

Each least squares mean represents four gilts.
P-values are from single degree of freedom contrast. Fat1 represents the comparison between low- and
high-fat diets. Fat2 represents the comparison between low- and high-fat diets with no supplemental Cr.
Cr represents the comparison of Cr added vs. non-added within pigs fed the high-fat diet. Linear and
quadratic effects of dietary Cr were tested within pigs fed the high-fat diet.
3
The midline fat depth was measured at the first rib, the last rib, and the last lumbar vertebrae. Average
backfat depth was calculated as a mean of three fat depth values at the first rib, the last rib, and the last
lumbar vertebrae. The off-midline fat depth and longissimus muscle area (LMA) were assessed at primal
cuts of 10th rib.
4
Fat-free lean (FFL) values were estimated using the equations in Pork Composition & Quality Assessment
Procedures (NPPC, 2000): Initial FFL, kg = (0.418 × initial BW, kg) – 1.825; Carcass FFL = 3.899 +
(0.465 × hot carcass weight, kg) – (3.914 × 10th rib fat, cm) + (0.2115 × LMA, cm2); FFL gain, kg =
carcass FFL, kg – initial FFL, kg; Daily FFL gain, kg/d = FFL gain, kg ÷ days on test (60.5 d on average);
Carcass FFL, % = carcass FFL, kg ÷ hot carcass weight, kg.
5
Backfat depth and LMA were adjusted to 41.6 kg cold carcass weight using the equations: Adjusted fat
depth, cm = actual fat depth, cm × (41.61/3 ÷ cold carcass weight1/3, kg); Adjusted LMA, cm2 = actual
LMA, cm2 × (41.62/3 ÷ cold carcass weight2/3, kg).
2
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5.4. Discussion
Several methods of dietary fat inclusion are available: 1) high-fat/high-energy due
to high energy density of fat, 2) high-fat/isoenergetic diet by lowering energy density
with the inclusion of low- or non-energy ingredients, and 3) high-fat/isoenergetic intake
by reducing feed allowance. We used the first method to maximize the nutritional stress,
although it may be unclear if the effects are caused by high-fat and/or high-energy in the
diet. Thus HFD had high energy as well as high fat concentrations compared to the LFD.
In the present experiment, as expected, the HFD resulted in dramatic changes in growth
performance, respiration, and body fat deposition. To the best of our knowledge, this is
the first study to investigate the effects of CrPic in the pigs fed over 30% of fat in the diet.
In most pig trials supplemental Cr treatments were lower than 1,000 ppb and the
effects of Cr have been inconclusive. The excretion of Cr may increase in stress
situations (Anderson, 1994) and dietary supplementation of Cr as CrPic at concentrations
of 200, 400, 800, and 1,200 ppb has resulted in linear beneficial effects in heat stressed
poultry (Sahin et al., 2002b). In human studies, moreover, 1,000 μg/d of Cr
(approximately 2,000 ppb Cr assuming 500 g daily intake) from CrPic had improved
positive effects in diabetic subjects (Anderson et al., 1997; Martin et al., 2006) compared
to lower levels. Thus, we used 1,000 and 2,000 ppb of supplemental Cr concentration
with this nutritional stress.
5.4.1. Growth performance
In the present study, the high inclusion level of dietary fat clearly resulted in
greater weight gain, and reduced feed intake and feed:gain. In agreement, pigs near
market weight fed 10% poultry fat in the diet for 28 d gained 4% faster, consumed 11%
less feed and had 14% lower feed:gain (Azain et al., 1991). Although the studies using
over 30% of fat in swine diets have been sparse, in a meta-analysis of swine studies,
including over 3% supplemental fat caused increased weight gain and feed efficiency,
and decreased feed intake (Azain, 2001).
Energy intake was higher in the pigs fed HFD than in the pigs fed LFD because
reduced feed intake was compensated by high energy concentration in HFD. During
overall period, ADFI was 19% lower but energy concentration was at least 38% higher in
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HFD group compared to LFD group. Similarly, ME:gain was unaffected by dietary fat
concentration whereas feed:gain was 27% lower in HFD group than in LFD group.
The effects of Cr on growth performance of pigs have been variable. Some
researchers have reported that supplemental CrPic to the swine diet may improve weight
gain (Mooney and Cromwell, 1995) and feed efficiency (Lindemann et al., 1995). Others
have reported that dietary CrPic effects on growth performance were absent or may be
even negative (Boleman et al., 1995; Mooney and Cromwell, 1999; Matthews et al.,
2001). In a review of supplemental CrPic in pig trials, an interaction between
supplemental Cr and dietary protein level was suggested (Lindemann, 1999), in that
supplemental Cr improves feed efficiency in the pigs fed protein marginal to the
requirement whereas not in the pigs fed excess protein. In the present study, supplemental
Cr increased feed:gain in pigs fed HFD throughout the 8-week feeding trial. The
increased feed:gain due to supplemental Cr was associated with the numerical decrease in
weight gain, and it may be related to the decreased fat deposition in the pigs fed
supplemental Cr (Table 5.8). In a recent study of mice fed HFD, similarly, supplemental
Cr decreased BW gain and body fat mass (Bhattacharya et al., 2006).
5.4.2. Respiratory rate
The present study demonstrates apparent elevation of respiratory frequency in the
pigs fed the HFD. In contrast, respiratory rate was unaffected by 13% of dietary fat in
lactating sows (Schoenherr et al., 1989). In our study, however, the HFD included over
30% fat. An accentuated respiratory rate was observed on d 41 perhaps due to the
hyperthermal environment. The increased respiratory rate of pigs in high ambient
temperature has been reported in multiple studies (Schoenherr et al., 1989; Quiniou and
Noblet, 1999; Renaudeau et al., 2001). In the present study, the elevated respiration
frequency by HFD was not moderated by dietary Cr supplementation.
5.4.3. Plasma cortisol and insulin
High-fat feeding has been suggested to influence the hypothalamic-pituitaryadrenal axis, elevating blood corticosteroid concentration (Brindley et al., 1981; Pascoe et
al., 1991; Tannenbaum et al., 1997). In the present study, circulating cortisol
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concentration tended to be elevated in the pigs fed HFD compared with the pigs fed LFD
on d 42. The increased cortisol concentration due to the dietary fat was reversed only
numerically (P = 0.386) by supplemental Cr, although the d 42 and d 56 responses raise
interesting questions about longer periods of supplementation.
Dietary fat has been reported to elevate blood insulin and glucose (Reaven et al.,
1967; Muurling et al., 2002). Supplemental Cr lowered circulating insulin concentration
in rats fed HFD (Striffer et al., 1998) and in swine (Lien et al., 2001). In the present study,
plasma insulin concentration of pigs fed HFD linearly decreased by Cr supplementation
on d 14.
5.4.4. Carcass traits
Diets enriched with fat have been known to induce obesity in humans (Lissner
and Heitmann, 1995; Shepard et al., 2001) and experimental animals (Masek and Fabry,
1959; Lemonnier et al., 1975). In the present study, as anticipated, the consumption of
HFD resulted in marked increases of carcass weights, perirenal fat weight, and back fat
depths compared with the LFD group.
The BW was only numerically decreased (P = 0.461, linear) by supplemental Cr
in the pigs fed HFD (Table 5.4). However, supplemental Cr decreased slaughter BW (P =
0.132) and hot carcass weight (P = 0.083) of the pigs fed HFD in a linear trend (Table
5.8). The improved significance may be attributed both to the increased degree of
freedom by considering each individual animal as an experimental unit and to the
extended feeding period to the slaughter date.
The effects of supplemental Cr on the carcass characteristics of pigs have been
inconsistent. Since Page et al. (1993) reported that the supplemental Cr increased LMA
and percentage of muscling but decreased the tenth rib back fat, similar effects of
supplemental Cr have been demonstrated in multiple studies (Lindemann et al., 1995;
Lien et al., 2001). In other studies, contrastingly, supplemental Cr was ineffective in
modulating carcass leanness or fatness of pigs (Evock-Clover et al., 1993; Mooney and
Cromwell, 1999; Matthews et al., 2001). Mooney and Cromwell (1995) observed
increased muscle percentage and decreased fat percentage of dissected carcass by
supplemental Cr, but found no changes in backfat thickness or LMA. More recently,
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effects of CrPic on the pigs under nutritional stress of deficient dietary energy (van de
Ligt et al., 2002a) or dietary amino acids (van de Ligt et al., 2002b) were assessed. In
these experiments, supplemental Cr had no or only minor effects on carcass traits.
In the present study, the supplemental Cr from CrPic moderated the increased
carcass fat measures due to the HFD. The effects of Cr on body composition of the
animals fed HFD have been rarely studied, but our findings are strongly supported by a
study employing obese mice induced by HFD (Bhattacharya et al., 2006). They observed
reductions of body weight gain (3.04 vs. 7.29 g), body fat mass gain (0.95 vs. 3.13 g),
and visceral fat mass gain (0.26 vs. 1.09 g) by dietary Cr as Cr carnosinate
(Carnochrome) in mice fed experimental diets for 14 weeks (P < 0.05). In a recent study
of patients with non-insulin-dependent (Type 2) diabetes mellitus taking an antidiabetic
drug (sulfonylurea), dietary CrPic intake for 24 weeks decreased weight gain (0.9 vs. 2.2
kg; P < 0.05), the changes of body fat percentage (0.12 vs. 1.17 %), subcutaneous fat (P <
0.05), visceral fat (P < 0.05), and total abdominal fat (P < 0.01) compared with placebo
group (Martin et al., 2006). Our findings agree with these data in that CrPic moderated
increased body weight gain and body fat percentage.
Although many studies including the present study have reported that Cr may
decrease body fat storage, the mechanism has not been fully elucidated. Trivalent Cr has
been shown to potentiate the action of insulin (Mertz et al., 1974; Vincent, 2000) and
theoretically should increase glucose uptake in adipocytes and muscle cells. Indeed, the
lipogenic rate in the porcine adipose was accelerated by supplemental Cr with no changes
of lipolysis in contradiction to decreased whole body fat deposition (Lien et al., 2001).
They hypothesized that Cr stimulates protein synthesis and only a little remaining energy
can be used for fat storage. In a genomic study of subcutaneous adipose tissue, niacinbound Cr supplementation upregulated genes related to glycolysis, muscle contraction,
muscle metabolism, and muscle development (Rink et al., 2006). They suggested that
supplemental niacin-bound Cr may trigger myogenesis in the fat tissue.
Taken together, a HFD decreased feed intake, and increased weight gain and feed
efficiency. The respiratory rate and carcass fat retention were elevated by HFD
consumption. The increased body weight and fat retention were moderated by
supplemental Cr as CrPic.
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5.5. Implications
The present research indicated that the high-fat diet fed to pigs induced obesity in
spite of less feed consumed and higher feed efficiency compared with those fed the lowfat diet. Pigs fed the high-fat diet had more frequent respiration and showed increases in
carcass weights, perirenal fat weight, and back fat depths compared with the low-fat diet
group. The supplemental Cr as CrPic attenuated the increased carcass weight and carcass
fat measures due to the fat-enriched diet in pigs especially barrows which are normally
fatter than gilts. Further research to elucidate effects and mechanism of chromium on the
pigs fed the high-fat diet seems warranted.

Copyright © Beob Gyun Kim 2007
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CHAPTER 6. Chromium (III) Picolinate Affects Cortisol and DHEAs Secretion in
H295R Human Adrenocortical Cells
Abstract
Dietary chromium (III) picolinate (CrPic) effects on circulating steroid hormones
have been reported in various experimental animal models. However, direct effects of
CrPic on adrenocortical steroidogenesis are uncertain. The H295R cell line, derived from
human adrenocortical carcinoma cells, serves as a model system for adrenal steroid
metabolism studies. Therefore, the objective of our study was to determine the effects of
CrPic on cortisol and dehydroepiandrosterone sulfate (DHEAs) secretion from H295R
cells. In experiment 1, 24 h of exposure to CrPic (0, 0.1, 1, 10, 100, and 200 μM) dosedependently increased cortisol secretion (P < 0.05). When forskolin (10 μM) was
included in the incubation media, CrPic had both a linear (P < 0.001) and quadratic (P <
0.001) effect on cortisol secretion with the highest cortisol secretion at 0.1 μM of CrPic
and the lowest at 200 μM of CrPic. In experiment 2, 48 h exposure to CrPic (200 μM)
decreased cortisol (P < 0.07) release from forskolin-stimulated cells during a 24 h
collection period. Additionally, 1 μM of CrPic increased DHEAs (P < 0.05) secretion
from these cells. In experiment 3, 48 h exposure to CrPic (100 μM) decreased cortisol (P
< 0.05) and DHEAs (P < 0.01) from forskolin-stimulated cells during a 24 h collection
period. In experiment 4, a 24 h exposure to forskolin followed by 24 h exposure to both
forskolin and CrPic (100 and 200 μM) also decreased both cortisol (P < 0.001) and
DHEAs (P < 0.01) secretion. This study suggests that at high concentrations, CrPic
inhibits aspects of steroidogenesis in agonist-stimulated adrenocortical cells.
Key words: chromium, cortisol, DHEAs, steroid, H295R, adrenocorticoid
6.1. Introduction
Trivalent chromium (Cr) is an essential micro nutrient for humans and animals
(Anderson, 1987; Offenbacher and Pi-Sunyer, 1988). Since the first report on the
essentiality of Cr in rats (Schwarz and Mertz, 1959), the roles of Cr have been widely
studied in humans, animals, and in vitro models. A well-known function of Cr is to
potentiate the action of insulin (Mertz et al., 1974; Vincent, 2000). Chromium (III)
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picolinate (CrPic) is a biologically active form of Cr for insulin internalization in muscle
cells (Evans and Bowman, 1992).
The effects of a variety of dietary Cr sources on adrenal steroid hormones have
been investigated, but results are inconclusive. Dietary Cr decreased circulating adrenal
steroids in young stressed calves (Moonsie-Shageer and Mowat, 1993; Mowat et al.,
1993), in epinephrine challenged lambs (Gentry et al., 1999), in stressed dairy cows
(Pechova et al., 2002), and in postmenopausal women (Roussel et al., 2002). In other
studies, however, dietary Cr had no effects on adrenal steroids (van Heugten and Spears,
1997; Baldi et al., 1999; Pollard et al., 2002).
A human adrenocortical carcinoma cell, NCI-H295, maintains hormonal and
enzymatic characteristics similar to those of normal human adrenocortical cells (Gazdar
et al., 1990; Rainey et al., 1993; Staels et al., 1993). The H295R, a cell line used in the
current study, is a subpopulation of H295 that forms a monolayer in culture (Rainey et al.,
1994), and has been extensively used as a model system in adrenal steroid metabolism
investigations (Rainey et al., 2004; Vakharia and Hinson, 2005; Oskarsson et al., 2006;
Mikhaylova et al., 2007).
The effects of Cr on insulin secretion from islets of Langerhans (Ghafghazi et al.,
1980) and on catecholamine secretion from bovine medullary cells were reported (Liu
and Lin, 1997). To the best of our knowledge, however, direct effects of Cr on
adrenocortical steroidogenesis have not been reported. Therefore, our objective was to
investigate the effect of CrPic on cortisol and dehydroepiandrosterone sulfate (DHEAs)
secretion from H295R adrenocortical cells.
6.2. Materials and methods
6.2.1. Materials
Human NCI-H295R adrenocortical cell line derived from human adrenocortical
cells was obtained from the American Type Culture Collection (ATCC, Manassas, VA).
The sources for the other materials are given below.
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6.2.2. Cell culture
Cells were cultured in an equal mixture (vol/vol) of Dulbecco’s Modified Eagle’s
Medium and Ham’s F-12 medium (DMEM/F-12, Invitrogen, Chicago, IL) containing
HEPES (15 mM), sodium pyruvate (0.5 mM), and sodium bicarbonate (1.2 g/L)
supplemented with 1% ITS Plus (insulin, 6.25 μg/mL; transferrin, 6.25 μg/mL; selenium,
6.25 ng/mL; bovine serum albumin, 1.25 mg/mL; linoleic acid, 5.35 μg/mL, BD
Bioscience, Bedford, MA), and Nu-Serum (2.5%, BD Bioscience). Cells were grown in
75 cm2 flasks under a humidified atmosphere of 95% air/5% carbon dioxide at 37°C. The
medium was changed every 3 d and cells were detached weekly using a solution of
0.25% trypsin-EDTA for subcultures at a ratio of 1:4. For experiments, cells were
subcultured from 70% confluent cultures into 24 well culture plates (Exp. 1) or 12 well
culture plates (Exp. 2-4).
6.2.3. Treatment structure
The treatment structure for each experiment is demonstrated in Table 6.1. In
experiment 1, treatments included six levels of CrPic (0, 0.1, 1, 10, 100, and 200 μM)
with or without forskolin (10 μM) in the media for 24 h of incubation. In experiment 2,
three levels of CrPic (0, 1, and 200 μM) were used for 48 h of incubation with or without
forskolin in the media for the last 24 h. In experiment 3, treatments included negative
control (media), and four levels of CrPic (0, 100, 200, and 400 μM) for 48 h of
incubation with forskolin during the last 24 h. In experiment 4, treatments included
negative control (media), and 24 h exposure to forskolin followed by 24 h exposure to
both forskolin and four levels of CrPic (0, 100, 200, and 400 μM). In experiment 2, 3,
and 4, media samples for steroid assay were collected from the last 24 h of incubation
and kept frozen at -20°C until steroid analysis.
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Table 6.1. Treatment structure for experiment 1 to 4
├─── Media sampling period1 ───┤
−24 h

0h

Exp 1

+24 h

├────── Forskolin −/+ ──────┤
├─ CrPic 0, 0.1, 1, 10, 100, and 200 μM ┤

Exp 2

├────── Forskolin −/+ ──────┤
├────────────── CrPic 0, 1, and 200 μM ──────────────┤
├────── Forskolin −2/+ ─────┤

Exp 3

├──────────── CrPic 0, 100, 200, and 400 μM ───────────┤
Exp 4

├───────────────── Forskolin −2/+ ────────────────┤

├─ CrPic 0, 100, 200, and 400 μM ─┤
Media samples were collected after the last 24 h in all the experiments.
2
Forskolin-free medium without CrPic treatment was used as a negative control group.
In experiment 3 and 4, therefore, five treatment groups included a negative control and
four CrPic levels with forskolin (10 μM) stimulation.
1

6.2.4. Analysis of cortisol and DHEAs
The cortisol and DHEAs concentrations in the sample media collected from each
well were determined using coated tube radioimmunoassays from Diagnostic Products
Corporation (Los Angeles, CA). Briefly, steroid standard solution was made by
dissolving cortisol and DHEAs (Steraloids, Newport, RI) to DMEM/F-12. Media samples
or standards were added to antibody-coated tubes. Radiolabeled cortisol (125I) was added
to tubes and incubated for 45 (cortisol assay) or 30 (DHEAs assay) minutes at 37°C using
a waterbath. Then, all moisture in the tube was thoroughly removed and the radioactivity
was measured using a Packard Cobra Auto-gamma counter (Packard Instrument Co.,
Meriden, CT). Calibrators and samples were analysed in triplicate and duplicate,
respectively.
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6.2.5. Protein determination
After removing media, the cells in each well were solubilized in sodium dodecyl
sulfate (SDS, 5%) and protein content was determined using the colorimetric detergent
compatible (DC) protein assay kit (Bio-Rad, Hercules, CA). The DC protein assay
technique is similar to Lowry protein analysis. Bovine serum albumin was used as a
standard.
6.2.6. Calculations and statistical analysis
The steroid analysis results were standardized to the concentration of steroid per
mg of protein using the protein concentration of each well. The standardized steroid
concentration was divided by the result from the CrPic and forskolin-free media (i.e., the
control treatment). Values were expressed as mean ± SEM. Each well was considered an
experimental unit. Orthogonal polynomial contrasts were conducted to test linear and
quadratic effects of CrPic on cortisol secretion using SAS (1988). Appropriate
coefficients for unequally spaced log concentration of CrPic were obtained using the
interactive matrix language procedure (Proc IML) of SAS (1988). Because the logarithm
of zero is undefined, 0.01 μM, one log units lower than the lowest concentration (0.1 μM)
in experiment 1, was used for zero concentration of CrPic in Proc IML. The unpaired
Student’s t-test was applied to compare the means of the different CrPic treatments. Pvalues less than 0.05 were considered as statistically significant.
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6.3. Results
In experiment 1, 24 h of exposure to CrPic (0, 0.1, 1, 10, 100, and 200 μM)
affected cortisol production in a dose dependent manner (Figure 6.1). In the absence of
forskolin, a linear increase of cortisol was observed (P < 0.05). When forskolin (10 μM)
was included in the incubation media, CrPic had both a linear (P < 0.001) and quadratic
(P < 0.001) effect on cortisol secretion. At 0.1 and 1 μM CrPic potentiated stimulatory
effects of forskolin on cortisol release (P < 0.05), but at 200 μM CrPic diminished effects
of forskolin (P < 0.001).

w /o forskolin

400

Cortisol (% of untreated)

w / forskolin

*

*

350
300
250

***

200
150

*

100

*

*

50
0
0

0.1

1

10

100

200

CrPic (μM)

Figure 6.1. Effects of CrPic on the cortisol secretion by agonist-stimulated or nonstimulated H295R cells (n=8). In the absence of forskolin, the exposure to CrPic had a
linear (P < 0.05) effect on cortisol secretion. When forskolin (10 μM) was included in the
media, CrPic had both a linear (P < 0.001) and quadratic (P < 0.001) effect on cortisol
secretion. Differences significant from 0 μM CrPic treatment of same forskolin inclusion
level are indicated: *, P < 0.05; ***, P < 0.001.
In experiment 2, a 48 h exposure to CrPic (0, 1, and 200 μM) had linear (P < 0.05)
and quadratic (P < 0.05) effects on cortisol secretion from forskolin-stimulated cells
during a 24 h collection period (Figure 6.2-a). The lowest cortisol release was at 200 μM
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of CrPic (P < 0.07). In the absence of forskolin, however, cortisol production was
unaffected by CrPic. The secretion of DHEAs was quadratically (P < 0.001) affected by
CrPic in forskolin-stimulated cells with the highest DHEAs release at 1 μM of CrPic (P <
0.05; Figure 6.2-b). In the forskolin-free media, CrPic affected DHEAs secretion linearly
(P < 0.05) and quadratically (P < 0.07). The secretion of DHEAs was lowest at 1 μM of
CrPic (P < 0.05).
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Figure 6.2. Effects of CrPic on the cortisol (a) and DHEAs (b) secretion by agoniststimulated or non-stimulated H295R cells (24 h pretreatment of CrPic; n=4). The
exposure to CrPic had linear (P < 0.05) and quadratic (P < 0.05) effects on cortisol
secretion from forskolin-stimulated cells. The secretion of DHEAs was quadratically (P <
0.001) affected by CrPic in forskolin-stimulated cells. Differences significant from 0 μM
CrPic treatment of same forskolin inclusion level are indicated: †, P < 0.07; *, P < 0.05.
In experiment 3, a 48 h exposure to high concentration of CrPic (100, 200, and
400 μM) decreased cortisol (P < 0.05) secretion from forskolin-stimulated cells during a
24 h collection period (Figure 6.3-a). The dose-dependent effect of CrPic on cortisol
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secretion was linear (P < 0.001). In the same experiment, DHEAs secretion in agoniststimulated cells was also decreased (P < 0.01) in high concentration of CrPic groups (100,
200, and 400 μM; Figure 6.3-b). The dose-dependent effect of CrPic on DHEAs secretion
was linear (P < 0.001) and quadratic (P < 0.01).
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Figure 6.3. Effects of CrPic on the cortisol (a) and DHEAs (b) secretion by agoniststimulated H295R cells (24 h pretreatment of CrPic; n=4). The exposure to CrPic had
linear (P < 0.001) effects on cortisol secretion. The effects of CrPic on DHEAs secretion
were linear (P < 0.001) and quadratic (P < 0.01). Differences significant from 0 μM CrPic
with forskolin are indicated: *, P < 0.05; **, P < 0.01; ***, P < 0.001.

In experiment 4, a 24 h exposure to forskolin followed by a 24 h exposure to both
forskolin and CrPic (100, and 200 μM) decreased both cortisol (P < 0.001) and DHEAs
(P < 0.01) secretion (Figure 6.4-a,b). The linear effects of CrPic were observed on
cortisol (P < 0.001) and DHEAs (P < 0.01) secretion.
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Figure 6.4. Effects of CrPic on the cortisol (a) and DHEAs (b) secretion by agoniststimulated H295R cells (24 h pretreatment of forskolin; n=4). The exposure to CrPic had
linear effects on cortisol (P < 0.001) and DHEAs (P < 0.01). Differences significant from
0 μM CrPic with forskolin are indicated: *, P < 0.05; **, P < 0.01; ***, P < 0.001.
6.4. Discussion
In the present study, we used H295R cells as a model system and forskolin as an
agonist (stressor) for adrenocortical steroid secretion. In stress situations, the
hypothalamic-pituitary-adrenal

axis

is known

to

be

activated.

The

pituitary

adrenocorticotropic hormone (ACTH) released from the pituitary regulates glucocorticoid
synthesis in the adrenal cortex. In the human adrenocortical cell line, H295R, however,
ACTH effects on steroidogenesis are relatively insignificant perhaps due to the lack of
ACTH receptors (Rainey et al., 1993; Penhoat et al., 2000) whereas forskolin bypasses
ACTH receptors and triggers steroid synthesis (Rainey et al., 1993). Thus, forskolin was
employed as an agonist in our study, and this agonist (10 μM) dramatically increased
cortisol and DHEAs secretion from H295R cells (Figures 6.1 to 6.4) in agreement with
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other studies (Rainey et al., 1993; Gell et al., 1998; Ehrhart-Bornstein et al., 2003) and
our pilot study (data not shown). Forskolin is known to activate adenylate cyclase
(Seamon et al., 1981), followed by increased cyclic adenosine monophosphate (cAMP) in
the cell and the activation of the protein kinase A (PKA) signal transduction pathway
(Litvin et al., 1984; Rainey et al., 1993). The effect of forskolin is also induced through
the PKA-independent pathway (Ding and Staudinger, 2005).
The results of experiment 1 indicate that the low concentration of CrPic (0.1 and 1
μM) increases the secretion of cortisol, but high concentration of CrPic (200 μM)
dramatically inhibits the secretion of cortisol from agonist-stimulated adrenocortical cells.
In contrast, adrenocortical cells cultured in forskolin-free media, CrPic (10 and 100 μM)
slightly increased the cortisol secretion (Figure 6.1). Similar dual effects of Cr were
observed in catecholamine secretion from bovine adrenal medullary cells (Liu and Lin,
1997). High concentrations of CrCl3 (500 to 1,000 μM) significantly inhibited
catecholamine release stimulated by 56 mM of K+ from adrenal medullary cells.
Similarly, when 10 μM of 1,1-dimethyl-4-phenylpiperazinium (DMPP) was used as an
agonist, CrCl3 (5 to 1,000 μM) significantly inhibited catecholamine release. In the
adrenal medullay cells cultured without agonist, a slight increase of catecholamine
secretion by CrCl3 was reported. Insulin release from isolated rat islet of Langerhans was
also inhibited by high concentration of CrCl3 (250 to 1,500 μM) in a dose dependent
manner (Ghafghzi et al., 1980).
The decreased cortisol release from agonist-stimulated adrenocortical cells by
high concentration of CrPic was confirmed in the following experiments (Figure 6.2 to
6.4). In experiment 2, 3, and 4, cells were pretreated with CrPic or forskolin to mimic
either a situation of CrPic administration followed by stress or a situation of stress
occurrence followed by CrPic administration, respectively. In experiment 2, cells were
pretreated with CrPic for 24 h, and the CrPic treatment concentrations continued during
the following sampling period. The doses of CrPic (0, 1, 200 μM) were based on the
results in experiment 1. As anticipated, CrPic affected cortisol release from agoniststimulated cells in a linear and quadratic manner consistent with experiment 1. However,
further enhancement of CrPic effects by pretreatment relative to cotreatment was not
observed. In experiment 3, a 48 h treatment of CrPic at 100, 200, or 400 μM inhibited
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cortisol secretion from forskolin-stimulated cells. In contrast, in experiment 1, a 24 h
treatment of CrPic at 100 μM had no effects on cortisol release from agonist-stimulated
cells. These observations are consistent with the concept of an effect being related to both
dose and time. Although periods longer than 48 h of CrPic treatments were not tested in
the present study, the current results suggest that longer treatment of CrPic may be more
effective in regulating forskolin effects.
The inhibitory effect of CrPic on cortisol secretion observed in the current study
may partially explain decreased blood cortisol concentration in stressed calves (Chang
and Mowat, 1992; Moonsie-Shageer and Mowat, 1993; Mowat et al., 1993) and dairy
cows (Pechova et al., 2002) by dietary supplementation of Cr-yeast or chelated Cr. In
other studies, however, supplemental dietary Cr had no effect on circulating cortisol
concentration in immune stressed pigs (van Heugten and Spears, 1997) fed 0.2 mg/kg Cr
from CrCl3, CrPic or Cr-nicotinate, weaning stressed piglets (Baldi et al., 1999) fed 0.3
mg/kg Cr from Cr yeast, and steers (Pollard et al., 2002) fed 0.2 or 0.4 mg/kg Cr from Cr
yeast. The discrepancy of cortisol responses by dietary Cr in animal studies may be
attributed to the dosage and source of Cr, duration of dietary Cr treatment, source and
intensity of stress, animal species, and environmental variation. It may be that the most
important factors on the effects of dietary Cr are the animal species and the dosage of Cr
as most of stressed ruminants had lower circulating cortisol concentration with high dose
(> 0.4 mg/kg) supplementation of dietary Cr.
The increase of cortisol secretion from the cells pretreated with forskolin is
notable (Figure 6.4-a). Forskolin stimulation during the 24 h of media collection period
increased cortisol secretion by three to five-fold (Figure 6.1, 6.2-a, and 6.3-a).
Pretreatment of forskolin for 24 h before the media collection period induced ten-fold
increase in cortisol secretion (Figure 6.4-a). The higher fold change of cortisol secretion
by pretreatment of forskolin implies that the second 24 h of cortisol secretion is higher
than the first 24 h of that in the cortical cells cultured for 48 h with forskolin. In
agreement, compared with 24 h of incubation with 10 μM forskolin, approximately three
times higher cortisol concentration was reported in 48 h incubation with forskolin
(Rainey et al., 1993; Asif, 2004). This result may be attributed to intracellular cAMP
accumulated during the pretreatment period.
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The release of DHEAs was also inhibited by high concentration of cortisol in
agonist-stimulated adrenocortical cells (Figure 6.3-b and 6.4-b). In postmenopausal
women, dietary Cr tended to decrease serum DHEAs and cortisol (Roussel et al., 2002).
The present study indicates that CrPic can appreciably regulate steroid secretion
from agonist-stimulated cells, but minimally from non-stimulated cell. Thus the action
sites of CrPic may be closely related to the sites affected by forskolin. H295R cells
stimulated with forskolin have been reported to induce increases in cAMP, steroidogenic
acute regulatory protein (StAR), several enzymes involved in the adrenal steroidogenic
pathway, and organic anion transporter 3 (OAT3) (Rainey et al., 1993; Bird et al.. 1998;
Zenkert et al., 2000; Asif et al., 2006; Oskarsson et al., 2006). Because high
concentration CrPic inhibited the secretion of both cortisol and DHEAs from agoniststimulated cell in our study, we postulate that CrPic affects the factors related to cortisol
and DHEAs synthesis in common. These factors include cAMP, StAR, cytochrome P450
enzyme (CYP)11A1, and CYP17A1. Cholesterol transport is triggered by StAR, which is
the rate limiting step in the steroid synthesis. Desmolase, also called CYP11A1, converts
cholesterol to pregnenolone, a common precursor of adrenal steroidogenic pathway. This
precursor can be converted to 17α-hydroxy pregnenolone by CYP17A1, which can be
transformed to either cortisol or DHEAs by further steps. Oskarsson et al. (2006) reported
that the mRNA of CYP17A1 was increased 5-fold by 24 h of forskolin exposure to
H295R cells, and CYP17A1 expression was the highest compared to the other enzymes.
These steroidogenesis regulating factors are affected by cAMP through PKA pathway.
Asif et al. (2006) observed that OAT3 expression, involved in cortisol and DHEAs
transport, was markedly potentiated by forskolin exposure but the enzymes of
steroidogeneis were increased to a lesser extend. Further studies to elucidate detailed
mechanism of CrPic on steroidogenesis in the adrenal cortex seem warranted.
This study suggests that at high concentrations, CrPic inhibits aspects of
steroidogenesis in agonist-stimulated adrenocortical cells.
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CHAPTER 7. General Discussion
Trivalent chromium has been shown to potentiate the action of insulin (Mertz et
al., 1974; Vincent, 2000) and accordingly to modulate carbohydrate, protein, and lipid
metabolism (Davis and Vincent, 1997; Cefalu et al., 2002; Bernao et al., 2004). In
addition, Cr has been suggested to alleviate stress associated effects in animals and
humans (Chang and Mowat, 1992; Anderson, 1994; NRC, 1997). The objective of the
present research was to study the effects of dietary Cr on pigs exposed to a variety of
stressors. These stressors included heat or cold stress, immune stress, and stress of highfat feed. The doses of supplemental Cr in the present animal studies were 0, 1,000, and
2,000 ppb while the Food and Drug Administration (FDA) in the United States allows
200 ppb Cr in the swine diet when it is supplemented as Cr picolinate (CrPic). The high
concentration of supplemental Cr in this research was based on poultry studies that
showed linear effects of supplemental Cr of 200 to 1,200 ppb in thermal stress situations
(Sahin et al., 2001; Onderci et al., 2003). The cell culture study (Chapter 6) preceding the
animal studies also suggests that at high concentration, CrPic inhibits cortisol secretion
from agonist-stimulated adrenocortical cells. As a source of supplemental Cr, the organic
form of trivalent Cr, CrPic, was used based on previous reports suggesting that Cr is
more available as an organic chelate (Page et al., 1993).
In a number of animal and human studies, the effects of dietary Cr on adrenal
steroid hormones have been assessed, but the results are inconsistent (Moonsie-Shageer
and Mowat, 1993; Gentry et al., 1999; Roussel et al., 2002; Baldi et al., 1999; Pollard et
al., 2002). Thus, in addition to the animal studies effects of Cr on adrenocortical steroid
secretion from adrenocortical cells were studied employing a human adrenocortical cell
line, NCI-H295R.
In the thermal stress study (Chapter 3), heat stress clearly caused feed intake
reduction and weight gain retardation as anticipated. Similar responses by high ambient
temperature have been reported in a number of studies (Stahly and Cromwell, 1979;
Stahly et al., 1979; Schenck et al., 1992ab; Kerr et al., 2003). However, dietary Cr
supplementation did not affect the growth performance of pigs either in high ambient
temperature or in thermoneutral environment. In many poultry trials, dietary
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supplementation of Cr ameliorated the negative effects of heat stress on growth and egg
production performance (Sahin et al., 2002ab; Onderci et al., 2005; Sahin et al., 2005).
In the present study, cold stress resulted in increased feed intake and feed:gain in
agreement with previous reports (Stahly and Cromwell, 1979; Stahly et al., 1979; Frank
et al., 2003). However, dietary Cr supplementation had no beneficial effects on
performance of pigs in a low ambient temperature. In poultry studies, dietary
supplementation of Cr increased weight gain, egg production, and feed efficiency of birds
in a cold stress (Sahin et al., 2001; Sahin et al., 2002c).
The discrepancy between the present studies and poultry studies may be attributed
to the physiological differences between these species and/or the degree of thermal stress.
Although the ambient temperatures of thermal stress treatments were over or below the
thermoneutral zone, and the feed intake was affected by the thermal stress, it may be that
the degree of thermal stress was not unduly stressful to the pigs and which they were able
to manage by altering feed intake.
In the immune stress study (Chapter 4), the endotoxin challenge acutely resulted
in growth retardation, feed intake reduction, body temperature elevation, hyperpnea,
plasma cortisol elevation, and plasma glucose reduction, which are consistent with
literature. However, supplemental Cr failed to alleviate the effects of this type of immune
stress in pigs.
The acute weight loss by LPS challenge may be attributed to increased defecation,
increased urination, and reduced feed intake (Johnson and von Borell, 1994; Warren et al.,
1997; Sakumoto et al., 2003). Supplemental Cr of 0, 1,000 or 2,000 ppb had no effects on
weight gain or feed intake of pigs challenged with immune stress in agreement with other
reports with lower doses of Cr (van Heugten and Spears, 1997; Lee et al., 2000).
In the present study, the endotoxin-induced elevation of body temperature and
plasma cortisol concentration was observed as shown in other studies (Warren et al.,
1997; Sakumoto et al., 2003). However, supplemental Cr did not affect body temperature
or circulating cortisol concentration of pigs under immune stress. Similarly, Lee et al.
(2000) reported that rectal temperature was elevated by LPS but dietary Cr had no effects
on rectal temperature in pigs under immune stress. While van Heugten and Spears (1997)
also failed to detect effects of Cr on serum cortisol concentrations in pigs injected with
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ACTH, Lee et al. (2000) did report that dietary Cr decreased plasma cortisol
concentration at 2 h post secondary LPS challenge. Multiple injections of endotoxin may
result in high glucose concentration for an extended period and potentially cause glucose
intolerance. In addition, extended immune stress may lead to urinary excretion of Cr and
thus Cr deficiency. Therfore, the possibility that supplemental Cr alleviates longer term
immune stress cannot be ruled out.
In the dietary stress study (Chapter 5), the high inclusion level (30% crude fat in
calculated composition) of dietary fat caused 10% faster weight gain, and 19% reduced
feed intake and 27% lower feed:gain compared to the control (3% crude fat). The HFD
treatment resulted in clear hyperpnea and an increase of plasma cortisol concentration in
the pigs. As expected, the consumption of HFD resulted in marked increases of carcass
weights, perirenal fat weight, and back fat depths compared with the LFD group.
Supplemental Cr increased feed:gain in pigs fed HFD. The increased feed:gain
due to supplemental Cr was associated with the numerical decrease in weight gain, and it
may be attributed to the decreased fat deposition in the pigs fed supplemental Cr.
Circulating cortisol concentration was elevated in the pigs fed HFD compared with the
pigs fed LFD on d 42. The increased cortisol concentration due to the dietary fat was
reversed only numerically by supplemental Cr. In the present study, plasma insulin
concentration of pigs fed HFD tended to decrease by Cr supplementation on d 14. In
other studies, supplemental Cr lowered circulating insulin concentration in rats fed HFD
(Striffer et al., 1998) and in swine (Lien et al., 2001).
The supplemental Cr as the CrPic form moderated the increased carcass fat
measures including visceral fat and backfat thickness due to the HFD in the present study.
Although the effects of Cr on body composition of the animals fed HFD have been
scarcely studied, our findings are strongly supported by a study employing obese mice
induced by HFD (Bhattacharya et al., 2006). They observed reductions of body weight
gain, body fat mass gain, and visceral fat mass gain by dietary Cr from Cr carnosinate
(Carnochrome) in mice fed experimental diets for 14 weeks. In a recent study of patients
with non-insulin-dependent (Type 2) diabetes mellitus taking an antidiabetic drug (Martin
et al., 2006), dietary CrPic intake for 24 weeks decreased BW gain, the changes of body
fat percentage, subcutaneous fat, visceral fat, and total abdominal fat compared with the
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placebo group. Our findings agree with these data in that CrPic moderated increased body
weight gain and body fat percentage.
In the adrenocortical cell study (Chapter 6), the low concentration of CrPic (0.1
and 1 μM) increased the secretion of cortisol, but high concentration of CrPic (200 μM)
dramatically inhibited the secretion of cortisol from forskolin-stimulated adrenocortical
cells (experiment 1). Further experiments confirmed the inhibitory effect of high
concentration CrPic (100 to 400 μM) on cortisol release from agonist-stimulated
adrenocortical cells. Similarly, Liu and Lin (1997) reported that high concentrations of
CrCl3 (500 to 1,000 μM) significantly inhibited catecholamine release from adrenal
medullary cells stimulated by K+ or 1,1-dimethyl-4-phenylpiperazinium. Insulin release
from isolated rat islet of Langerhans was also inhibited by high concentration of CrCl3
(250 to 1,500 μM) dose-dependently (Ghafghzi et al., 1980).
In experiment 2, 3, and 4, cells were pretreated with CrPic or forskolin to mimic
either a situation of CrPic administration followed by stress or a situation of stress
occurrence followed by CrPic administration, respectively. In experiment 2, cells were
pretreated with CrPic for 24 h, and the CrPic treatment concentrations (0, 1, 200 μM)
continued during the following sampling period. As anticipated, CrPic affected cortisol
release from agonist-stimulated cells linearly and quadratically in agreement with
experiment 1. However, further enhancement of CrPic effects by pretreatment relative to
cotreatment (experiment 1) was not observed. In experiment 3, a 48 h treatment of CrPic
(100, 200, or 400 μM) inhibited cortisol release from agonist-stimulated cells.
Interestingly, in experiment 1, a 24 h treatment of CrPic at 100 μM had no effects on
cortisol release from agonist-stimulated cells. These observations are consistent with the
concept of an effect being related to both dose and time. Although periods longer than 48
h of CrPic treatments were not tested in the present study, the current results suggest that
longer treatment of CrPic may be more effective in regulating forskolin effects in
adrenocortical cells.
The inhibitory effect of CrPic on cortisol secretion observed in the current study
may partially explain decreased blood cortisol concentration in stressed calves (Chang
and Mowat, 1992; Moonsie-Shageer and Mowat, 1993; Mowat et al., 1993) and dairy
cows (Pechova et al., 2002) by dietary supplementation of Cr-yeast or chelated Cr.
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The present study indicates that CrPic can appreciably regulate steroid secretion
from agonist-stimulated cells, but minimally from non-stimulated cell. Thus the action
sites of CrPic may be closely related to the sites affected by forskolin. H295R cells
stimulated with forskolin have been reported to induce increases in cAMP, steroidogenic
acute regulatory protein (StAR), several enzymes involved in the adrenal steroidogenic
pathway, and organic anion transporter 3 (OAT3) (Rainey et al., 1993; Bird et al.. 1998;
Zenkert et al., 2000; Asif et al., 2006; Oskarsson et al., 2006). Because high
concentrations of CrPic inhibited the secretion of both cortisol and DHEAs from agoniststimulated cell in the present study, it may be that CrPic affects the factors related to
cortisol and DHEAs synthesis in common. These factors include cAMP, StAR,
cytochrome P450 enzyme (CYP)11A1, and CYP17A1.
Taken together, thermal stress, immune stress, and dietary stress induced clear
changes in growth performance and some physiological parameters consistent with
previous studies. Thus the stress models employed in the present study were valid for
testing stress alleviating effects of dietary Cr. Stress moderating effects of dietary Cr
supplementation were not observed in thermal or immune stressed animals, although we
are unable to rule out the possibility of dietary Cr effects in more severely stressed
animals. However, the increased body weight and fat retention by high-fat diet
consumption were moderated by supplemental Cr indicating potential values of dietary
Cr in obese human.
In agonist-stimulated adrenocortical cells, high concentrations of CrPic inhibited
aspects of steroidogenesis. Although Cr concentration in the mammalian blood even with
supplemental Cr of 2,000 ppb would be much lower than the 200 μM concentration that
dramatically inhibited cortisol secretion in vitro, long term treatment with lower
concentration potentially have similar effects to short term treatment with high
concentration as shown in our in vitro study. In addition, dietary Cr is accumulated in the
adrenal gland of pigs in a linear manner with supplemtal Cr concentration (Lindemann et
al., 2004). Therefore, the inhibitory effects of high concentration Cr on cortisol secretion
in vitro at least partially explain decreased circulating cortisol concentration by dietary Cr
in stressed animals. In the present animal studies, however, plasma cortisol
concentrations were largely unaffected by supplemental Cr.
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Further studies to assess the effects of Cr on pigs in severely hot or cold
environment or under chronic immune stress and to elucidate the mechanism of Cr
effects on the pigs fed the high-fat diet seem warranted. Further research to elucidate
detailed mechanism of CrPic on steroidogenesis in the adrenal cortex in vitro and in vivo
may also be needed.
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APPENDICES
Appendix 1. Cold stress study (Exp. 2 and 3) in Chapter 3
In Exp. 2, the cold stress affected growth performance, but dietary Cr treatment
had no effect on the growth of pigs (Table A.1). Pigs in low ambient temperature (LT)
had higher feed:gain (1.59 vs. 1.45; P < 0.001) than pigs in NT during d 14 to 21. Pigs in
LT had higher ADG (712 vs. 542 g/d; P < 0.001) and ADFI (1,064 vs. 842 g/d; P =
0.002) than pigs in NT during d 21 to 26. During d 14 to 26, pigs in LT tended to have
higher ADFI (975 vs. 885 g/d; P = 0.079) and feed:gain (1.54 vs. 1.49; P = 0.070) than
pigs in NT. However, dietary treatments of Cr had no effects on ADG, ADFI, or
feed:gain.
There was an interaction tendency between ambient temperature and
supplemental Cr for plasma cortisol on d 18 (P = 0.074; Table A.2). Plasma glucose
concentration tended to be lower in the pigs in LT (6.84 vs. 7.20 mmol/L; P = 0.059) than
the pigs in NT on d 15. But other blood measure measurements were unaffected by the
neither ambient temperature nor dietary Cr treatments.
In Exp. 3, similar effects of thermal treatments were observed as in Exp. 2 (Table
A.3). During D 14 to 28, LT resulted in increased ADFI (1,077 vs. 1,000 g/d; P = 0.044)
with increased feed:gain (1.61 vs. 1.53; P = 0.011) compared with NT. Supplemental Cr
had no effects on the growth performance. Ambient temperature × supplemental Cr
interaction was significant for ADFI (P = 0.044).
Plasma cortisol and glucose were unaffected by the temperature or dietary Cr
treatments (Table A.4).

161

Table A.1. Effects of low ambient temperature (Temp) and dietary chromium (III)
picolinate (CrPic) supplementation on body weight, feed intake and feed:gain of pigs
(Exp. 2)1
Temp2: Neutral (26.5°C)
Cold (16.0°C)
Temp effect CrPic effect
Interaction
Cr, ppb: 0 1,000 2,000
0 1,000 2,000
Pr SEM Pr SEM
Pr
SEM
Body weight, kg
D0
5.97 5.97 5.98 5.98 5.98 5.96 0.939 0.02 0.959 0.02 0.844 0.03
D7
7.09 7.12 6.98 7.32 7.07 7.36 0.073 0.07 0.638 0.08 0.202 0.11
D 14
10.13 10.46 10.03 10.27 10.13 11.02 0.248 0.15 0.470 0.19 0.081 0.26
D 21
14.49 15.15 14.27 14.26 13.84 15.35 0.712 0.29 0.683 0.35 0.106 0.50
D 26
17.13 18.03 16.88 17.80 17.51 18.83 0.216 0.37 0.821 0.46 0.209 0.65
D 0 to 7
ADG, g
161 165 144 190 156 201 0.085 9.6 0.669 11.7 0.187 16.6
ADFI, g
196 188 184 211 192 203 0.281 7.7 0.597 9.5 0.850 13.4
Feed:gain 1.22 1.17 1.29 1.12 1.22 1.04 0.167 0.05 0.931 0.06 0.214 0.08
D 7 to 14
ADG, g
434 477 435 421 437 523 0.621 15.6 0.216 19.2 0.091 27.1
ADFI, g
506 523 510 483 480 560 0.861 20.4 0.488 25.0 0.414 35.3
Feed:gain 1.16 1.09 1.18 1.14 1.10 1.07 0.140 0.02 0.258 0.02 0.221 0.03
D 14 to 21
ADG, g
623 670 606 570 531 618 0.122 25.0 0.934 30.6 0.262 43.3
ADFI, g
903 992 852 922 845 966 0.917 32.1 0.986 39.3 0.107 55.6
Feed:gain 1.45 1.48 1.41 1.62 1.59 1.56 <0.001 0.02 0.206 0.02 0.563 0.03
D 21 to 26
ADG, g
527 577 522 708 732 696 <0.001 23.6 0.517 28.9 0.949 40.9
ADFI, g
825 882 818 1076 1060 1056 0.002 36.1 0.865 44.2 0.827 62.6
Feed:gain 1.57 1.54 1.58 1.51 1.45 1.51 0.123 0.03 0.528 0.04 0.935 0.05
D 0 to 14
ADG, g
297 321 290 306 296 362 0.239 10.5 0.431 12.8 0.064 18.2
ADFI, g
351 356 347 347 336 382 0.847 13.0 0.686 15.9 0.490 22.5
Feed:gain 1.18 1.11 1.20 1.14 1.13 1.06 0.034 0.16 0.398 0.02 0.032 0.03
D 14 to 26
ADG, g
583 631 571 628 615 651 0.292 23.0 0.905 28.1 0.499 39.8
ADFI, g
870 946 838 986 934 1003 0.079 32.4 0.942 39.7 0.309 56.2
Feed:gain 1.49 1.50 1.47 1.57 1.52 1.54 0.070 0.02 0.690 0.02 0.590 0.03
1
Each mean represents three pens of three pigs/pen.
2
Ambient temperature during d 14 to 26. The ambient temperature before d 14 was maintained in
the thermoneutral zone. On d 14 the ambient temperature was changed to induce thermal
stress, and the low temperature was maintained until the end of the experiment.
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Table A.2. Effects of low ambient temperature (Temp) and dietary chromium (III)
picolinate (CrPic) supplementation on plasma cortisol and glucose concentration of pigs
(Exp. 2)1
Temp2: Neutral (26.5°C)
Cr, ppb:

0

1,000 2,000

Cold (16.0°C)
0

1,000 2,000

Temp effect CrPic effect Interaction

Pr SEM

Pr SEM

Pr SEM

Cortisol, ng/mL
D 15 (1)3 68.6 76.9 62.9

50.0 46.8 64.4 0.122 7.0

0.937 8.6 0.430 12.1

D 18 (4) 46.8 67.4 38.6

67.8 52.2 78.7 0.123 6.8

0.978 8.3 0.074 11.8

D 25 (11) 54.3 69.9 80.9

75.1 44.0 63.2 0.462 7.2

0.489 8.8 0.154 12.5

Glucose, mmol/L
D 15 (1) 7.20 7.49 6.90

6.69 6.83 6.99 0.059 0.13 0.541 0.16 0.216 0.22

D 18 (4) 6.87 6.74 6.73

6.85 6.47 7.78 0.417 0.22 0.240 0.27 0.190 0.38

D 25 (11) 6.62 7.00 6.81

7.31 6.85 6.86 0.522 0.22 0.940 0.26 0.506 0.37

1

Each mean represents six pigs.
Ambient temperature during d 14 to 26. The ambient temperature before d 14 was maintained in
the thermoneutral zone. On d 14 the ambient temperature was changed to induce thermal
stress, and the low temperature was maintained until the end of the experiment.
3
The numbers in the parenthesis represent the days after the thermal stress.
2
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Table A.3. Effects of low ambient temperature (Temp) and dietary chromium (III)
picolinate (CrPic) supplementation on body weight, feed intake and feed:gain of pigs
(Exp. 3)1
Temp2: Neutral (25.9°C)
Cold (13.8°C)
Temp effect CrPic effect
Interaction
Cr, ppb: 0 1,000 2,000
0 1,000 2,000
Pr SEM Pr SEM
Pr
SEM
Body weight, kg
D0
6.40 6.42 6.40 6.38 6.39 6.40 0.786 0.04 0.982 0.04 0.951 0.06
D7
8.08 8.05 8.12 7.87 8.10 8.04 0.351 0.06 0.489 0.07 0.458 0.10
D 14
11.29 10.80 11.12 10.28 10.97 10.76 0.212 0.21 0.915 0.26 0.322 0.37
D 21
16.09 14.44 15.28 14.37 15.59 15.25 0.659 0.31 0.885 0.38 0.064 0.53
D 28
21.08 19.33 20.25 19.25 20.53 20.35 0.752 0.38 0.856 0.47 0.117 0.66
D 0 to 7
ADG, g
240 233 246 212 245 234 0.368 7.0 0.446 8.6 0.304 12.2
ADFI, g
272 268 318 251 343 301 0.534 13.7 0.130 16.7 0.120 23.7
Feed:gain 1.15 1.15 1.29 1.19 1.43 1.29 0.230 0.06 0.452 0.07 0.398 0.10
D 7 to 14
ADG, g
459 393 428 345 409 389 0.279 28.3 0.987 34.7 0.440 49.0
ADFI, g
629 515 608 483 575 518 0.177 28.6 0.938 35.0 0.151 49.5
Feed:gain 1.38 1.32 1.42 1.40 1.43 1.36 0.740 0.05 0.962 0.06 0.640 0.09
D 14 to 21
ADG, g
685 520 594 584 661 642 0.369 21.8 0.523 26.8 0.028 37.8
ADFI, g
970 752 855 870 955 968 0.127 30.7 0.430 37.6 0.045 53.2
Feed:gain 1.42 1.45 1.45 1.49 1.44 1.51 0.224 0.02 0.724 0.03 0.511 0.04
D 21 to 28
ADG, g
713 699 710 697 706 729 0.946 32.5 0.947 39.8 0.954 56.2
ADFI, g 1175 1067 1179 1171 1238 1258 0.095 31.5 0.493 38.6 0.320 54.6
Feed:gain 1.69 1.53 1.66 1.68 1.76 1.73 0.159 0.04 0.792 0.05 0.325 0.08
D 0 to 14
ADG, g
349 313 337 278 327 311 0.230 15.3 0.926 18.7 0.317 26.5
ADFI, g
450 392 463 367 459 410 0.392 18.3 0.693 22.4 0.085 31.7
Feed:gain 1.30 1.25 1.37 1.32 1.40 1.33 0.297 0.03 0.698 0.03 0.185 0.05
D 14 to 28
ADG, g
699 609 652 640 683 685 0.566 19.2 0.734 23.5 0.175 33.2
ADFI, g 1072 910 1017 1021 1097 1113 0.044 23.7 0.343 29.0 0.044 41.0
Feed:gain 1.54 1.50 1.56 1.59 1.61 1.62 0.011 0.02 0.452 0.02 0.628 0.03
1
Each mean represents three pens of two pigs/pen.
2
Ambient temperature during d 14 to 28. The ambient temperature before d 14 was maintained in
the thermoneutral zone. On d 14 the ambient temperature was changed to induce thermal
stress, and the low temperature was maintained until the end of the experiment.
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Table A.4. Effects of low ambient temperature (Temp) and dietary chromium (III)
picolinate (CrPic) supplementation on plasma cortisol and glucose concentration of pigs
(Exp. 3)1
Temp2: Neutral (25.9°C)
Cr, ppb:

0

1,000 2,000

Cold (13.8°C)

0

1,000 2,000

Temp effect CrPic effect Interaction

Pr SEM

Pr SEM

Pr SEM

Cortisol, ng/mL
D 15 (1)3 57.9 72.1 56.6

51.5 61.9 50.8 0.424 6.5

0.435 8.0 0.978 11.3

D 18 (4) 57.3 57.6 54.1

66.5 68.6 51.9 0.432 5.3

0.496 6.5 0.740 9.2

D 27 (13) 67.9 53.6 79.3

80.1 85.2 64.9 0.236 5.7

0.897 7.0 0.082 9.9

Glucose, mmol/L
D 15 (1) 6.95 7.13 6.75

7.22 6.59 6.92 0.842 0.13 0.474 0.16 0.163 0.22

D 18 (4) 7.47 6.67 6.56

7.04 7.12 7.17 0.287 0.14 0.212 0.17 0.078 0.24

D 27 (13) 7.35 6.83 6.74

6.79 7.13 7.08 0.918 0.17 0.863 0.21 0.248 0.30

1

Each mean represents six pigs.
Ambient temperature during d 14 to 28. The ambient temperature before d 14 was maintained in
the thermoneutral zone. On d 14 the ambient temperature was changed to induce thermal
stress, and the low temperature was maintained until the end of the experiment.
3
The numbers in the parenthesis represent the days after the thermal stress.
2
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Appendix 2. Body weight and weight gain of pigs during d 0 to 35 in the experiment
in Chapter 4

Table A.5. Body weight gain of the animals before phosphate buffered saline (PBS) or
lipopolysaccharide (LPS) challenge1
Injection2: PBS
Cr, ppb:

LPS

SEM

P-values3

0

0

1,000

2,000

PBS vs. LPS LPS

Linear Quadratic

6.03

5.96

5.90

5.90

0.09

0.300

0.572 0.688

0.783

8.49
12.00
15.81
19.97
23.97

8.20
12.00
16.67
21.48
26.45

8.26
12.34
17.02
21.58
26.22

8.36
12.31
17.05
21.94
27.28

0.19
0.31
0.48
0.64
0.76

0.344
0.553
0.061
0.035
0.007

0.304
0.993
0.219
0.114
0.033

0.622
0.537
0.634
0.676
0.510

0.938
0.682
0.821
0.888
0.555

426
569
572
513

431
677
709
585

460
660
663
581

458
687
763
611

19
28
33
21

0.307
0.004
0.002
0.004

0.853
0.014
0.008
0.024

0.398
0.832
0.188
0.459

0.571
0.580
0.048
0.554

BW, kg
D0
D7
D 14
D 21
D 28
D 35
ADG, g/d
D 0 to 14
D 14 to 28
D 28 to 35
Overall
1

Each least squares mean represents six pigs.
At 0 h, phosphate buffered saline (PBS) or lipopolysaccharide (LPS) was intraperitoneally
injected. The volume of LPS solution was determined to deliver 50 μg/kg BW, and PBS was
filled to make 5 ml.
3
P-values are from single degree of freedom contrast. PBS vs. LPS represents the contrast
between pigs injected with PBS and pigs injected with LPS and fed 0, 1,000, or 2,000 ppb of
supplemental Cr; LPS represents the contrast between pigs injected with PBS and pigs injected
with LPS and fed 0 ppb of supplemental Cr. Linear and quadratic effects of dietary CrPic were
tested within the LPS challenged groups.
2
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Appendix 3. Photo-micrograph of adrenocortical carcinoma cells in Chapter 6

Figure A.1. Photo-micrograph of H295R cells at 48 h (a), 72 h (b), and 96 h (c) of
incubation
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Appendix 4. H295R adrenocortical cell culture procedure
A.4.1. Formulus for culture medium and cryoprotectant medium
Complete culture medium
For 50 mL total add:
1.25 mL (2.5%)

Nu-Serum

(BD Biosciences: Discovery Lab #355100)

0.50 mL

ITS+ Premix (BD Biosciences: Discovery Lab #354352)

0.05 mL (0.1%)

Antibiotics

(Sigma #A5955)

to
48.2 mL

DMEM/Ham’s F12 (Invitrogen #11330032)

Cryoprotectant medium
For 5 mL total add:
4.50 mL (90.0%)

Nu-Serum

0.05 mL

ITS+ Premix

0.25 mL (5.0%)

DMSO (ATCC #4-X)

0.20 mL

DMEM/Ham’s F12
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A.4.2. H295R adrenocortical cell culture procedure
Split/Subculture
1. Warm 0.25% Trypsin-0.53 mM EDTA (ATCC 30-2101) to 37°C.
2. Make up 100 mL complete media for H295R cells (ATCC 30-2101) to 37°C.
3. Remove all culture medium from 75 cm2 flask.
4. Rinse with 1.5 mL warm Trypsin-EDTA and remove it.
5. Add 5 mL warm Trypsin-EDTA and let sit 5 to 15 minutes at 37°C (observe when they
start lifting from bottom; do not knock flask or cells will clump).
6. Add 8 mL warm complete culture media.
7. Put cells in 15 mL conical tube, spin 125 × g for 10 minutes.
8. Pour off media and resuspend in 1 mL warm complete culture media.
9. Split cells 1:4 into 75 cm2 flasks containing 15 mL complete culture media.
10. Incubate at 37°C with 5% CO2 and ambient air.
11. Change media every other day.
12. Cells split every week or so.

Freeze cells in liquid nitrogen
1. Make 10 mL of cryoprotentant medium and warm it to 37°C.
2. Follow Split/Subculture protocol through #7 and freeze approximately 5 millon cells
per vial.
3. Pour off media and resuspend in 2 mL warm cryoprotectant media.
4. Split cells 1:2 into cryoprotectant vials marked with name, date, and passage number
(this way, when you bring them up from frozen you add one passage).
5. Put in Styrofoam container with lid (tight fit) and place in -80°C overnight.
6. Add to Jackson’s holders and submerge in Liquid Nitrogen the next day.

Thaw cells from frozen vials in liquid nitrogen
1. Make up 50 mL complete media for H295R cells and warm to 37°C.
2. Thaw for 1 to 2 minutes in 37°C water bath.
3. Spray outside of vial with ethanol.
4. Add 9 mL of warm complete media to 15 mL conical tube.
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5. Add thawed cells to 9 mL media in the 15 mL conical tube.
6. Spin 125 × g for 7 minutes.
7. Pour off media and resuspend in 1 mL warm complete culture media.
8. Add 14 mL complete culture media to 75 cm2 flask (plain vessel with vented cap)
9. Add cells to flask.
10. Incubate at 37°C with 5% CO2 and ambient air.
11. Change media every other day.
12. Cells split every week or so.
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